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ABSTRACT
Nausea and vomiting in pregnancy (NVP), wliich is known to affect nearly 70% of all 
pregnant women, has been associated with favourable pregnancy outcomes such as 
decreased risk of miscarriage, low birth weight and prematuie delivery.
The aim of this research was to determine the mechanism by which these protective 
effects of NVP may be brought about. Women suffering from NVP may decrease 
theii" intake due to the symptoms, may increase their intake to alleviate symptoms, or 
may change the quality of then diet.
Both a retrospective questionnaire survey (n~201) and a prospective cohort study 
(n=52 )were caiiied out between April 1999 and August 2001. Women were recruited 
mainly from two GP clinics in Guildford.
It was found from both studies that the prevalence of NVP in the Guildford area is 
similar to that reported in other studies. Although this study found no relationship 
between NVP and birth weight and gestational age, women with NVP had higher cord 
IGF-1 levels compaied to women without NVP (p=0.044). In addition, duration of 
NVP was inversely related to birthweight to placental ratio (p=0.011).
Forty three women provided complete dietaiy information. It was found that energy 
intakes did not differ between women who had NVP compared with women who had 
no NVP, however the quality of diet vaiied between women with NVP and those 
without NVP. This is probably due to the feet that women with NVP had a high risk
of cravings and aversions in pregnancy, leading to the difference in intake of certain 
nutrients such as riboflavin, calcium, zinc and copper. The strong association between 
NVP and aversions in pregnancy (P= 0.026) found in the retrospective study could 
lend further support to the “Embryo protection” hypothesis, which states that NVP is 
a protective mechanism, which has evolved to prevent the mother from the ingestion 
of foods that could be haimful to the fetus.
Further studies using larger sample sizes, covering a range of socio-economic status 
and different regions aie needed before definite conclusions can be drawn.
( c ) Buthaina Al-Rasasi 2003
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1. INTRODUCTION
Nausea and vomiting in pregnancy (NVP) is one of the most common complaints in 
pregnancy, affecting 50-90% of all pregnant women during the first 20 weeks of 
gestation (Broussard and Richter, 1998). NVP usually begins at 4-6 weeks gestation, 
peaks at 8-12 weeks gestation and diminishes by week 20 gestation (Anderson, 1994). 
NVP is usually limited to the first trimester of pregnancy, but in 20% of women, 
symptoms continue tlnoughout pregnancy (Broussard and Richter, 1998). It is 
recommended that if a woman experiences symptoms beyond 20 weeks gestation, 
other causes of nausea and vomiting should be investigated and excluded (Broussard 
and Richter, 1998).
I J  Terminology and classification
NVP is usually known by the lay term “morning sicloiess”, which stems from the 
typical onset of symptoms in the morning with improvement during the day. 
However, this is not a universal pattern as symptoms may be experienced during the 
night, all day or as biphasic peaks at the beginning and end of the day (Gadsby et al, 
1993). A study by Gadsby et al (1993) foimd that although the period from 6:00a.m to 
12:00 noon was the most common time for symptoms to occur, only 4% of women 
experienced only morning sickness. The term nausea and vomiting in pregnancy 
(NVP) is the preferred term. Although the term may be bland, it has several 
advantages. First, it is imbiased towards any putative cause, second, it allows for a
spectrum of severity, and third, it differentiates between the subjective symptom of 
nausea and objective sign of vomiting (Deuchar, 1995).
Witliin the term NVP, symptoms can be classified as mild (nausea only), moderate 
(nausea and vomiting), and severe (hyperemesis gravidaiumi) (Deuchai*, 1995). Mild 
to moderate is a normal physiological condition rather than a pathological state 
associated with pregnancy.
Hyperemesis gravidarum (HG) occurs in 0.3-2% of women (Broussard and Richter, 
1998). HG can be defined as the extreme of NVP resulting in dehydration, ketosis and 
electrolyte and metabolic distinbances (Broussard and Richter, 1998). In this thesis, 
the main emphasis will be on mild to moderate NVP.
1,2 Factors affecting NVP
Correlations with NVP are controversial, which could be due to methodological and 
analytical variations, such as statistical methods used. Moreover, factors that are 
associated with increased risk of NVP are inter-related, and only a few studies have 
identified independent risk factors for NVP (Broussard and Richter, 1998).
In separate studies, NVP has been positively associated with a number of maternal 
factors, such as primigravidas (Klebanoff et al, 1985), NVP in previous pregnancies 
(Gadsby et al, 1997), multiple gestation ( Jarnfelt-Sarnsioe et al, 1983), intolerance of 
oral contraceptives (Jarnfelt-Samsioe, 1983), women with less than 12 years 
education (Klebanoff et al, 1985), mother’s experience of NVP (Gadsby et al, 1997),
non smokers (Gadsby et al, 1997, Klebanoff et al, 1985), heavier placenta (Gadsby et 
al, 1997), younger women (Klebanoff et al, 1985) and women weighing at least 1701b 
(Klebanoff et al, 1985).
It has been reported that NVP is more common in Westernized countries, particularly 
in rural populations, and is rare in African, Native American, Eskimo, and some 
Asian populations except for Japan (Broussard and Richter, 1998). NVP has also been 
associated with large and infrequent meals and str*ess associated with pregnancy, 
notably poor communication with partner and health carers (latrakis et al, 1988). 
Women reporting their occupation as housewife have also been found to be at 
increased risk for NVP (Wiegel and Wiegel, 1988).
LSAetiology of NVP
The recorded association of NVP with pregnancy goes back as far’ as 2000 B.C 
(Broussard and Richter, 1998), however, it is surprising to note that the exact 
aetiology of NVP has not yet been elucidated. A number of physiological and 
psychological factors have been implicated.
1.3.1 Metabolic and endocrine factors
There is strong evidence to suggest a link between hmnan chorionic gonadotrphin 
hormone (hCG) and NVP (Forbes, 2002). The principle reason being the fact that 
serum hCG levels pealc dur ing the first trimester when the frequency of NVP peaks 
(Masson et al, 1985). Several studies failed to find this association, this could be due 
to small sample sizes, no clear definition of NVP (Forbes, 2002), or due to the fact 
that there is varying biologic activity of different hCG isoforms (Goodwin, 2002).
Other endocrine factors investigated include progesterone and oestrogen. As for 
oestrogen, Jarnfelt-Samsioe et al (1983) found that women who did not tolerate oral 
contraceptives due to side effects such as nausea had a higher incidence of NVP. 
Further support for this effect is the association between NVP and nulliparous, 
overweight and non-smoking women, all of whom have elevated urinary and 
circulating oestrogen levels (Depue et al, 1987). Again, tlie role of oestrogen remains 
controversial (Broussard and Richter, 1998). The effect of progesterone on gastric 
motility, as will be seen in section 1.3.1.2 , makes it seem as an important factor in the 
aetiology of NVP. Progesterone levels rise rapidly during the first trimester when 
symptoms of NVP peak (Broussard and Richter, 1998).
Another hormone studied is thyroxine. Mori et al (1988) measured the serum levels of 
free thyroxine (T4), thyroid stimulating hormone (TSH) and hCG in 132 women in 
ear'ly pregnancy and in non pregnant women. They found that there was a significant 
decrease in serum TSH and an increase in free T4 in early pregnancy compared to the 
non-pregnant controls. They found that the increased free T4 and hCG and decrease in 
TSH correlated with the severity of morning sickness. They also found that there was 
a positive correlation between the levels of hCG and fi-ee T4 and a negative 
corrleation with TSH. Mori et al (1988) postulated that the thyroid gland may be 
physiologically activated in early pregnancy, possibly by hCG, and may induce NVP. 
The levels of the thyroid hormones retmned to normal after improvement of emesis. 
The authors reported that the increase in T4 and decrease in TSH during pregnancy 
are not indications of thyrotoxicosis and may not necessitate treatment. Broussard and
Richter (1998) reported that results remained controversial regarding the relationship 
between the thyroid hormones and HG.
Responses to the main trigger of NVP may be varied due to the increased receptor 
sensitivity or increased susceptibility of the mother to the stimulation of the major 
pathways to NVP. The main pathways include vestibular*, gastrointestinal and 
olfactor*y (Goodwin, 2002).
1.3.1.1 Vestibular
It has been reported that women with motion sickness are more likely to have NVP 
(Goodwin, 2002). The vestibular* system may par*ticipate in the pathogenesis of NVP 
either* because pre-existing sub-clinical vestibular* dysfrrnction renders the women 
more susceptible to the hormonal trigger* for NVP or* because the normal vestibular 
system is adversely affected by a strong hormonal tr igger for* NVP. In a study by 
O’Brien and Naber (1992), twenty five percent of one hundr*ed and for*ty seven 
women reported recumbent rest as a method of improving NVP. This provides some 
evidence that the vestibular* system may have a role to play in NVP.
1.3.1.2 Gastro intestinal tract ( GIT)
The hormone progesterone causes relaxation of smooth muscles; this has an effect on 
the oesophagus, stomach and small bowel. In the oesophagus, elevated progesterone 
levels alter the lower* oesophageal sphincter fmiction, which contributes to heartburn 
and NVP. Progesterone also causes delays in gastric emptying, also contributing to 
NVP. In addition, progesterone has an effect on small bowel transit time, which could 
also be an explanation for* NVP (Broussard and Richter, 1998). Gastric motor 
dysfunction has been implicated in NVP (Goodwin, 2002). Jednak et al (1990) using
the eiectrogastrogram found a mixtui*e of bradygastrias and tachygastrias in women 
with symptoms. In their study, Jednak et al (1990) demonstrated that protein- 
dominant meals, especially in liquid form, reduced NVP possibly by reducing gastric 
slow wave dysrhytlimias. However, Maes et al (1999) found that gastric emptying of 
solids was not significantly delayed in pregnant women and suggested that gastric 
dysrhytlimias were not a causative factor of NVP.
1.3.1.1 Taste and olfaction
Goodwin (2002) reports that one of the most common observations of clinicians 
caring for women with NVP is that they develop aversions to certain smells and 
tastes. Spatial taste patterns and taste acuity was studied in sixty women with twenty 
one high vomit and thirty nine low vomit based on obstetric histories. Women in the 
high vomit group were less likely to be non-tasters and more likely to have high 
perception of bitterness on the posterior tongue (Sioporra, 2000). Flaxnian and 
Sherman (2000) documented more than twenty studies of women with cravings and 
aversions, however, few describe these changes and NVP. Cravings and aversions 
will be discussed in section 1.6.
1.3.2 Psychological factors
In the early 1970s over 50% of obstetricians contributed NVP to psychological factors 
(Semmens, 1971). Adverse psychological factors such as umesolved conflict, 
undesired pregnancies, denial of pregnancy and negative relationships with the 
pregnant woman’s mother were associated with NVP (Fitzgerald, 1984).
1.4 Management of NVP
NVP is usually self-limiting; management depends on severity of symptoms 
experienced and ranges from conservative dietary modifications and lifestyle changes 
in mildly symptomatic women to drug therapy and total parenteral nutrition (TPN) in 
women with HG (Broussar d and Richter, 1998).
1.4.1 Non-Pharraacological treatment (conservative)
Mild to moderate NVP during the first trimester is usually treated with conservative 
management such as dietary or lifestyle changes, or both (Mazotta et al, 1999). 
Suggestions include small frequent meals, rich in carbohydrates (Anderson, 1994, 
O’Brien et al, 1997, Broussard and Richter, 1998), avoidance of high fat meals 
(Broussard and Richter, 1998), avoidance of odours that worsen symptoms 
(Anderson, 1994, Broussard and Richter, 1998), avoidance of iron tablets (Anderson, 
1994, Broussard and Richter, 1998), eating before getting out of bed (O’Brien et al, 
1997), rest (Anderson, 1994, O’Brien et al, 1997), fresh air, exercise and being in 
water (O’Brien et al, 1997), maintaining a good level of hydration (O’Brien et al, 
1997), separating drinlcs and food (Anderson, 1994, O’Brien et al, 1997), and 
avoiding long journeys (Anderson, 1994).
1.4.2Pharmacologic treatment
Since the thalidomide disaster in the late 1950s and early 1960s, pharmacologic 
interventions used to treat women suffering from NVP have been viewed with gr*eat
trepidation (Mazzotta et al, 1999). Phainiacologic therapy should be considered in 
women who have continued nausea and vomiting despite conservative measures. The 
risk-to-benefit ratio must justify the use of any dmg during pregnancy (Broussard and 
Richter, 1998). All drugs should generally be avoided in the first twelve weeks of 
pregnancy when fetal organs are still developing (Anderson, 1994).
Today, common pharmacologic agents used for the treatment of NVP include 
antiemetics, antihistamines and anticholinergics, promotility agents, other agents such 
as corticosteroids, droperidol, diphenydrarnine, ondansetron and Bendectin 
(dicyclomine hydrochloride, doxylamine succinate and pyridoxine hydrochloride) 
(Broussard and Richter, 1998). Bendectin was first marketed in the USA in 1956 and 
was the only dmg approved by the FDA, however, it was taken off the market in 1983 
due to anecdotal reports of possible congenital malformations associated with its use. 
In Canada, the equivalent of Bendectin, marketed as Dilectin is still in use and is often 
used as first line therapy for NVP (Broussard and Richter, 1998). According to a 
study of 26 European countries, Einarson et al (1998) found that in the UK, dietary 
changes and the consumption of ginger were the most frequently recommended 
therapies for mild nausea, promethazine and metoclopromide for moderate NVP and 
intra-venous fluids, 5HT3 antagonists and dornperidone for severe NVP.
1.4.3Alternative therapies
Alternative therapies are becoming more popular to pregnant women, yet there is a 
dearth of research to support or refute the efficacy of alternative therapies 
(Ziederistien, 1998). The main studied therapies are
1.4.3.1. Acupressure
This involves stimulation of or pressure on an acupuncture point known as 
preicardium 6 or the Neiguan point, on the volar surface of the forearm approximately 
three fingerbreadths above the wrist (Murphy, 1998).
Acupressure wrist bands (Seabands) are usually used for this purpose. Several clinical 
trials have been conducted, such as that canied out by Belluomini et al (1994) on 60 
women for 3 days, where manual acupressure on the P6 point was tested against a 
dummy point. They found a significant decrease in symptoms of nausea in the 
tr*eatment group, however, no difference was seen in frequency and severity of 
vomiting. Another study was canied out by O’Brien et al (1996) on 161 women for 7 
days, where they compared wr’ist bands on the P6 point, wrist bands on a dummy 
point and no intervention. They found no differences across the groups. Thus, the 
results remain equivocal (Murphy, 1998). In addition, Murphy (1998) reported that 
although beneficial effects may have been seen, the placebo effect camiot be ruled 
out.
1.4.3.2. Ginger
The first clinical trial canied out using ginger was to test its effect on motion sickness. 
Mowrey and Clayson (1982) found that 1 gram of powdered ginger was more 
effective in the prevention of motion sickness than the standard anti-histamine 
treatment diemenhydrinate. Fischer-Rasmussen et al (1990) conducted a double-blind 
cross-over study on 27 women in Denmark to investigate the effect of ginger in
women with NVP. They showed that 1 gram of ginger was superior to a placebo in 
relieving symptoms in women with HG. Murphy (1998) reported that the efficacy of 
ginger was due to its aromatic, carminative and absorbent properties. According to 
Mowrey and Clayson (1982), the action of ginger is unlike antiemetics, which act on 
the CNS. The authors speculated that ginger had its action on the gastiointestinal tract 
itself, probably by increasing gastric motility.
Ginger root contains a tlnomboxane synthetase inliibitor, which may affect 
testosterone receptor binding in the fetus (Broussard and Richter, 1998). However, the 
evidence is still weak as for its benefits, therefore further studies ai*e needed before 
any definite conclusions can be drawn (Jewell and Young, 2000).
Other herbal remedies include chamomile, peppermint and raspbeny leaf, however 
results are still contradictory, and there are not enough studies canied out related to 
their safety, therefore, they should be taken with caution (Wilkinson, 2000).
1.4.3.3 Vitamin B6 (Pyridoxine)
Two main studies examined the effect of vitamin B6 on NVP. Vutyavanich et al 
(1995) conducted a double-blind placebo-controlled trial on 336 women, where a dose 
of 30 mg/day was used. They found that although symptoms of nausea seemed to 
improve, there was no effect on vomiting. The other study was carxied out by 
Salrakian et al (1991), was of similar* design, and conducted on 59 women. The 
authors found a beneficial effect in women with severe nausea and vomiting, but not
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ill cases of mild NVP. Thus there could be a dose response (Jewell and Young, 2000). 
Although evidence seems to show a beneficial effect, further work is still needed.
1.9.3.4. Otlier treatments
Other treatments include hypnosis, sensoiy afferent stimulation and homeopathy. 
However, fiu'ther studies ai*e needed before any definite conclusions about hypnosis 
and sensory affluent stimulation can be drawn (Broussard and Richter, 1998). As for 
homeopathy, in her review, Murphy (1998) did not find any trials that were conducted 
to test the effect on NVP.
LSEffects of NVP
A number of human, clinical studies have reported that NVP in the first 20 weeks of 
gestation is associated with favourable outcomes such as reduced risk of miscarriage 
(Wiegel and Wiegel, 1989), reduced perinatal death (Teirson et al, 1986, Wiegel and 
Wiegel, 1989), higher birth weight (Tierson et al, 1986), and reduced premature 
delivery (Tierson et al, 1986). However, some studies foiuid no relationship between 
NVP and pregnancy outcome. In a retrospective study canied out by Wiegel and 
Wiegel (1989) on 903 women in Los Angeles, they found that there was a decreased 
incidence of miscarriage in women who had experienced vomiting din ing pregnancy, 
but no other statistically significant associations between NVP and other outcomes of 
pregnancy were reported. We can see that the results of different studies are 
somewhat varied, these differences could be due to differences in sample size, 
experimental design or definition of NVP (Wiegel and Wiegel, 1989). Although 
results are conflicting, on the whole, there seems to be some benefit from NVP. The
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absence of symptoms may be due to either a decreased sensitivity to alterations in 
hormone levels or due to abnormal pregnancies (Broussard and Richter, 1998).
Another possible outcome of NVP has been shown by Crystal et al (1999). College 
students, who could provide information about their mothers’ symptoms of NVP 
during pregnancy, either completed a survey or rated and consumed 10 snack foods. 
The authors found that offspring of women who reported to have experienced 
moderate or severe vomiting showed a statistically significant greater preference for 
snack foods rated as saltiest than those whose mothers reported no or mild vomiting. 
They also ate more foods that contained higher sodium levels in the test period. 
Effects were found to be sti'onger in Caucasian subjects compared to Asians. Crystal 
et al (1999) concluded that moderate to severe vomiting dming pregnancy can be 
associated with significantly higher salt intake in offspring and that a gestational event 
such as volume depletion or electrolyte loss due to maternal vomiting may he an 
important determinant of salt intake and preference in adulthood.
Boneva et al (1999) carried out a case-contiol study in Atlanta on over 4,000 infants. 
The authors foimd that symptoms of nausea that stalled within the first two months of 
pregnancy, and occurred on a daily basis, or more frequently, was associated with a 
reduced risk of giving birth to a child with congenital heart defect. This effect tended 
to disappear with less severe levels of NVP. In addition, the gi'oup of mothers who 
took anti-nausea medication, especially Bendectin, had a lower risk of giving birth to 
a child with a congenital heai't defect than did those who did not use medication or 
those who did not have nausea during pregnancy, suggesting that pregnancy 
hormones and factors, or alternatively, a component of Bendectin (possibly 
pyridoxine) may be important for normal heart development (Boneva et al, 1999).
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Mai’tin et al (1999) found that women who continued to suffer from NVP during the 
second and third trimesters, were at increased risk of having a child with lower 
sensory thresholds and emotional intensity in infancy, and were reported to be lower 
in task persistence at age five. At age twelve, these children were viewed by teachers 
as more careless with their work and having more attention and learning problems.
Enger et al (1997) studied 450 women in America who were diagnosed with breast 
cancer before the age of forty, and healthy controls without cancer. They found that 
women who required medical treatment for severe nausea and vomiting during 
pregnancy were twice as likely to be diagnosed with breast cancer within five years as 
women who required no such treatment or did not suffer from NVP. They speculated 
that this could be due to the high levels of oestrogen which some authors believe is 
associated with NVP (see section 1.5.1)
Although many different effects have been reported, Gadsby et al (1993) reported that 
most of the studies on NVP were carried out retrospectively, and were likely to he 
biased towards more severe symptoms and less accurate because of their retrospective 
nature. Thus a lot of further work is still needed to elucidate the true effects of NVP.
1,6 Cravings and aversions during pregnancy
Cravings were defined by Dickens and Trethowan (1971) as ‘a compulsive urge for a 
food or drink not previously disliked’. Aversions were defined by Dickens and 
Trethowan (1971) as ‘a definite revulsion against food or drink not previously
disliked’. Pica were described by Schwab and Axelson (1984) as The craving for and 
ingestion of substances not usually considered appropriate for human consumption, 
such as baking soda, corn meal, and ice’.
The occurrence of dietary cravings and aversions during pregnancy is well known, yet 
relatively little is known of the aetiology or epidemiology of this complex of 
symptoms (Tierson et al, 1985).
According to a study conducted by Dickens and Trethowan (1971) on 100, 
primipar ous, married, British women, the incidence of cravings in these women was 
51%, and aversions was 62%. Dickens and Trethowan (1971) also found that the most 
craved food items were fruit and fruit drinks, sweets, chocolates, ice-cream, milk and 
dairy products. Tea, coffee, cocoa, vegetables, meat, fish and eggs were the most 
common food items avoided. In this study, the authors found that cravings and 
aversions occuired more frequently in those women with a histoiy of pica in 
childhood, of appetite change in response to emotional stress and in women who 
smoked before pregnancy. The authors also found a tiend for higher reportings of 
cravings and aversions in those women who dranlc alcohol before pregnancy 
compared to those who were teetotal. There was also a statistically increased 
incidence of cravings in those women with a history of food fads in childhood. 
Dickens and Trethowan (1971) also reported that aversions and cravings occiuxed 
more commonly together than separately.
As for the time of onset of these symptoms during pregnancy, Dickens and Trethowan 
(1971) found that aversions were more commonly experienced during the first 
trimester and progressively less so in the second and third trimester. The same was
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tl'ue for cravings although the time of onset were more evenly distributed. The authors 
foimd that once begun, the duiation of the symptoms were similar', with a slightly 
higher tendency for aversions as opposed to cravings to persist over tow or more 
trimesters, which is probably due to the fact that aversions usually appeared earlier on 
in pregnancy compared to cravings.
A study carried out by Hook (1978) on 250 women in New York fomid that the most 
craved foods were ice-cream, sweets, candy and chocolate, fruits, milk and fish. 
Aversions included meats, poultry, alcohol, coffee and sauces flavoured with oregano.
The aetiology of cravings and aversions has several explanations. One explanation for 
cravings is the metabolic energy requirement associated with the developing fetus. 
However, Hook (1980) states that despite an increased need for protein, many women 
reported an aversion to meats and poultry.
Hook (1980) suggests that with respect to aversions, an important fraction appears to 
be mediated by the development of NVP as a response to ingestion of specific foods. 
However, Dickens and Trethowan (1971) found that neither the absence nor presence 
of cravings and/or aversions was shown to bear any relationship to the occurrence of 
NVP druing pregnancy whether mild, moderate or severe. Diminished ingestion of 
some specific foods also appears to be mediated by less specific symptoms such as 
lack of desire for them, non-specific hear’t burn or increased sensitivity to its side 
effects such as alcohol (Hook, 1980).
Another theory put forward is that aversions are a result of mechanisms, which have 
evolved to protect the fetus from factors selectively toxic to it. The drop in intakes of
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alcohol, coffee and smoking that occui* in eaidy pregnancy, result in lowering fetal 
exposure to embryotoxins (Hook, 1980). The reasons cited by women is a change in 
desire for them, rather than concern for the infant, or due to the doctor’s advice.
Other explanations include the alteration in the sense of taste and smell of pregnant 
women (Dickens and Trethowan, 1971). There is an impaired sense of taste in 
pregnancy thus pregnant women tends to crave strong tasting substances, which could 
be sweet, sour or savoury (Dickens and Trethowan, 1971). It has been shown that 
there are differences in bitter-taste perception in women with a history of severe 
vomiting during pregnancy (Sipiora et al, 2000).
Tierson et al (1985), suggested that cravings and aversions may not be biologically 
determined at all, instead simply learned behaviours due to factors such as cultural 
practices.
The most common explanation for pica is that it is due to a vitamin or mineral 
deficiency (Dickens and Trethowan, 1971). However, Dickens and Trethowan (1971) 
reported that in view of the extraordinary substances craved, such as soap, coal, 
petrol, moth balls and metal polish, it may not be due to a need to compensate for a 
dietary deficiency, but some other unknown factor.
Whatever the cause of the aversions and cravings, it can be seen that they are not 
limited to a few isolated individuals, but affect a large proportion of the pregnant 
population.
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1.7 Maternal nutrition and pregnancy outcome
There has been increased interest in maternal nutrition since Barker and his colleagues 
showed strong associations between infant and placental size and the risk of later 
chronic diseases, such as cardiovascular* disease, hypertension and non-insulin 
dependent diabetes. The early in utero period is especially important as it represents a 
period of rapid cell division, occurring at different times in different tissues. During 
these critical periods of selective tissue growth, the nutritional and hormonal 
enviromnent may result in reduction in cell number, changes in the distribution of cell 
type and in the resetting of hormonal feedback. This is the basis of the fetal origins 
hypothesis put forward by Barker and his colleagues, which contends that 
undernutrition during these critical periods of fetal development may lead to changes 
which program later health risks (Scott, 2002)
The importance of maternal nutrition in developing countries is widely recognised. In 
industrialised countries, although the effect of maternal nutrition may not be as 
obvious, studies have shown pregnancy outcomes to be affected by maternal nutrition. 
One example is the severe famine that affected the Netherlands in the winter of 1944- 
1945, and occurred in a society which had been generally adequately nourished 
(Lumey, 1998). Compared to pre-famine controls, there was a decrease of about 300g 
in birth weight and 80g in placental weight in those infants exposed in the third 
trimester of pregnancy. Although there was no effect on birth weight in infants 
exposed in the first trimester, there was an increase in placental weight, thus placental 
weight to birth weight ratio was also increased (Lumey, 1998). The increase in 
placental weight was interpreted as compensatory for the reduction in maternal energy
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intake (Limiey, 1998). We have seen that nutrient restriction in eaiiy to mid gestation 
does not have an effect on birth weight, this provides evidence for the historical 
notion that during pregnancy, nutrient pariitioning favours the conceptus at the 
expense of the dam (Wallace, 2000). Although this shows that the fetus is little 
affected by changes in maternal nutrition, several studies challenge this view. For 
example, Godfrey et al (1996) have shown that women who consume high energy 
intakes in early pregnancy (expressed by carbohydrate intake) had infants with lower 
birth weights and smaller placentas, especially if combined with low intakes of animal 
protein in late pregnancy (Godfrey et al, 1996).
It can be seen that maternal nutrition in early pregnancy may have a role to play in 
fetal development, and since NVP may affect a nutritional challenge in early 
pregnancy, it may seem paradoxical that NVP is associated with a favourable 
pregnancy outcome. Some possible mechanisms will be discussed in the following 
sections.
1,8 Possible mechanisms
One possible mechanism by which NVP may be associated with a favourable 
outcome of pregnancy is that despite causing discomfort and distress associated with 
food, NVP may not result in reduced intake but may actually increase it (Taggart, 
1961).
Another possibility is that NVP may lead to a reduced energy expenditure, and hence 
will alter the balance in favour* of maternal and fetal tissue growth.
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Alternatively, quality of diet may be altered. Pregnancy is a period in the life cycle of 
women in which changes in food-related behaviour* may occur* through contact with 
health professionals or* their own beliefs about pregnancy (Shwab and Axelson, 1984). 
In addition to modifications in customai*y diets such as increases and decreases in 
usual food intake and avoidances of some foods, certain appetite compulsions such as 
cravings, aversions and pica have been associated with pregnancy (Schwab and 
Axelson, 1984).
Another* possibility could be that NVP, which coincides with the most sensitive 
periods of embryonic organogenesis, protects the developing embr-yo by causing 
women to reject or* avoid foods containing potentially harmful teratogens or* 
abortifacents (Hook, 1980; Profet, 1988). Actively metabolizing tissues ar*e more 
vulnerable to toxins than dormant ones, and differentiating cells are more vulnerable 
than cells that reproduce more of the same type. Hence, it is thought that the 
embr*yonic and fetal tissues may be vulnerable to lower* concentrations of toxins than 
adult tissues. Vulnerability rises rapidly fr*orn the level characteristic of a quiescent 
egg in an ovary, to a peak in the critical stage of organ formation and tissue 
differentiation, then declines slowly towards the adult level at term (Nesse and 
Williams, 1994).
The vulnerability curve corresponds almost exactly to the course of NVP. This led 
Profet (1995) to hypothesize that nausea and food aversions in pregnancy evolved to 
impose dietary restrictions on the pregnant woman and thereby minimize exposure to 
toxins. Profet (1995) reported that the food the pregnant woman chose to eat was 
usually bland and without the strong odours and flavoms provided by “toxic”
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compounds. However, Profet was criticized by Brown et al (1997) who found no 
relationship between NVP and the intake of vegetables and other foods that Profet 
described as harmful. In addition, the adverse effects such as miscarriage and 
congenital abnormalities associated with these foods (according to Profet) were not 
observed. However, Flaxman and Sherman (2000) investigated the concept further 
and hypothesized that NVP causes women to avoid foods that were more likely to be 
contaminated with pai'asites and pathogens at a time when pregnancy caused 
immunosuppression, leaving women more vulnerable to infection. This was supported 
by the findings that societies such as Bhil, Mbimdu, Omalia, Papago, Siriono, 
Tarahumara and Woleai, where NVP had never been observed, were more likely to 
have only plants as their staple diet. Flaxman and Sherman (2000) analyzed the results 
of 20 studies and found that the most coimnon aversions were to meat and non­
alcoholic beverages.
A flirther explanation could be that NVP leads to a decreased intake which causes 
placental compensation.
1.8.1 Placental compensation
The effect of maternal nutrition on fetal and placental growth has mostly been studied 
in animals. Fetal and placental responses to imdernutrition in ewes depend on the 
magnitude, timing and duration of nutrient restriction (Symonds et al, 2001). Maternal 
nutrient restriction in eai’ly gestation tends to increase placental weight at term. In a 
study carried out by Heasman et al (1999) where ewes were fed 50% of their 
requirements during eai'ly to mid pregnancy, there was a reduction in placental weight 
at 80 days gestation, which was followed by an increase in placental weight close to
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term, although no effect on birth weight was seen. However, they did find that fetuses 
of nutrient restricted ewes had longer crown-rump lengths compaied to controls. 
Experiments performed in sheep have demonstrated that severe undernutrition 
reduces placental mass but lesser reductions in maternal intalce have the opposite 
effect (Robinson et al, 1995; Gadd et al, 2000). It seems that the placenta undergoes 
an adaptive compensatory response to mild maternal undernutiition dming this period 
of rapid placental growth thus optimizing tiansplacental exchange efficiency. In 
animal farming, it is common practice to transfer sheep from a good pasture to poorer 
pastm*e just for the early period of gestation in order to promote fetal growth by 
stimulating placental development. This practice is called “flushing” (McCrabb et al, 
1992). It could be that NVP is associated with a favomable pregnancy outcome 
because maternal nutrient restriction early in gestation favours placental development.
1.9 Factors associated with pregnancy outcome
Changes in maternal and fetal endocrine status in early pregnancy may mediate the 
inverse relationship between energy intake in early gestation and enlianced placental 
growth (Huxley, 2000). The mechanisms by which maternal nutrient intake affect 
fetal and placental growth seem to he mediated by the insulin-like growth factor axis.
The insulin-like growth factors (IGF)-1 and II are low moleculai* weight, single chain 
peptides with structural homology to proinsulin. The IGFs promote cellular* mitosis 
and differentiation in a variety of cell types and have been particular ly implicated in 
fetal and placental growth (Kleffens et al, 1998). The IGFs mediate tliese effects by 
binding to specific IGF receptors (type 1 and 2) on target cell surfaces (Kleffens et al.
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1998). Both IGF-1 and 2 have their effect primaiily thi*oiigh type 1 receptors 
(Gluckman and Harding, 1997). The IGFs circulate bound to a family of binding 
proteins. Six IGF binding proteins (IGFBPs) have been determined, and characterized 
IGFBP 1 through 6 (Kleffens et al, 1998).
IGF-I and IGF-II are found in most fetal and placental tissues as early as the pre­
implantation stages of embryonic development (Robinson et al, 1995). There have 
been numerous reports that IGF-1 levels ar e low in the cord blood of term neonates, in 
comparison to adult serum values, when measured by bio- or radioimmunoasay 
(Ashton et al, 1985, Gluckman, 1995). Levels of IGF-1 are positively correlated with 
fetal weight (Aston, 1985, Gluckman, 1995), length (Ashton, 1985) and placental 
weight (Ashton, 1985). Gluckman (1995) reported that the lower values of IGF-1 in 
the cord blood were associated with reduced concentrations of IGFBP-3 and high 
concentrations of IGFBP-2 and 1 relative to the adult.
In intra-uterine growth retardation (lUGR), circulating levels of IGF-1 are reduced in 
cord blood samples, and in humans this is associated with a reduction in IGFBP-3 and 
elevation in IGFBP-1 and 2 (Gluckman, 1995). Gluckman (1995) reported that the 
dominant influence on fetal IGF-1 levels, at least in the second half of pregnancy 
seemed to be nutrient status, in particular glucose availability to the fetus. Similar ly, 
the IGFBPs are affected by nutritional status, with IGFBP 3 falling and IGFBP 1 and 
2 rising with nutrient restriction. According to Gluckman (1995), fetal mice 
homozygous for dysfunctional IGF-1 have proformd embryonic and fetal growth 
retardation.
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IGF-2 mRNA is higher in fetal tissues compared to postnatal tissues (Gluckman, 
1995). Allelic disruption experiments in mice show that knockout of IGF-2 causes 
embryonic growth retardation only at embryonic days 11-16, after which this has no 
effect. It is postulated that IGF-2 has a role in early embryonic development, when 
IGF-1 levels may be insignificant, however, later on IGF-1 becomes the dominant 
IGF (Gluckman, 1995). The reason why there is a developmental switch from IGF-2 
to IGF-1 is not clear. One explanation is that IGF-2 appears to require greater degrees 
of nutritional and hormonal change for it to be affected. Thus, during early 
development, when it may be desirable for the fetus to be less sensitive to 
environmental influences, such as substrate limitation, IGF-2 is the dominant 
influence. Whereas in late gestation, where it is appropriate that the fetus responds to 
substrate limitation with reduced growth, IGF-1 is the primary influence (Gluckman 
and Harding, 1997).
The placenta is a source of both IGFs and IGFBPs and is a target for IGF action 
(Gluckman, 1995). It may be that IGF-1 and IGF-2 play a role in the paracrine 
regulation of placental development. However, mice with a disrupted IGF-1 do not 
have impaired placental growth, whereas, IGF-2 gene disruption does cause placental 
growth retardation (Gluckman, 1995).
The supply of nutrients fr om the mother to the fetus is an important factor in late 
gestation fetal growth (Gluckman, 1995). Elevations in IGF-1 seem to partition 
nutrients between the placenta and fetus in favour of the fetus (Gluckman, 1995). 
Gluckman (1995) suggested that maternal IGF-1 may also play a role in determining 
nutrient supply to the fetus. Maternal serimi levels of IGF-1 increase during 
pregnancy, but there is no relationship between maternal and cord serum IGF-1,
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suggesting that there is no significant transfer across the placenta (Wihnian et al, 
1988). This suggests that the effects of maternal IGF-1 ar e mediated by the placenta 
(Wiliman et al, 1998). Caufiiez et al (1993) reported that maternal IGF-1 could 
regulate placental transfer of nutrients to the fetus. This in tiuii could increase fetal 
IGF-1 secretion and bioavailability and thus promote fetal growth. Maternal IGF-1 
concentrations correlate with birth weight (Cufiiez et al, 1995), and in pregnancies 
complicated by lUGR, maternal IGF-1 levels are reduced (Gluclonan, 1995).
Thus we can see that both IGF 1 and 2 have an effect on fetal growth. The dominant 
influence on IGF-1 in late gestation is nutrient supply to the fetus. This effect seems 
to be mediated by insulin release by the fetus.
Both IGF-1 and 2 may act in a paracrine way to affect fetal organ and placental 
growth. Fetal IGF-1 is the major determinant of fetal paititioning to favoui* fetal 
growth. Placental fimction is affected by both maternal and fetal IGF-1. Placental 
IGF-1 may influence both placental growth and function (Gluckman, 1995).
Godfrey et al (1996) reported that motliers with high energy intakes in early 
pregnancy and low protein intakes in late pregnancy produced smaller babies with 
smaller placentas. They found that this was associated with a reduction in 
concentrations of insulin, proinsulin and IGF-1 in cord blood. They speculated that 
this may be mediated by the effect maternal diet has on placental gi'owth.
An important point to consider is that cord levels of IGF-I and II in neonates may not 
be indicative of fetal life, and may have changed mai'kedly during the later stages of
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gestation (Ashton et al, 1985), Another point is that cord levels are influenced by the 
processes of parturition (Ashton, 1985, Godfrey et al, 1996). Godfrey et al (1996) 
found no changes in their results even when taking into account type of labour onset 
and mode of delivery.
To summarise, NVP may be associated with a favourable pregnancy outcome, 
especially increased birth weight tlnough adaptation to a reduced nutrient intake in 
early gestation favouring compensatory placental development which subsequently 
optimises fetal development. During the early stages of development, when 
trophoblastic invasion is occurring and the placenta is establishing, the predominant 
growth factor involved in promoting growth via the type-1 receptor is IGF-11, which 
is fairly resistant to fluctuations in maternal nutrient intake so placental growth is 
maintained. However, IGF-2 levels remain unchanged as they are not affected by 
nutrition, thus ensuring embryonic and placental growth (Huxley, 2000). NVP usually 
stops by the second tr imester, which coincides with the time of transition fr om IGF-2 
to IGF-1 in the maintenance of fetal growth. IGF-1 is sensitive to nutritional intake, 
and thus will cause a reduction in fetal size if there is a reduction in intake (Huxley, 
2000).
It is necessary to be cautious when drawing conclusions fr om mechanisms elucidated 
in different species, as the structure of the primate discoid placenta and the 
cotyledonous placenta of ruminants are very different (Goad et al, 2002). In addition, 
none of the species studied share identical expressions of IGFs and IGFBPs (Goad et 
al, 2002). In addition, placental weight per se is a gross measurement; weight alone
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does not necessarily indicate placental efficiency of nutrient transfer (Coad et al, 
2002).
Another explanation could be that NVP affects nutrient partitioning via altered 
metabolism. During the first half of pregnancy, increased sensitivity to insulin 
promotes maternal anabolism, hi the second half of pregnancy, increasing insulin 
resistance stimulates maternal catabolism and maintains higher substrate levels, 
favouring placental transport when fetal gi'owth is high. Altering intake in early 
gestation could moderate the extent of deposition of maternal stores (Coad et al, 
2002).
It could be that by causing reduced energy intalce in eaily gestation, NVP could lower 
maternal insulin levels and IGF-1 levels thus ensuring nutrient partitioning to the 
placenta and therefore the fetus (Huxley, 2000). As insulin potentially inlribits hCG 
production (Barnea et al, 1993), reducing maternal insulin levels would optimise hCG 
production. Mori et al (1988) have reported that hCG could activate the thyroid, 
stimulating the release of thyroxine, which stimulates placental growth (Huxley, 
2000). Mori et al (1988) report that both hCG and thyroxine concentrations correlate 
with the onset and severity of NVP. Msuzaki et al (1997) reported that a high 
abundance of mRNA for leptin has been shown in the human placenta, with the 
highest amounts found in the chorionic villi at 8 weeks of gestation (cited by 
Symonds et al, 1998). This led Huxley (2000) to hypothesize that since the peak of 
leptin production correlates with the peak incidence of NVP, then placental leptin 
production in early pregnancy may act thr'ough the maternal hypothalamus to suppress 
appetite and reduce maternal energy intake. Maternal dietary intake is also inversely
26
related to peripheral progesterone concentration so a lower nutrient intake in early 
gestation facilitates progesterone production which has positive effects on growth of 
the enibiyonic inner cell mass (Wallace, 2000).
It is important to remember that as well as severity and timing of undernutrition, 
maternal nutritional status pre-pregnancy is also important. Symonds et al (1998) 
reviewed studies in sheep and reported that maternal body weight had a laige 
influence on placental weight and that the placental response to maternal nutrient 
restriction was determined by maternal body weight pre-conceptionally. Symonds et 
al (1998) reported that imderfeeding of heavy ewes resulted in a larger placenta, 
whilst in light ewes, placental mass was reduced. This has some similarity in human 
studies. A retrospective study carried out in Jamaica by Thame et al (1997), found that 
mothers who were thin had babies with a lower birth weight, shorter, smaller head 
circumference, lighter placenta and lower placentarbirth weight ratio.
Huxley (2000) also put forward the concept that maternal BMI pre-pregnancy could 
determine whether a woman experienced NVP or not. Huxley (2000) reported that in 
women with a normal BMI, the body fat stores ar*e sufficient and demands of the 
developing placenta override the maternal drive to anaholic synthesis of fat in early 
gestation. Huxley (2000) postulated that these women will experience symptoms of 
NVP that may lead to a reduction in nutrient intake and lower fat accretion. Huxley 
(2000) cited a study carried out by Lindsay et al (1997) which found that in women 
with a normal BMI, only 29% fat accumulation occurred during early pregnancy. 
Moreover, Klebanoff et al (1985) found that NVP was reported more often in women 
weighing more than 1701b compared to those weighing less than 1701b. As a result of
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the decreased intake in women with NVP, Huxley (2000) suggested that circulating 
levels of maternal insulin and IGF-1 fall, inliibiting anabolic maternal synthesis and 
fat deposition, ensming a more favourable nutrition partitioning in favour of the 
placenta.
On tire other hand, Huxley (2000) suggested that women with a low BMI, will have 
less experiences of NVP, due to a stronger maternal anabolic drive to fat accretion, 
overriding the needs of the placenta. Huxley (2000) cited a study by Allen (1994) 
which found that women in the lowest tertile of BMI increase their energy intake and 
gain more weight throughout gestation, whereas women in the highest tertile of BMI, 
decrease their energy intake and lose substantial amount of peripheral fat throughout 
pregnancy. In their study to assess changes in skinfolds during pregnancy, Taggart et 
al (1967) found that the increase in skinfolds during pregnancy was greater in 
underweight than in overweight women. In support of this, Symonds et al (1998) cited 
a study by Masuzaki et al (1997) where the authors reported that there was a positive 
correlation between circulating levels of leptin and BMI in non-pregnant women. 
Schubring et al (1997) found that leptin concentr ation were correlated with BMI only 
when gestational age was taken into account (cited by Symonds et al, 1998). Thus an 
interpretation could be that in imderweight women, reduced levels of leptin cause an 
increase in appetite and therefore an increase in weight. Huxley (2000) proposed that 
increased intakes in these women caused impaired placental development and 
elevated maternal insulin levels. This in turn resulted in a reduced production of hCG 
and thyroxine, leading to the absence of symptoms of NVP.
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1.10 Maternal nutrition and health outcomes in the offspring
Maternal nuti’ition dming pregnancy plays a pivotal role in the regulation of fetal and 
placental development in sheep, and therefore has the potential to influence both 
short- and longer-term health outcomes.
In sheep, Symonds et al (1998), found that following caesarean section, light ewes 
who were nutrient restricted during pregnancy delivered lambs who were at increased 
risk from hypothermia compar ed with offspring of heavy ewes. A casar ean section is 
known to significantly compromise the ability of newborn lambs to thermoregulate, 
and also causes a decrease in the amount and activity of brown adipose tissue. Light 
ewes that had to mobilize body stores dming pregnancy deliver lambs that possess 
less brown adipose tissue compared to heavy ewes.
Longer-term outcomes were considered by Kelly and Ralph (1988) who fomid that 
poor nutrition during fetal life reduced the potential for both the quality and quantity 
of wool in young Merino sheep.
In humans, the incidence of morbidity and mortality dming the neonatal period is 
known to be higher in LEW babies. Furthermore, many epidemiological studies have 
shown that LEW babies are also at increased risk of certain diseases in adulthood 
(Barker, 1994). Studies have also shown that alterations in conformation at birth, 
irrespective of birth weight, may also play a role in the programming of friture health 
outcomes (Barker, 1994). For example, proportionately small babies are at increased
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risk of raised adult blood pressure, but do not have an increased risk of developing 
CHD. By down regulating growth in response to eaiiy undernutiition, the fetus may 
reduce its demands for nutrients, making it less likely to subsequently experience 
relative undernutrition m later gestation (Godfrey, 1998). As adults, 
disproportionately short babies tend to have abnormalities of systems controlled by 
the liver, including clotting factor synthesis, cholesterol metabolism, and aie at 
increased risk of CHD (Godfr ey, 1998). This may due to the fact that in utero, nutrient 
restriction may have evoked the brain sparing reflex later in gestation, where nutrients 
are diverted to the brain at the expense of the trunk, limbs and abdominal viscera 
(Godfrey, 1998). Thin babies aie at increased risk of insulin resistance and CHD in 
later life. Their thinness reflects reduced subcutaneous fat and skeletal muscle due to 
undernutrition in the weeks prior to deliveiy (Godfrey, 1998)
Effects on placental growth may also have long term consequences. In a retrospective 
study on 449 men and women in Preston, Bai'ker et al (1990) found that highest blood 
pressuies occurred in those who had been small babies with large placentas.
1.11 The Research Problem
NVP is a very common symptom of early pregnancy, and has been associated with 
positive outcomes of pregnancy such as increased birth weight and gestational age. 
The reason behind this positive effect remains unknown; several possible mechanisms 
have been hypothesised.
Firstly, NVP may cause women to decrease their intake. Both human and animal 
studies have shown placental compensation as a response to maternal undernutrition 
in early pregnancy. This may or may not be accompanied by an effect on birthweight. 
However, Gadsby et al (1997) was alone in showing that women with NVP had larger 
placentas, thus this area requires fLuther investigation. In addition, it is important to 
remember that placental size may not reflect placental function. Heasman et al (1999) 
showed that although birth weight may not be affected by maternal nutrition, there 
was an effect on fetal conformation. This may have long term consequences as Barker 
and his colleagues have shown that a thin baby is at greater risk of non-insulin 
dependent diabetes and coronary heart disease (CHD) in later life, whereas the short 
baby is at greater risk of hypertension, abnormal cholesterol metabolism and CHD.
Alternatively, NVP may cause women to increase their intake. Taggart (1961) 
reported an investigation that she conducted in Aberdeen on appetite in pregnancy. 
Although poor appetite and reduced food intake was reported to sometimes 
accompany NVP, it was much more usual for appetite to be normal or even increased.
NVP can also result in dietary changes affecting quality of diet. There have been very 
few studies, that have looked at the type of diet consumed by women with NVP. A 
lot of controversy remains in the area of maternal nutrition, NVP and pregnancy 
outcome. The role of this study is to try and find some of the answers.
Elucidating the mechanisms by which NVP has a positive effect on birth weight will 
help identify what nutritional advice is appropriate. In addition, it will help to identify 
whether women with NVP should be treated to prevent symptoms or encoiuaged to
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endure tireur, as if NVP had an effect on pregnancy outcorrres, this is irrrportant for the 
prevention of future diseases.
1.12 The Hypothesis
The null hypothesis is “NVP does not have a beneficial effect on pregnarrcy outcome 
in terms of the irrfarrt and his/her poterrtial for development”.
1.13 The Aim of the Study
The aim of the study is to assess
• the inciderrce of NVP in the Guildford area
• whether NVP does or does rrot have a herreficial effect on pregnarrcy outcome
• how NVP may have a beneficial effect on outcome of pregnancy
1.14 The study objectives
The study was divided irrto two phases: The first phase involved the administration of 
a questioimaire survey arrd the second phase involved a prospective survey.
1.14.1 The Questionnaire Study
The retrospective questiorrrraire sru'vey was conducted to:
1) Gain sorrre backgrourrd irrfornration about the incidence arrd rrature of NVP in 
pregirant women living in the Guildford area, and to compare the results with 
those in the literatme.
2) Assess the feasibility of carrying out a prospective study
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To this end, the questionnaire allowed information to be gained about:
1) The incidence of mild, moderate and severe NVP in the Guildford ar ea.
2) The birth weight, head circumference and length of those babies born to mothers 
with NVP and those without it.
3) Dietary cravings and aversions dining pregnancy.
4) Dietary remedies and treatments used to reduce symptoms of NVP.
5) Maternal weight gain in women with and without NVP.
6) Factors that could affect NVP.
7) Whether women with NVP are more likely to change their diet during pregnancy 
compared to women witliout NVP.
1.14.2 The Prospective Study
In the prospective study, women were monitored during pregnancy in order to 
determine why NVP may have a beneficial effect. The objectives of this study where 
to assess whether the beneficial effects of NVP were associated with one or more of 
the following factors:
Women who experience NVP may:
1) Increase their intake to alleviate their sickness.
2) Reduce then intake.
3) Change the quality of the diet to reduce NVP.
2. SUBJECTS AND METHODS (QUESTIONNAIRE
SURVEY)
2.1 Study Design
A retrospective questionnaire sui'vey was conducted in order to obtain some 
background information about NVP in the Guildford area.
Questionnaires are used in all forms of epidemiological studies to measuie exposures 
both to possible causal agents e.g. nutrient intake and to confounding vai'iables e.g. 
age or gender. They may also be used to measine outcomes e.g. disease status in cross 
sectional studies (Margetts and Nelson, 1997). There aie two different methods for 
administering questionnaires; self-administered or interviewer administered. In this 
study, self-administered questiomiaires were used. These have the advantage of being 
lower in cost and provide no scope for interviewer bias. However, they have the 
disadvantage of tending to partial completion, uniesolved or unidentified problems, 
and they require the subject to be literate (Maigetts and Nelson, 1997).
The outcomes which it was hoped the questionnaire survey would show were the 
incidence of NVP in the Guildford ai*ea, the mean differences in pregnancy outcomes 
between women with NVP and those without NVP and the maternal and other factors
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ill relation to occurrence of NVP, and the relationship between those factors and 
pregnancy outcomes.
2.2 Development of Questionnaire
2.2.1. Questionnaire Format
The questionnaire should be designed to ask the minimum amount about a subject’s 
experiences, which will provide sufficient information to investigate the reseaich 
question (Margetts and Nelson, 1997). Wording should avoid any suggestion that a 
particular answer is preferred ie leading questions should be avoided. Questions 
should follow a logical sequence, as fai* as possible; it should be the sequence Üiat the 
respondents might expect to follow. Each question must be justified in terms of the 
objectives of the study (Maigetts and Nelson, 1997).
In this study, the questionnaire consisted of thirty-nine questions over ten A4 pages 
(See Appendix I), which were divided into three pails
1) Pait 1 : Information ahout the woman (consisting of twenty-seven questions)
2) Paif 2: Information about the par tner (consisting of seven questions)
3) Part 3 : Information about the baby (consisting of five questions)
The questionnaire contained both open and closed questions. Open questions are those 
which allow the respondents to answer in their own terms. These were used for non- 
categorical data. Closed questions are those, which specify in detail the possible 
answers (Margetts and Nelson, 1997). Margetts and Nelson (1997) suggests that
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epidemiological questionnaires usually should contain a majority of closed questions 
to reduce the possibility of interview, response, interpretation and coding bias, and to 
facilitate processing. Examples of closed and open questions used in this study are:
1) Open question: Did any foods, medication or alternative remedy help to alleviate 
the symptoms? Please explain.
2) Closed question: Were you hospitalised due to the nausea and vomiting.
Yes/No
The researcher generated questions with advice fi'om the supervisors, based on the 
literature. The questionnaire designed provided information on the following aspects:
1) Women’s details e.g. weight, height, birth weight, paiity, etlinic origin, education, 
socioeconomic status (based on occupation and level of education), smoking and 
alcohol use both before and duiing pregnancy, exercise pre-pregnancy and during 
pregnancy, diseases during pregnancy. These aie factors known to affect birth 
weight and placental weight, and aie also associated with NVP.
2) Pai-tner’s details e.g. height, birth weight, education, socio-economic status (based 
on both occupation and level of education), and smoking habits. These were asked 
as they are known to affect pregnancy outcome and to also to get the family’s 
socio-economic status.
3) Babies’ details e.g. birth weight, head circumference, length, and length of 
gestation, gender. The women provided the growth data from the “Red” baby 
book.
4) Types of NVP, duration of NVP, treatments used for NVP, diet in pregnancy and 
change due to NVP, cravings and aversions. These were asked in order to find out
about NVP and dietaiy changes during pregnancy in women living in the 
Guildford area.
5) Main person providing dietaiy advice. This question was adapted from that used 
by the OPCS in the infant feeding survey. The aim of this question was to identify 
the main provider of dietaiy advice to the women. The main advice giver could 
tlien be taigeted in the future with updated advice about NVP.
2.2.2. Questionnaire evaluation
Piloting is an essential pait of the development of any questionnaire, as it allows 
questions which are poorly imderstood or ambiguous, or which evoke hostile or other 
imdesirable responses to be identified. Thus questionnaires can then be modified until 
the researcher is sm*e that the response is a true response as so far as the subject is able 
to provide it (Margetts and Nelson, 1997).
In this study, 10 questionnaires were sent to women in the EIHMS depailment at the 
University of Surrey. These women had all given birth to a baby in tlie previous yeai\ 
Once the questionnaires were received, the comments made were used to modify the 
questionnaire to the final version that was then sent out to the women who were 
recruited from the GP clinics. The principle modifications made were:
1) Modifications made to the pilot information sheet
• The pilot infomiation sheet advised that the time taken to complete the 
questionnaire was 10 minutes, however from the pilot study, the women reported
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that it took them about 15 minutes to complete, so the information sheet was 
modified.
2) Modifications made to the questionnaire
• In the pilot questionnaire, information about the woman was divided into two 
sections, one pre-pregnancy and the other experience during pregnancy. This 
caused confusion and was thus changed to one section about the woman, asking 
questions about both pre and during pregnancy.
• In the pilot questionnaire, the women were asked at what age they had completed 
full time education and what qualifications they had obtained. Some women 
misimderstood this as they had gone back to education later on in life. The 
question was changed to ask which qualifications the woman had obtained.
• The pilot instruction sheet was too detailed. It was simplified as it made the 
questionnaire seem too difficult to answer.
• The pilot questiomiaire had a line to put the baby’s date of birth, this was changed 
to boxes, and to match the format used for the woman’s date of birth.
• The pilot questionnaire asked about work duiing pregnancy, then the women were 
asked to explain tliis. This was imcleai*, so the question was changed to make it 
cleai' that the question was asking about the number of hours worked per day and 
the stage in pregnancy the woman stopped working.
• In the pilot questionnaire, questions regaining when nausea started and for how 
long it lasted were closed questions, giving the woman a choice of specific times 
during pregnancy. It was found that the women had different answers to those 
provided, so the questions were changed to open questions
• In the pilot questionnaire, the women were asked whether NVP caused them to 
change their diet in any way. This question was not well answered in the pilot
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study, so it was changed to ask whether NVP caused them to eat more of a certain 
food, and another question which asked whether NVP caused them to eat less of a 
certain food. In this fashion, it was made clearer what the question wanted.
In the pilot questionnaire, the women were asked how NVP affected their weight 
during pregnancy. However it was found that women were not usually weighed 
throughout pregnancy, and therefore the question was omitted.
In the pilot questionnaire, dietary aversions and cravings were asked about in one 
open question. This was changed into two open questions in order to get more 
information about the cravings and aversions diuing pregnancy.
2.3 Subjects and Recruitment
2.3.1. Subject Numbers
In order for the study to have 80% power at the 5% significance level, it was 
estimated that 200 women were needed. The sample size calculations were 
undertaken by Dr loamiis Vlachonikolis, Reader in Medical Statistics, University of 
Surrey. These were based on the expected endpoints of the study, which was birth 
weight in this case. The calculations took into account the mean birth weight and 
standard deviation, which were obtained from the literatui*e, and the degree of change 
in birth weight expected due to NVP. In this study, the mean birth weight was taken 
as 3500g (500g), and an expected change in birth weight of 150g.
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2.3.2. Subject Characteristics
Women with and without NVP who had delivered in the past yeai' who consented to 
take part in the study were recruited from Fairlands Medical Centre, Guildford and 
StXuke’s Medical Centre, Guildford, imtil the target of 200 women was met.
2.3.3. Recruitment Method
Dr. Jolm Nichols at Fairlands Medical Centre provided a computer printout of all the 
women belonging to the siugeiy, who had delivered in the past yeai'. The printout 
provided only the women’s name and address, no further information about the 
women was given. At St.Luke’s Medical Centre, the health visitors provided the list 
of women, with only the women’s name and address. At both surgeries, the midwives 
and health visitors advised the reseaidier if there were any women who were 
unsuitable for the study, such as those women who had miscairied, or whose baby had 
died.
Each women was sent:
1) An information sheet which provided details of the study. It also stressed the 
confidentiality and anonymity with which all data would be treated. (See 
Appendix II). The information letter was adapted from that used in the OPCS 
survey of Infant Feeding.
2) Two consent forms. One was to be retained by the women, and the other was to be 
sent back to the reseaicher (See Appendix III).
3) Two pre-paid envelopes, one for the consent form and the other for the 
questionnaire, as they had to be sent in sepaiate envelopes for reasons of 
confidentiality.
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4) One questionnaire.
Recruitment began in April, 1999. Originally 276 questionnaires were sent which was 
the total number of women provided by the two surgeries, excluding any unsuitable 
women. Questionnaires were sent out using first class stamps. Each woman was asked 
to complete the questionnaire within one month’s time, and to send it in the pre-paid 
envelope provided. The pre-paid envelopes had second class stamps and were 
addressed to the surgery the women belonged to. A box was placed at both surgeries 
to collect questiomiaires and consent forms, and the reseai'cher emptied these once a 
week. Each questionnaire had a reference number in order to maintain confidentiality. 
The researcher had a list of the women’s names and the corresponding reference 
number, thus allowing a record of the women who sent back the questiomiaires to be 
kept. A reminder letter (See appendix IV) was sent to those women who did not 
respond within one month’s time, asking the women to respond within two weeks. In 
order to achieve the tai'get of 200 questiomiaires, recruitment continued until 
December, 2000. The total number of questionnaires sent out duiing the recruitment 
period was four hundred and forty.
2.4 Data Entry of Questionnaires
The strictest rules of data handling and anonymity were observed in all data handling. 
As the questiomiaires were retimied, the data was entered into the Statistical Package 
for Social Sciences Version lO(SPSS) by reference number only, in a secured 
personal computer, which was accessed by the reseaicher only. The questiomiaires 
were stored in a locked cabinet.
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Margetts and Nelson (1997) report that coding a questionnaire is vital and space must 
be allocated for code numbers. They suggest that the coding scheme be decided upon 
prior to administration as tliis often highlights problems with question design and 
helps to ensure that appropriate variables are being collected for analysis. In this 
study, coding of the questioimaire was not carried out initially, it was done after the 
responses were received, as the coding was based on the type of answers received. 
However most questions were formatted in a way that they would be able to be coded 
easily.
Each closed question was assigned a variable name. The variable name was unique to 
the question, and helped in the identification of the coiTesponding questions. Each 
answer was given a number e.g. 1= yes, 2=no. A coding guide was then constructed 
(See Appendix V), which showed the meaning of all the numerical responses. This 
was then used to claiify the output from the SPSS analysis.
Most of the answers were inputted in numerical form, which is the preferred way of 
inputting data, according to Margetts and Nelson (1997).
Open questions had sepaiate spreadsheets for each question. They cannot be added to 
main database as. there were a variety of responses, which made it difficult to code. 
The responses to the first questiomiaire received were put as separate vaiiables in the 
spreadsheet, then as the next questiomiaires were opened, more variables were added 
if it was an item not already mentioned.
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2.5 Data Analysis
Initially, descriptive statistical analysis was undertaken. The mean values, standard 
deviations and ranges were obtained for data such as maternal weight, height, birth 
weight. Frequency distributions were also obtained for data such as percentages of 
women suffering from NVP. Following this, compaiative statistics were carried out 
using appropriate paiametric or non-paiametric tests.
For relationships between categorical vaiiables, such as maternal characteristics and 
occiuTence of NVP, Chi-square tests were used. In 2 X 2 tables, Yates’ CoiTection for 
continuity was used, as this compensates for the overestimate of the chi-squaie value 
when used with a 2 X 2 value (Pallant, 2001). With some categories, eg socio­
economic status, level of education and level of income, the numbers in some cells 
were too small to carry out the Chi squaie tests, so the categories were re-arranged 
into 2 equal groups, based on the fifty percentile cut-off points, calculated using 
SPSS. For associations between continuous variables, such as between birth weight 
and length, Peai'son coiTelation was used. Wlierever a positive significant correlation 
was determined, a scatter plot of the two correlates was generated to assess whether or 
not the association was spurious. Independent samples t-tests were used to compare 
the outcome from two different groups, such as the birthweight of babies born to 
women with NVP compared to those born to women without NVP. To compare the 
outcome of tluee or more groups, such as the birth weight of babies born to 
housewives, part-time workers or women working full-time. One way analysis of 
variance (ANOVA), and the Tukey post hoc test was used. For relationships between 
continuous vaiiables and categorical vaiiables, such as maternal weight, height and 
occurrence of NVP, Peaison correlations were used.
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The results of the statistical tests were considered significant at p<0.05.
For the open questions, only descriptive statistics could be carried out. Frequency 
tables were generated and graphs produced.
2.6 Categorisation of sample population
i) Socio-economic status
Both mother and partner’s occupations were included in the questioimaire as 
open questions, and the responses were used to classify the socio-economic 
status for each family. The socio-economic status of each family was 
determined by comparing the job description of the main family breadwimier 
(household reference person) with the Standaid Occupational Classification 
(OPCS, 1991). This task was completed using guidelines compiled by OPCS 
(OPCS, 1991). There are six different social classes:
I Professional occupations e.g. lawyers, doctors and accountants
II Managerial occupations e.g. teachers, nuises and managers
IIIN Skilled occupations non-manual e.g. typist, shop assistant
HIM Skilled occupations manual e.g. miner, bus driver
IV Partly skilled occupations e.g. faim worker, bus conductor
V Unskilled occupations e.g. cleaner, labourer
An additional category was used in this study for families where, both members were 
unemployed. Only resident parents were included in the assessment of social class. In
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the case of families with two full-time employed parents, the pai'ent with the 
occupation with the higher rated social class was deemed the household reference 
person.
ii) Education
Information about both maternal and paternal education was requested using closed 
questions, which had 5 different groups
1) None
2) GSCE
3) A-Levels
4) Degree
5) Post degree
The level of education was sometimes used to clarify the socio-economic status, as 
sometimes the job title provided by the woman or her partner may be misunderstood, 
and equated to a higher or lower social class. Thus the researcher always compared 
the profession to the level of education in order to make a more accurate judgement 
about the individual’s social class.
iii) Income
Household income per aimum (before tax is deducted) was divided into 5 categories
1) less than £9,999 (per amium)
2) £10,000-£19,999 (per annum)
3) £20,000-£29,999 (per annum)
4) £30,000-£39,999 (per amuun)
5) over £40,000 (per amium)
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This was adapted from the questionnaire for mothers of low birth weight babies used 
by Lynne Marriot (2001) in the study titled: A Dietary Intervention Strategy to Foster 
Optimum Growth and Development in Preterm Infants after Hospital Dischaige
iv) Information about NVP
Information about NVP was requested and divided into three categories 
(Deuclw, 1995)
1) Mild (nausea only)
2) Moderate (both nausea and vomiting)
3) Severe (leading to weight loss)
Women who reported being hospitalised due to NVP were put into a fourth category 
(hyperemesis gravidaium) when the data was inputted into the computer.
2,7 Ethical Approval
2.7.1 Main study
The study protocol, together with tlie information letter for the women, a letter of 
consent for the women, a copy of the questionnaire, letters of approval from the two 
sui’geries, as well as the ethics application form was submitted to the South West 
Surrey Local Research Ethics Committee on 23.11.99. The Ethics Committee met on 
07.12.99. The Committee made some comments about the study . Modifications were 
made to the information letter, consent form and questiomiaire as advised by the 
Ethics committee, and re-submitted to the ethics committee on 15.12.99. The 
Chairman of the Ethics Committee approved the study subject to ratification by the 
full Committee and this was granted on 25.01.00 (See Appendix VI). The reference 
number of this study was ECU 8/99
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2.7.2 University of Surrey
An application for an endorsement of the approval for the questiomiaire study was 
made to the Advisory Coimnittee on Ethics of the University of Suney on 18.01.00. 
The study protocol, information letter to the women, consent form, a copy of the 
questiomiaire, a copy of the approval letter by the South West Surrey Local Reseaich 
Ethics Committee and the application form were submitted. The committee made 
some comments about the study. The necessary changes were made and the 
application was re-submitted. Permission by the Advisoiy Committee on Ethics was 
granted on 15.02.00 (See Appendix IV). The reference nimiber of this study was 
ACE/2000/11/EIHMS
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3.RESULTS OF QUESTIONNAIRE STUDY
3.1 Study Population
A total of four hundred and forty questionnaires were sent out between April, 1999 
and December, 2000. Two hundred and twenty one questionnaires’were returned; a 
response rate of 50%, Of the two hundred and twenty one questionnaires, eight had to 
be excluded, as they were incomplete. Eight questionnaires belonged to women of 
non-white ethnic origin, these were excluded as it has been reported that cultural, 
dietary and other factors associated witli country of origin may produce results not 
comparable with those obtained from British subjects (Dickens and Trethowan, 1971). 
In addition, four questiomiaires were excluded as they belonged to women who had 
multiple gestations, and the progress and outcome of these pregnancies differs from 
single gestations. Two hundred and one questionnaires were assessed as suitable for 
analysis.
3.1.1 Descriptive Characteristics
The mean age of the women at the time of delivery was 32 years SD 4.61, the 
youngest women being 17 yeai's and the oldest 44 years. The mean pre-pregnancy 
BMI was 27.8 kg/ni^ SD 3.45. Of the two hmidred and one women, one hundred and 
eighty six (93%) were mairied or living with their paitner. 95 (47.3%) women were 
first time mothers.
48
Thirteen women (6.5%) reported smoking during pregnancy, nine women smoked 
between one and nine cigarettes per day and foui* women smoked betvx^ een ten and 
twenty per day. As for alcohol intake, ninety six (47.8%) women reported drinking 
alcohol dming pregnancy, with two women drinking less tlian one unit a week, fifty 
fbui' women diank one to two units a week, ten women di*anlc three to foui’ units a 
week and twenty nine women dranlc more tlian four units a week. One hundred and 
seventy six women (88%) consmned nutritional supplements. As might be expected. 
Folic acid was the most common supplement, taken by one hundred and twenty six 
women (71.6%).
As for socio-economic status, 79% of the women were of social classes I and II. This 
may not reflect the National average (Figuie 3.1.a), however the women all lived in 
Guildford, which is known to be an affluent area.
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Figure 3.1.a Socio-economic status of study population compared with National
average
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■  Questionnaire survey, 
Guildford, 1999)
Tables 3.1.a and 3.1.b show the descriptive characteristics of the study population in 
terms of n (the total number of responses to the question) and n% (the number and 
percentage of the total respondents ticking each option). For some characteristics, data 
was not provided by every respondent.
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Table 3.1.a Categorical characteristics of study population
Ckuact0ristic,i;^ 3%^ *" n(% )
Marital status
199
Single 13(6.5)
Living with husband/partner 186(93.5)
Smoking pre-pregnancy 201
Yes 32(15.9)
No 169(84.1)
Smoking during pregnancy 201
Yes 13(6.5)
No 188(93.5)
Alcohol pre-pregnancy 201
Yes 157(78.1)
No 44(21.9)
Alcohol during pregnancy 201
Yes 96(47.8)
No 105(52.2)
Supplements pre-pregnancy
Yes 123(61.2)
No 78(38.8)
Supplements during pregnancy 201
Yes 176(88)
No 24(12)
Number o f children 
(excluding this pregnancy)
201
None 95(47.3)
One 73(36.3)
Two 28(13.9)
Three 4(2)
Five 1(0.5)
Household Income per annum 193
<£9,999 4(2.1)
£10,000-19,999 11(5.7)
£20,000-29,999 29(15)
£30,000-39,999 39(20.2)
>£40,000 110(57)
Education 197
None 2(1)
GSCE 55(27.9)
A-Level 34(16.9)
Degree 88(43.8)
Post degree 18(9)
Socioeconomic status 201
Unemployed 8(4)
Unskilled occupations (V) 1(0.5)
Partly skilled occupations ( IV) 2(1)
Skilled occupations- manual (HIM) 12(6)
Skilled occupations- non manual (11 IN) 20(10)
Managerial occupation (II) 84(41.8)
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Professional occupations (1) 74(36.8)
Occupation o f women 201
Full-time 103(51.2)
Part-time 40(19.9)
Housewife 58(28.9)
Table 3.1.b Age and anthropometric data of study population
Characteristic M ew fS D ) ^ Min 4^" Max
Age (years) 197 32.08(4.61) 17 44
Pre-pregnancy 
weight (kg)
201 63.22(11.35) 44.5 112.0
Weight gain in 
pregnancy (kg)
183 13.76(5.05) 4 31.6
Mother’s birth 
weight (kg)
166 3.34(0.59) 1.0 4.6
Height (m) 200 1.67(0.07) 1.5 1.83
BMI (kg/m2) 200 22.76(3.45) 17.34 36.37
3.2 NVP
3.2.1 Symptoms of NVP
Of the two hundred and one women in this sample, one hundred and forty six 
(72.6%), reported having experienced NVP. Within this, eighty-four women (57.5%) 
reported suffering from mild NVP (nausea only), forty-three (29.5%) moderate 
(nausea and vomiting) and seventeen women (11.6%) reported severe NVP. Two 
women (1.4%) had to be hospitalised due to the severity of NVP and in this study 
have been classed as suffering from Hyperemesis Gravidarum.(Figure 3.2.a).
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Figure 3.2.a Distribution of symptoms of NVP
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3.2.2 Onset and Duration of NVP
Of the one hundred and forty six women with symptoms, 95.9% of women reported 
symptoms of NVP to have started by week 10 gestation. For 32.4% of women, 
symptoms started immediately or before 4 weeks gestation. (Figure 3.2.b)
Figure 3.2.b Distribution of onset of NVP
1 2 3 4 5 S 7 8 8 10 12 16 24
Onset of NVP (weeks)
53
The mean length of duration of symptoms was 12.73 weeks SD 8.34, ranging from 2 
weeks gestation to 38 weeks.
73.6% of women ceased having symptoms by 20 weeks gestation. In thirteen women 
(9.3%) symptoms lasted for the duration of pregnancy. (Figure 3.2.c)
Figure 3.2.C Distribution of cessation of NVP
6 * 11 13 16 17 18 21 23 26 27 32 39 41
Cessation of NVP (weeks)
Type of NVP was positively related to both onset and duration of NVP {P= 0.034) 
and (P = 0.012) respectively.
3.2.3 Episodic Nature of Symptoms
The times throughout the day when episodes of nausea occurred are shown in Figure 
3.2.iv. Sixty one women (41.8%) reported symptoms to have occurred for a few hours 
a day, fifty six women (27.9%) reported symptoms lasting throughout the day, 
eighteen women (12.3%) had symptoms only in the mornings and eleven women 
(7.5%) reported symptoms solely in the evenings. (Figure 3.2.d)
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Figure 3.2.d Distribution of time of day that NVP occurred
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3.2.4 Factors Related to NVP
The factors investigated in relation to occurrence of NVP are shown in Tables 3.2.a 
and 3.2.b. The relationships between categorical maternal characteristics and 
occurrence of NVP was examined by the Chi squared test. Analysis showed that 
women who smoked pre-pregnancy were less likely to suffer from NVP (P = 0.040) 
(Figure 3.2.e). This was also true for women who smoked during pregnancy (P = 
0.001) (Figure 3.2.f). There was a trend for women who drank alcohol during 
pregnancy to be at higher risk from NVP {p = 0.068), however, this relationship failed 
to reach the significance at the 5% level.
For income, level of education, socio-economic status and parity, the variables had to 
be examined by subgroup to enable statistical analysis (Chi squared test) to be 
performed, as some cells did not meet the minimum expected cell frequency. Thus
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two equal sized groups were created based on the 33.33 percentile and the 66.67 
percentile cut-off points calculated using SPSS. Household income was divided into 
less than £40,000 and more than £40,000. Level of education was divided into A- 
levels or lower and degree and higher. Socio-economic status was divided into socio­
economic group II and below and socioeconomic group I.
NVP was more likely to occur in multiparous women (P= 0.039) (Figure 3.2.g) and 
in women of higher education levels (P= 0.024) (Figure 3.2.h).
Table 3.2.a Relationship of NVP with different categorical variables
Characteristic Siflnificaiice\'^ x
Marital status 0.337 199
Occupation 0.669 201
Smoking pre-pregnancy 0.031* 201
Smoking during pregnancy 0.001* 201
Alcohol pre-pregnancy 0.186 201
Alcohol during pregnancy 0.068 201
Supplement use pre-pregnancy 0.959 201
Supplement use during pregnancy 0.158 200
Parity 0.039* 201
Income 1.000 201
Socio-economic status 1.000 201
Education 0.036* 201
Exercise pre-pregnancy 1.000 201
Exercise during pregnancy 0.499 201
Infant Gender 0.608 200
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Figure 3.2.e Relationship between smoking pre-pregnancy pregnancy and NVP
8  40
Smoking
Figure 3.2.f Relationship between smoking during pregnancy and NVP
Smoking
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Figure 3.2.g Relationship between parity and NVP
Parity
Figure 3.2.h Relationship between level of education and NVP
A-LoveMower
Pearson product-moment correlation was used to investigate the relationship between 
NVP and different continuous variables; no correlations were found.
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Table 3.2.b Relationship of NVP with different continuous variables
Characteristic
Correlation 
coefficient tP value) N
Age (years) -.026 (0.721) 197
BMI (kg/m2) -.084 (0.238) 200
Weight gain in pregnancy (kg) 0.064 (0.391) 183
Pre-pregnancy weight (kg) -0.015 (0.830) 201
3.2.5 Effect of NVP on Intake
3.2.5.1 Women’s perception of effect of NVP on intake
Fifty-eight women (28.9%) perceived their intake to have decreased due to NVP, 45 
women (31%) perceived their intake to have increased and the remaining 42 women 
(20.9%) perceived that their intake was not affected by NVP.
3.2.5.2 Foods which alleviated symptoms
When asked in an open question whether there were any foods which the woman 
consumed more of as they helped reduce symptoms of NVP, 68.1% (n= 98) reported 
consuming more of at least one food. The majority of women found that grains and 
starches helped reduce symptoms of NVP. This was followed by fruit, sweets and 
non-alcoholic beverages (Figure 3.2.i).
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Figure 3.2.i Foods found to alleviate symptoms of NVP
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Food category abbreviations: “Sweets” is sweets, desserts and chocolate, “Fruit” is 
fruits andfruit juices, “G&S” is grains and starches, “Dairy” is dairy products and 
ice-cream, “Meat” is meats, fish, poultry, eggs and meat alternatives, “Veg” is 
vegetables, “Other ” is for foods that do not fit into the categories,
“N-A ” is nonalcoholic beverages, “Fried” is friedfoods and junk foods, “Stim ” is 
stimulating drink such as tea, coffee, “Alcohol” is alcoholic beverages, “ESS” is 
ethnic, strong and spicy foods.
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3.2.5.3 Foods which exacerbated symptoms
When the women were asked in an open question whether they had reduced the 
consmnption of specific foods as they worsened the symptoms of NVP, 70.1%(n= 
101) reported consuming less of some specific foods. Ethnic foods, sti'ong flavoured 
foods and spicy foods were reported most often to worsen symptoms of NVP. This 
was followed by stimulating drinks and vegetables (Figiue 3.2.j).
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Figure 3.2.j Foods found to exacerbate symptoms of NVP
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Food category abbreviations: “Sweets” is sweets, desserts and chocolate, “Fruit” is 
fruits andfruit juices, “G&S” is grains and starches, “Dairy” is dairy products and 
ice-cream, “Meat” is meats, fish, poultry, eggs and meat alternatives, “Veg” is 
vegetables, “Other” is for foods that do not fit into the categories,
“N-A ” is nonalcoholic beverages, “Fried” is friedfoods and junk foods, “Stim ” is 
stimulating drink such as tea, coffee, “Alcohol” is alcoholic beverages, “ESS” is 
ethnic, strong and spicy foods.
3.2.6 Advice sought for NVP
Only twenty-three women (15.8%) of the one hundred and forty six suffering from 
NVP reported seeking professional advice for their symptoms. Eight women asked
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their general practitioner (GP) for help. Table 3.2.c shows the type of advice given by 
the GP.
Table 3.2.c Advice given by doctors to women suffering from NVP
Number Advice
1 Anti-sickness medication and pressure bands
2 Eating little and often
3 Antisickness medication and hospitalisation
4 Anti-sickness medication and hospitalization
5 Rest
6 Anti-sickness medication and accupuncture
7 Acupuncture and pressure bands
8 Rest
Two women asked their midwives for help, one midwife advised pressure bands and 
ginger, the other only pressure bands.
The remaining thirteen women sought alternative medical help, nine women were 
advised to try pressure bands only, one woman both pressure bands and 
aromatherapy, one woman ginger and aromatherapy, and the third ginger and wrist 
bands.
The Chi-squared test was used to assess whether there was a relationship between 
severity of NVP and asking for advice. A significant relationship was found, where 
women with more severe NVP were more likely to ask for advice compared to those 
with mild or moderate NVP {P <0.001) (Figure 3.2.k).
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Figure 3.2.k Relationship between severity of NVP and asking for advice
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3.2.7 Methods used to alleviate symptoms
In the survey, the women were asked about the methods that they found to be most 
useful in alleviating symptoms of NVP. Eating little and often and carbohydrates were 
found to be the most effective methods of alleviation (Figure 3.2.1). Other methods 
not shown in the diagram include fi-esh air, stopping vitamins, fasting and intra 
venous fluids, lavender cushion, being in water, indigestion tablets, milk and 
maintaining a good level of hydration. Each of these was reported only once.
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Figure 3.2.1 Methods used to alleviate symptoms of NVP
( The numbers by the pie chart represent percentages of women reporting these 
methods)
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3.2.8 Effect of NVP on Outcome of Pregnancy
Independent-samples t-tests were conducted to compare the birth weight, length and 
head circumference of infants bom to women with NVP and without NVP. There was 
no significant differences in the birth weight, in women with NVP (mean = 3.48kg, 
SD =0.56) and without NVP (mean = 3.43kg, SD = 0.56) (P = 0.583). No significant 
differences were found in the infant length in women with NVP (mean = 51.67cm,
SD = 2.3) and women without NVP (mean = 51.30cm, SD = 2.20) (P= 0.361). 
Finally, no significant differences were found in the head circumference of infants 
bom to in women with NVP (mean = 35.19cm, SD = 1.6) and women without NVP 
(mean = 35.17cm, SD = 1.5) (P=0.184).
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3,3 Dietary Cravings and Aversions in Pregnancy
3.3.1 Incidence of cravings and aversions in pregnancy
One hundred and two (51.3%) women reported at least one craving during pregnancy. 
As for aversions, eighty-two women (41.4%) reported avoiding at least one food 
during the course of pregnancy.
3.3.2 Foods craved and avoided during pregnancy
The most commonly craved food category during pregnancy was sweets. This was 
followed by fruit, grains and starches and daiiy products (Figure 3.3.a). In this 
sample, there were three reportings of pica, one for coal, and two for ice-cubes.
As for aversions, the most commonly avoided foods were stimulating drinks such as 
tea and coffee. This was followed by vegetables and ethnic, strong and spicy foods 
(Figure 3.3.b).
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Figure 3.3.a Distribution of foods craved during pregnancy
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Food category abbreviations: “Sweets ” is sweets, desserts and chocolate, “Fruit ” is 
fruits andfruit juices, “G&S” is grains and starches, “Dairy” is dairy and ice-cream, 
“Meat” is meats, fish, poultry, eggs and meat alternatives, “Veg” is vegetables, 
“Other ” is for foods that do not fit into the categories,
“N-A ” is nonalcoholic beverages, “Pica ” is for foods not normally considered edible, 
“Fried” is friedfoods and junk foods, “Stim ” is stimulating drink such as tea, coffee, 
“Alcohol” is alcoholic beverages, “ESS” is ethnic, strong and spicy foods.
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Figure 3.3.b Distribution of foods avoided during pregnancy
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Food category abbreviations: “Sweets " is sweets, desserts and chocolate, “Fruit ” is 
fruits andfruit juices, “G&S” is grains and starches, “Dairy” is dairy and ice-cream, 
“Meat” is meats, fish, poultry, eggs and meat alternatives, “Veg” is vegetables, 
“Other” is for foods that do not fit into the categories,
“N-A ” is nonalcoholic beverages, “Fried” is friedfoods and junkfoods, “Stim ” is 
stimulating drink such as tea, coffee, “Alcohol” is alcoholic beverages, “ESS” is 
ethnic, strong and spicy foods.
3.3.2.1 Reasons cited for cravings and aversions
Out of the one hundred and two women reporting cravings, only thirty-nine gave an 
answer when asked about possible reasons for the cravings. Nineteen women said that
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they did not know why they craved some foods other than it being a definite urge for 
a food item. The remaining ten women gave a variety of reasons which are shown in 
Table 3.3.i. The most common reasons cited for cravings of specific food groups were 
hunger NVP, the food was bland, and to make up for a reduction in the consumption 
of tea.
Table 3.3.a Reasons cited for cravings of specific foods groups
Reason CHO
(n)
Sweets
(n)
N-A
(n)
Meat
(n) Dairy(n)
Fruit
(n)
Fried
(n) Stim(n)
Hunger/
NVP
2 1
Dizzy 1 1
Energy/
comfort
1
Strong
Taste
1
Vitamin/m
ineral
1 1
Cold 1 1
Easy to eat 1 1
Wet 1
Fresh
Taste
2
Make up 
for veg
1
Settle
stomach
1 1
Bland 1 1 1
Should not 
have it
1
Same
cravings
with
periods
2
Make up 
for tea
1 1 1
{CHO is carbohydrates, N-A 
such as tea, coffee)
is non-alcoholic beverages, stim is stimulating drinks
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As for aversions, thirty-nine women gave reasons for avoiding certain food groups. 
These are shown in Table 3.3.b. The most common reason cited for the avoidance of 
specific food groups was NVP.
Table 3.3.b Reasons cited for aversions to specific food groups
Reason CHO Sweets% A lc \ Meat Dairy Fruif^ Fried ESS Veg Stim
Heart
bum
1 1 1 3 1 1
Nausea 1 2 3 1 3 4 7 7 6
Smell 1 2 1 2 4
Bad taste 1 4
Metal
taste
1 1
Head
ache
1
Dislike 1 1
3.3.3 Factors related to cravings and aversions in pregnancy
The factors investigated in relation to cravings in pregnancy are shown in Tables 3.1.C 
and 3.1 .d.  The Chi-squared test were used to investigate the relationship between 
cravings in pregnancy and the categorical variables. A significant relationship was 
found between NVP and cravings, where cravings were more likely to occur in 
women with NVP compared to those without NVP (P  = 0.022) (Figure 3.3.c)
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Table 3.3.c Maternai characteristics investigated in relation to occurrence of 
cravings in pregnancy (categorical variables)
Characteristic N P Value
Marital status 197 0.928
Occupation 199 0.401
Smoking pre-pregnancy 199 0.307
Smoking during pregnancy 199 0.925
Alcohol pre-pregnancy 199 0.081
Alcohol during pregnancy 199 0.608
Parity 199 0.928
Income 199 0.769
Education 199 0.143
Socio-economic status 199 1.000
NVP 199 0.022*
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Figure 3.3.C Relationship between cravings and NVP
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Figure 3.3.d shows the percentage distribution of cravings of women with NVP 
compared to those with out NVP. The foods most commonly craved by women with 
NVP were sweets, grains and starches, fruit and dairy products. In women without 
NVP, the most commonly craved foods were fruit and dairy products, followed by 
meat, vegetables and sweets.
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Figure 3.3.d Distribution of foods craved during pregnancy by women with and
without NVP
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Food category abbreviations: “Sweets ” is sweets, desserts and chocolate, “Fruit ” is 
fruits andfruit juices, “G&S” is grains and starches, “Dairy” is dairy and ice-cream, 
“Meat” is meats, fish, poultry, eggs and meat alternatives, “Veg” is vegetables, 
“Other ” is for foods that do not fit into the categories,
“N-A ” is nonalcoholic beverages, “Fried” is friedfoods and junk foods, “Stim ” is 
stimulating drink such as tea, coffee, “Alcohol” is alcoholic beverages, “ESS” is 
ethnic, strong and spicy foods.
Pearson product correlations were used to investigate whether there were any 
relationships between some maternal continuous variables and cravings during 
pregnancy. No significant correlations were found.
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Table 3.3.d Maternai factors investigated in relation to cravings (continuous 
variables)
Characteristic N Correlation coefficient ( f  
Value)
Age (years) 196 -.060(0.402)
Pre-pregnancy weight (kg) 199 -.060 (0.391)
Weight gain in pregnancy (kg) 181 0.015 (0.843)
BMI (kg/m2) 198 -.079 (0.200)
The factors investigated in relation to occurrence of aversions in pregnancy are shown 
in Tables 3.3.e and 3.3.f
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Table 3.3.e Maternai factors investigated in relation to occurrence of aversions 
(categorical variables)
Marital status 196 0.275
Occupation 198 0.420
Smoking pre-pregnancy 198 0.768
Smoking during pregnancy 198 0.272
Alcohol pre-pregnancy 198 0.101
Alcohol during pregnancy 198 0.362
Parity 198 0.776
Income 198 0.989
Education 198 <0.001*
Socio-economic status 198 0.115
NVP 198 0.026*
Chi-square tests were used to investigate relationships between some maternal 
categorical characteristics and aversions in pregnancy. Aversions were found to occur 
more in women with NVP compared to those without NVP (P = 0.026) (Figure 3.3.e)
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Figure 3.3.e Relationship between aversions and NVP
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The foods most commonly avoided by women with NVP were stimulating drinks 
such as tea and coffee. This was followed by ethnic, strong and spicy foods, 
vegetables and meat. As for women without NVP, stimulating drinks were the most 
commonly avoided products, followed by ethnic, strong and spicy foods and fried 
foods (Figure 3.3.f).
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Figure 3.3.f Distribution of foods avoided during pregnancy in women with and
without NVP.
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Food category abbreviations: “Sweets ” is sweets, desserts and chocolate, “Fruit ” is 
fruits andfruit juices, “G&S” is grains and starches, “Dairy” is dairy and ice-cream, 
“Meat” is meats, fish, poultry, eggs and meat alternatives, “Veg” is vegetables, 
“Other” is for foods that do not fit into the categories,
“N-A ” is nonalcoholic beverages, “Fried” is friedfoods and junkfoods, “Stim ” is 
stimulating drink such as tea, coffee, “Alcohol” is alcoholic beverages, “ESS” is 
ethnic, strong and spicy foods.
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Chi-square analysis also showed a positive correlation between maternal education 
and aversions, where aversions were more likely to occur in women of higher 
education level {P < 0.001) (Figure 3.4.g)
Figure 3.3.g Relationship between aversions and maternal education
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There were no significant correlations between the continuous maternal 
characteristics investigated and occurrence of aversions.
Table 3.3.f Maternal factors investigated in relation to aversions (continuous 
variables)
Characteristic N Correlation coefficient (P 
Value)
Age (years) 194 -.072 (0.318)
Pre-pregnancy weight (kg) 198 -.008 (0.912)
Weight gain in pregnancy (kg) 181 0.089 (0.234)
BMI (kg/m2) 197 -.043 (0.552)
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3,4 Pregnancy outcomes
Of the two hundred and one infants bom, one hundred and sixteen were male (58%) 
and eighty-four were female (42%). Male infants had a mean birth weight of 3.49kg 
(SD 0.56), a mean length of 51.65cm (SD 2.25), a mean head circumference of 
35.46cm (SD 1.51) and a mean gestational age of 39.35 weeks (SD 1.76). Female 
infants had a mean birth weight of 3.43kg (SD 0.57), a mean length of 51.48cm (SD 
2.34), a mean head circumference of 34.83cm (SD 1.57) and a mean gestational age 
of 39.30 weeks (2.06). There were no significant differences between the sexes in 
birth weight {P = 0.447), length {P = 0.667) and gestational age (P = 0.849).
However, the difference in head circumference between males and females was found 
to be significant (P = 0.021) with the male infants having a significantly higher mean 
head circumferences than the female. The descriptive characteristics of all infants are 
shown in Table 3.4.a.
Table 3.4.a Descriptive characteristics of infants
Characteristic N Range Mean (SD)
Birth weight (kg) 201 1.4-4.7 3.47(0.56)
Length (cm) 128 46-57 51.58(2.28)
Head circumference 
(cm)
132 31-38 35.19(1.56)
Gestational age 
(weeks)
200 29-42 39.33(1.89)
The relationship between birth weight and both length and head circumference was 
investigated using Pearson product moment correlation coefficient. Preliminary 
analyses were performed to ensure no violation of the assumptions of normality, 
linearity and homoscedasticity. There was a strong positive correlation between birth 
weight and length (r = 0.753, P <0.001) (Figure 3.4.a). There was also a strong
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positive correlation between birth weight and head circumference (r = 0.730, P < 
0.001) (Figure 3.4.b). Length and head circumference also showed a strong 
correlation (r = 0.645, P  <0.001) (Figure 3.4.c). These correlations were significant in 
both male and female infants.
Partial correlation was used to explore the relationship between length and head 
circumference, while controlling for birth weight. There was a significant positive 
partial correlation between length and head circumference (r = 0.21, P = 0.028). 
However, an inspection of the zero order correlation (r = 0.645) suggests that birth 
weight had a strong effect on the strength of the relationship between the two 
variables.
Figure 3.4a Variation in length at birth with birth weight
Gender
1.6 2.0 2.5 S.O 3.5 4.0 4.5  5.0
Birth weight (kg)
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Figure 3.4.b Variation in head circumference (cm) at birth with birth weight(kg)
Gender
Birth weight (kg)
Figure 3.4.c Variation in length at birth with head circumference
Gender
Length (cm)
The relationship between gestational age and birth weight, length and head 
circumference was investigated using Spearman’s rank order correlation as 
gestational age was not normally distributed. There was a positive correlation between 
gestational age and birth weight (r = 0.404, P<0.001) (Figure 3.4.d). There was also a 
positive correlation between gestational age and length ( r = 0.400, P  <0.001) and
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between gestational age and head circumference (r = 0.428, P  <0.001). These 
correlations were significant in both male and female infants.
Figure 3.4.d Variation in birth weight in relation to gestational age.
gender of baby
2 8 3 0 3 2 M 3 6  38 40 42
Gestational age (weeks)
Partial correlation was used to explore the relationship between gestational age and 
both length and head circumference, while controlling for birth weight. No correlation 
was seen between gestational age and length ( r = 0.130, P = 0.141) and between 
gestational age head circumference (r = 0.160, P = 0.075). Thus birth weight had a 
large effect in the strength of the relationships between gestational age and both 
length and head circumference.
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3.4.1 Factors related to pregnancy outcomes
3.4.1.1 Maternal characteristics
Tables 3.4.b and 3.4.c show the list of variables tested in relation to pregnancy 
outcomes.
Table 3.4.b Maternal characteristics investigated in relation to pregnancy 
outcome (continuous variables)
Characteristic Correlation coefficient (P value)
Birth weight (kg) Length (cm) Head circumference 
(cm)
Maternal birth weight 
(kg)
0.241 (0.002)* 0.345 (<0.001)* 0.217(0.023)*
Maternal height (m) 0.105 (0.140) 0.166 (0.063) 0.125 (0.154)
Maternal BMI (kg/m^) 0.202 (0.004)* 0.076 (0.396) 0.157(0.074)
Maternal age (years) 0.050 (0.482) 0.036 (0.687) 0.079 (0.373)
Pre-pregnancy weight 
(kg)
0.260 (<0.001)* 0.168 (0.058) 0.228 (0.008)*
Weight gain in 
pregnancy (kg)
0.186 (0.012)* 0.295 (0.001)* 0.253 (0.005)*
Pearson correlation coefficients were used to investigate the relationships between 
maternal age and height and birth outcomes. No positive relationships were found.
Spearman rank correlations were used to investigate the relationship between 
maternal birth weight, pre-pregnancy weight, weight gain in pregnancy and maternal 
BMI. There was a positive correlation between maternal BMI and birth weight 
(Figure 3.4.e). Pre-pregnancy weight was correlated with both birth weight and head 
circumference (Figure 3.4.1). However, when Partial correlation was conducted to
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investigate the relationship between pre-pregnancy weight and head circumference, 
while controlling for birth weight, the relationship ceased to be significant {P = 
0.133). Weight gain in pregnancy was positively correlated with birth weight, length 
and head circumference (Figure 3.4.g). Again once partial correlation was conducted 
to control for birth weight, the relationship between weight gain and both length and 
head circumference ceased to be significant (P = 0.136) and (P = 0.516) respectively. 
Maternal birth weight was also positively correlated with infant birth weight, length 
and head circumference (Figure 3.4.h). Once birth weight was controlled using partial 
correlations, the relationship with infant length remained significant (P = 0.046, r = 
0.19). As for head circumference, the relationship ceased to be significant (P = 0.848, 
r = 0.019).
Figure 3.4.e Infant’s birth weight in relation to mother’s BMI
Gender
■ fMIWl* 
mate
Women's BMI (kg/m2)
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Figure 3.4.f Infant’s birth weight in relation to mother’s pre-pregnancy weight
Gender
40 s o  60 70 80 90 100 110 120
Women's pre-pregnancy weight (kg)
Figure 3.4.g Infant’s birth weight (kg) in relation to weight gain during
pregnancy
I ”  
I ■"I .
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Gender
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Weight gain during pregnancy (kg)
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Figure 3.4.h Infant’s birth weight (kg) in relation to mother’s birth weight
rn r .
Gender
Woman’s  birth weight (kg)
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Table 3.4.cMaternal characteristics investigated in relation to pregnancy 
outcome (categorical variables)
Characteristic P value
Birth w e i^ t  (kg) Length (cm) Head circumference 
(cm)
Marital status 0.765 0.590 0.791
Occupation 0.002* 0.022* 0.131
Smoking pre­
pregnancy
0.488 0.457 0.204
Smoking during 
pregnancy
0.745 0.667 0.392
Alcohol pre-pregnancy 0.545 0.139 0.787
Alcohol during 
pregnancy
0.594 0.936 0.692
Parity <0.001* 0.004* 0.033*
Income 0.764 0.679 0.490
Education 0.353 0.769 0.967
Socio-economic status 0.878 0.835 0.922
A one-way between-groups analysis of variance was conducted to explore the impact 
of maternal occupation on pregnancy outcome, as measured by birth weight, length 
and head circumference. Subjects were divided into those in full-time occupation, 
part-time occupation and housewives. There was a statistically significant difference 
in both birth weight and length for the three groups {P = 0.002) and {P = 0.022) 
respectively. Post-hoc comparisons using Tukey HSD test indicated that the mean 
birth weight for mothers in full-time occupation (mean = 3.34, SD = 0.55) was
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significantly different from the mean birth weight for housewives (mean = 3.66, SD = 
0.52). Birthweight in mothers in Part-time occupation (mean 3.51, SD -  0.58) did not 
differ significantly from either group Figure 3.4.i). The same was seen for birth 
length, where the mean length for those in full-time occupation (mean 51.07 SD = 
2.25) was significantly different from the mean length for housewives (mean 52.31 
SD = 2.23) but the mean length of those in part-time occupation (mean = 51.94, SD 
2.18) did not differ significantly from either group.
Figure 3.4.1 Variation in birth weight with maternal occupational status
Occupation
A one-way between groups analysis of covariance was conducted to compare the 
effect of maternal occupation on length. Birth weight was used as the covariate in this 
analysis. Preliminary checks were conducted to ensure that there was no violation of 
the assumptions of normality, linearity, homogeneity of variances, homogeneity of
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regi'ession slopes and the reliable measurement of the covariate. After adjusting for 
birth weight, there was no significant difference between the thr ee groups and length 
( f  = 0.344)
Independent sample t-tests were conducted to compare the categorical, chaiacteristics 
and pregnancy outcomes. There was a significant difference in birth weights in 
primiparous (3.31 SD 0.55) and multipai'ous women (mean = 3.61 SD 0.54) (P 
<0.001) (Figure 3.4.j). Significant differences were also seen between length in 
primiparous women (mean 50.98 SD 2.29) and imiltiparous women (mean 52.14 SD 
2.14) (P = 0.004). In addition, tlie mean head circumference was significantly 
different between primiparous women (mean 34.90 SD 1.48) and multiparous women 
(mean 35.48 SD 1.60) (P= 0.033).
However once a one way between groups analysis of covariance was conducted to 
compare the effect of parity on both length and head circumference while adjusting 
for birth weight, the differences ceased to be significant for both length (P = 0.513) 
and head circumference (P = 0.217).
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Figure 3.4.j Variation in birth weight with parity
Parity
3.4.1.2 Paternal characteristics
Table 3.4.d and e show some of the paternal characteristics, which were requested in 
the survey.
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Table 3.4.d Paternal characteristics (categorical variables)
Characteristic n n(% )
Smoking 198
Yes 43(21.7)
No 155(78.3)
Education 198
None 4 (2 .1 )
GSCE 54(28.6)
A-Level 25(13.2)
Degree 79(41.8)
Post degree 27(14.3)
Ethnic origin 198
White 195 (98.5)
Black African 1 (0.5)
Indian 1 (0.5)
Pakistani 1 (0.5)
Occupation 198
Full-time 194(98)
Unemployed 4 ^ 0
Table 3.4.e Paternal characteristics (continuous variables)
Characteristic N Min Max Mean (SD)
Height (m) 195 1.63 1.96 1.8 (0.063)
Birth weight (kg) 109 2 4.7 3.49 (0.59)
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Independent t-tests were canied out to investigate the effect of smoking on infant’s 
birth weight, length and head circumference. There were no differences in the mean 
birth (P=0.666), mean length (P = 0.446) or mean head circumference (P =0.791) 
in infants whose fathers smoked compared to those who did not smoke.
Pear son product correlation coefficient was used to investigate the relationships 
between father’s height and pregnancy outcome. There was a positive correlation 
between father’s height and infant length (P = 0.015, r = 0.217) (Figure 3.4.k). 
However, there were no significant relationships found between fathers height and 
birth weight or head circumference (P= 0.063, r = 0.133) and (P=0.474, r = 0.064) 
respectively.
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Figure 3.4.k Relationship between father’s height (m) and infant length (cm)
S  so
Father's height (m)
Father’s birth weight was also analysed with regard to pregnancy outcome using 
Pearson product correlations. There was a positive correlation between the father’s 
birth weight and the infant’s birth weight (P<0.001, r = 0.343) (Figure 3.4.1), length 
(P=0.036, r=0.241) and head circumference (P=0.004, r = 0.324). However, once 
partial correlations were conducted to investigate the relationship between father’s 
birth weight and both infant length and head circumference while controlling for the 
infant’s birth weight, both relationships ceased to be significant (P= 0.813) and (P = 
0.323) respectively.
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Figure 3.4.1 Relationship between father’s birth weight (kg) and infant birth 
weight (kg)
Gender
1.5 2.0 2.5 s o  5.5 4.0  4.5  5.0
Father’s  birth weight (kg)
3.5 Dietary advice during pregnancy
The women in this survey were asked whether they had received any dietary advice 
during pregnancy. Of the survey sample, one hundred and fifty two women (75.6%) 
had received some sort of dietary advice. The women were also asked who had 
offered the advice. It was found that the midwife was the main source of dietary 
advice in these women (Figure 3.5.a)
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Figure 3.5.a Distribution of dietary advice providers
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4.DISCUSSION OF QUESTIONNAIRE STUDY
4JN V P
4.1.1 Symptoms of NVP
In this study, 72.6% of the subjects experienced symptoms of NVP. This compares 
well with other studies that noted that 69%-89.4% of the sample experienced NVP 
(Brandes, 1967, Little and Hook, 1979, Jarnefelt-Samsioe et al, 1983, Tierson et al, 
1986, Vellacott et al, 1988, Wiegel and Wiegel, 1988, Wiegel and Wiegel, 1989, 
Gadsby et al, 1993, Lacroix et al, 2000, Fuiiieaux et al, 2001).
Of the women who had symptoms of NVP, it was found that 42.5% of women had 
symptoms of both nausea and vomiting. Again this compares well with other studies 
which reported vomiting in 32.2%-56% of women ( Klebanoff et al, 1985,Vellacott et 
al, 1988, Teirson et al, 1986, Wiegel and Wiegel, 1988, Wiegel and Wiegel, 1989, 
Andi'ews and Whitehead, 1990, Gadsby et al, 1993, Lacroix et al, 2000).
4.1.2 Onset and duration of NVP
It is generally believed that symptoms of NVP are only experienced during the first 
trimester (Vellacott et al, 1988, Lacroix et al, 2000), however, this study as well as 
others show that NVP continued into the second trimester.
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In this study, it was seen that symptoms of NVP are reported to start early on in 
pregnancy, with 32.4% of women experiencing symptoms by 4 weeks gestation, ie 
even before most women ai*e even aware that they are pregnant, thus, NVP is usually 
the first sign of pregnancy. By 10 weeks the majority of women (95.9%) had 
experienced symptoms of NVP. NVP lasted a mean of 3 months and by 20 weeks 
gestation, 73.6% ceased having symptoms.
This is supported by a study canied out by Jarnfelt-Samsioe et al (1983) who 
reviewed questionnaires mailed twice to women who had at least tluee children, the 
last being delivered between 1980 and 1981 at a imiversity hospital in Sweden. They 
found that in 91% of women, the onset of NVP was within the first trimester of 
pregnancy and in 75% of cases, symptoms lasted approximately three months.
Vellacott et al (1988) who canied out a study on 500 women who were recruited from 
antenatal clinic at St. Thomas’ Hospital, found that 87% of women had symptoms by 
8 weeks gestation, with 8% being affected even before the first missed period. 
However by the 12^ *' week gestation symptoms had ceased only in 27% of the sample.
Similar findings have also been reported by Wiegel and Wiegel (1989) in their study 
of a cohort of women in Los Angeles who had delivered a single baby between 
April 1983 and 3 March 1984. They found that symptoms started by 4-6 weeks, 
pealced at 8-12 weeks and diminished thereafter until by 20 weeks relatively few 
women experienced either nausea or vomiting.
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Similarly, Lacroix et al (2000) found that among the 160 women studied 
prospectively, nausea was recorded as eai'ly as 3 weeks gestation, with the mean 
gestational age of onset being 5.7 weeks. Vomiting began as early as 4 weeks 
gestation. They found that symptoms were greatest at 11 weeks gestation and the 
severity in those affected pealced at 11 to 13 weeks. Although the prevalence 
gradually declined in the second trimester, only half the women with NVP were 
completely relieved by 14 weeks gestation, and it was not until week 22 that nausea 
had resolved in 90% of all affected women.
Two other studies also found NVP to persist into the second trimester. Teirson et al 
(1986) who studied 414 upper middle class women from New York, prospectively 
during pregnancy, found that although NVP had resolved in 50% by week 15, 25% 
still experienced by week 20. Klebanoff et al (1985) using data collected for the 
Collaborative Perinatal Project which involved 56,000 pregnancies from 1959-1966, 
found that in 9% of women, vomiting continued even after week 22 gestation.
Thus it can be seen that in some women, symptoms seem to persist even beyond week 
20, and it is important that pregnant women ai e made aware of this to avoid anger, 
worry and disappointment if symptoms persist.
In this retrospective questionnaire study, women who had symptoms of nausea only 
started symptoms earlier (5.3 weeks) compared to those who had both nausea and 
vomiting (6.3 weeks). In addition, in women with mild NVP, symptoms lasted for a 
shorter duration that women with both nausea and vomiting. Also within the severity 
of symptoms, those women with more severe NVP had symptoms for a longer 
duration than those with nausea only. Two studied support these findings. Both
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Tierson et al (1986) and Zhou and O’Brien et al (1999) found that women with both 
nausea and vomiting had longer duration of symptoms compai ed to women with 
nausea only.
These findings imply that mild to moderate NVP is
• Common
• Usually the first sign of pregnancy
• Persistent
• A natural state of pregnancy rather than a pathological condition.
4.1.3 Episodic nature of symptoms
Of the women reporting symptoms of NVP, this study found that 41.8% reported 
symptoms to have occurred for a few hours per day, 27.9% reported symptoms lasting 
tluoughout the day, 12.3% had symptoms in the mornings only and 7.5% reported 
symptoms to have occuiTed only in the evenings. Thus it can be seen that nausea and 
vomiting ar e experienced beyond the morning hour s and some women complain of 
symptoms throughout the day. This finding is supported by other studies, suggesting 
that the term “Morning Siclaiess” is misleading and preferably should be avoided 
when referring to symptoms of NVP.
Jarnfelt-Samsioe et al (1983) surveyed 244 multigravida who had delivered at least 3 
children regarding their experiences of pregnancy, which had occurred within the 
previous two years. The researchers found that the intensity of nausea showed a 
diurnal variation with 50% of the women experiencing worst nausea in the morning,
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7% in the evening and 36% all day with no peak period. The remaining 7% had peaks 
of nausea both in the morning as well as in the evening.
In a study of 500 women at St. Thomas’ Hospital, London by Vellacott et al (1988), 
information was obtained about symptoms and possible associated factors by a 
comprehensive questionnaire, which was applied at the booking-in appointment. The 
patients were then followed up regulai'ly tlnoughout the pregnancy repeating those 
questions relevant, and a final postnatal questiomiaire evaluated outcome. The authors 
reported that although 80% of women complained of NVP in the morning, only 19% 
indicated that NVP was confined to this time. The usual pattern was for symptoms to 
persist throughout the day, with 46% complaining of NVP in the afternoon, 55% in 
the evening and 12% at night.
Dilorio’s study in 1985 on 92 pregnant teenagers found that early morning hours were 
the most common time of day for symptoms to occiu. 20% of respondents however 
noted that they were most likely to experience symptoms in the evening and another 
20% indicated that NVP lasted all day long.
In the studies mentioned above, as well as the one we conducted, subjects were asked 
to recall symptoms, with the period of recall ranging from a few hours, to a few days 
for those currently pregnant, to several years such as the study by Jaiiifelt-Samsioe et 
al (1983). The problem with recall is that only the intense periods of NVP are likely to 
be remembered, whereas, moderate and mild nausea may be forgotten (Dilorio et al, 
1992).
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However, in studies that were conducted prospectively with the women recording the 
symptoms as they felt them, similai* results were found, suggesting that recall of 
symptoms of NVP is good, and women do not “forget” their symptoms.
In a prospective study carried out by Dilorio et al (1992) on 19 women in America, 
the women were asked to keep a 7-day diary of their symptoms. It was found that 
although NVP was slightly more likely but not significantly to occur in the mornings, 
its occuiTence is not confined to this time, afternoon and evenings were also peak 
times for NVP to occur. The authors suggest that there aie four major peak times for 
NVP to occur, morning peak nausea, evening peak nausea, bimodal nausea and all 
day nausea.
In another prospective study carried out by Gadsby et al (1993) on 363 women in 
Leicester, who were asked to keep a diary of their symptoms until the symptoms 
ceased, it was found that although the most common time for symptoms to occur was 
in the morning, only 4% of the women had only morning sickness, while 95% had 
symptoms before and after midday. The authors reported a fairly equal distribution of 
symptoms tluoughout the day.
More recently, Lacroix et al (2000) cairied out a prospective study on 160 women in 
Canada. Subjects were asked to keep daily recordings of frequency, duiation and 
severity of symptoms. It was found that although 80.2% of women reported nausea in 
the morning, only 1.8% reported that nausea was limited to the morning only. In 3.7% 
nausea lasted until the afternoon, until after suppertime in 4.7% of women and all day
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long in 80%. In 10% of women, symptoms were not experienced in the morning at all, 
but they had symptoms at various times thioughout the day.
Results from different studies in different locations, using botli retrospective and 
prospective methods showed that NVP was not confined to the mornings. Thus the 
continued reference to NVP as “morning sickness” may be confusing for pregnant 
women , especially those who are pregnant for the first time and experiencing 
symptoms at other times of the day.
4.1.4 Factors related to NVP
4.1.4.1 Smoking pre-pregnancy
Women who smoked pre-pregnancy ai*e less likely to suffer from NVP than those 
women who did not smoke pre-pregnancy. This finding is supported by many studies 
which found the same association (Little and Hook, 1979, Jarnfelt-Samsioe et al,
1983, Klebanoff et al, 1985, Vellacott et al, 1988, O’Brien and Zhou, 1995, Gadsby et 
id ,1993).
Several authors have put forward hypotheses to try and explain this association. 
Smoking could stimulate gastric motility and activity, which is, known to diminish 
nausea (Jarnfelt-Samsioe et al, 1983). Smoking could have a tranquilizing effect on 
the women making them less prone to NVP (Vellacott et al, 1988). O’Brien and Zhou 
(1995) cite a study by Bremme (1990) which found that women who smoked had 
lower serum estriol and prolactin levels dming the first 20 weeks of pregnancy than 
did non-smokers. In addition to the effect of smoking on the endocrine system, 
O’Brien and Zhou (1995) speculate that smoking tends to blunt olfactory and
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gustatory senses. All sensory stimulation, particulai'ly those such as odours and 
alterations in taste perception were tioublesome for those who reported moderate to 
severe symptoms in another study carried out by the same authors in 1997. Flaxman 
and Sherman (2000) also speculate that smoking may reduce symptoms of NVP by 
interfering with the underlying neuroendocrine system or by damaging placental cells 
that may be responsible for triggering NVP. Possible aversion to smoking could again 
be part of the embryo protection hypothesis as cigar ette smoking is a known 
reproductive toxin known to adversely affect both fertility and fetal weight (O’Brien 
and Zhou, 1995).
4.1.4.2 Education
The incidence of NVP was associated with the level of education. Again this finding 
is not supported by other studies. Vellacott et al (1988) and Pettiti (1986) did not find 
a relationship between NVP and level of education. Klebanoff et al (1985) and 
Lacroix et al (2000) found the opposite effect, where the risk of vomiting increased 
with decreased level of education. This possible variation in results could be due to 
differences in the methodologies between the studies. Moreover, in tliis study, the 
majority of women had a degr ee or higher and thus could have biased the results. An 
explanation for oiu findings though is that the more educated the women, the more 
interest they took in their pregnancy, and concentrated more on what was happening, 
which could have psychologically caused the symptoms of NVP.
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4,1.43 Parity
Finally, we have observed that NVP occurred more often in multiparous as opposed to 
primiparous women. Pettiti (1986) in her post-pregnancy survey of 7,767 pregnancies, 
found that the risk of NVP increased with increased parity. Vellacott et al (1988), 
Gadsby et al (1993) and Bayley et al (2002) did not find an association between parity 
and NVP, while the opposite effect was observed by Klebanoff et al (1985) who 
found that first time mothers were more likely to suffer from NVP. O’Brien and Zhou 
(1995) in their prospective study on 126 women also foimd that vomiting was more 
common in nulliparous women. O’Brien and Zhou (1995) report that multiparous 
women have lower levels of circulating and urinary oestrogens and that there is some 
evidence that oestrogen production and metabolism are altered by a women’s first frrll 
term pregnancy so that the amount of free oestradiol is lower is subsequent 
pregnancies.
4.1.5 Effect of NVP on intake
In this study, 31% of women with NVP perceived their intake to have increased, 
while 28.9% perceived their intake to have decreased. As for the remaining 20.9%, 
they reported no change in intake.
In a study by Robinson et al (2001) on 494 women who were interviewed at fifteen 
weeks gestation, 34% of women reported increased intake and 35% reported a 
decreased intake. Of the women who reported an increase in intake, 64% attributed 
the change to increased himger, whilst 26% reported that increasing their intake 
helped alleviate nausea. On the other hand, those who reported a decreased intake, 
39% attributed this to being less hungry, whilst 53% reported that this was due to
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NVP. Robinson et al (2001) concluded that with the exception of women with severe 
nausea, there was no cleai' pattern of change in intake in relation to the degree of 
NVP, and that appetite changes during pregnancy strongly influence intake, 
independently of NVP.
In om* study we specifically asked the women with NVP about how they perceived 
NVP to have affected their intake, and roughly equal proportions of women reported 
an increase, decrease or no change in intake due to NVP. However, as the study was 
based on recall, and there was no specific question asking whether the change in 
intake could be due to other factors, these results cannot be taken for certain.
4,1.6 Advice sought for NVP
Only twenty-three women (15.8%) in this study reported seeking professional help for 
their NVP. Ten women reported asking their GP or midwife for help. Both medication 
and pressur e bands were the most common relief measiue advised. Hospitalisation, 
rest, eating little and often, acupimctiue and ginger followed this. The remaining 
thirteen women reported seeking alternative medical tlierapy. The majority of women 
were recommended pressiue bands, two women were advised to try aromatherapy and 
one woman ginger.
In a sur'vey carried out on one hundred and thirty clinicians who treated women with 
NVP, by Dilorio et al (1994), it was found that clinicians generally recommend eating 
small frequent meals, eating crackers and avoiding greasy and spicy foods. The 
respondents were least likely to recommend supportive therapies such as reassurance, 
rest and alternative therapies such as acupressiue and relaxation. Dilorio et al (1994)
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State that these measures recommended ai'e in accordance with what is found in 
midwifery and medical textbooks. However, this study and others such as that carried 
out by Dilorio (1985) foimd that resting and lying down was a very effective measure 
in relieving symptoms. Rest and lying down was not mentioned in any of the clinical 
textbooks reviewed by the researchers. This could be due to the fact that rest is not a 
specific relief strategy for nausea. The clinicians studied perceived that antiemetics 
were the most effective measure, however, though studies have shown that the most 
frequently merrtioned remedies were eating little and often and rest. Although 
clinicians perceived eating frequently to be effective, they did not perceive rest to be. 
This could be due to the fact that the clinicians do not ask their patients about the 
effectiveness of rest and lying down (Dilorio et al, 1994). The clinicians reported that 
the main source of information about effectiveness of remedies was from the women 
themselves, thus clinicians should encoumge women to share their experience of NVP 
(Dilorio et al, 1994)
In a study carried out by Power et al (2001) on four' himdred and eighty eight 
physicians about “Nutrition in Pregnancy”, the most frequently recommended remedy 
was eating small frequent meals (95.5%), eating crackers (88.5%), avoiding strong 
odorrrs (75.6%), antiemetics (71.3%) ginger (51.8%) and stopping iron supplements 
(50%). It was seen that women physicians were more likely to recommend ginger 
and herbal teas and less were less likely to prescribe other treatments like vitamin B6 
and acupressure. The authors concluded that the physicians seemed to be well 
informed about the current opinion on management of NVP, including the use of 
alternative remedies. The fact that over 70% of physicians prescribed anti-emetics 
shows that obsteti'icians and gynaecologists are willing to treat this condition
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aggressively. However, Vellacott et al (1986) reported that only fifty out of four 
hundred women with NVP in their study had actually taken medication for NVP. This 
could be due to the increased awareness of possible side effects of the medication, or 
due to the fact the interest was being shown in the women’s symptoms, making the 
women feel better.
In this study a very small number of women with symptoms of NVP actually asked 
for help to ease the symptoms. Many women feel that it is a normal process and that 
they have to put up with it, or they do not know that something can be done to relieve 
the symptoms. It is up to the caregivers to ask about the symptoms. We have seen that 
the clinicians are aware of the treatments available if they are asked. However, as this 
study is based on the women reporting whether help was asked for and what advice 
was being given, these results may not be very acciu ate in judging the doctors 
knowledge or the percentage of clinicians offering help for NVP. In addition, it may 
be up to the researchers in this field to increase the clinicians awar'eness about these 
symptoms and treatments available. A study in Canada on one hrmdr ed and two 
women carried out by Lee et al (2000) showed that since 1995 a campaign to increase 
awar eness of NVP and its treatment among healtii care professionals, using 
newsletters, ar ticles, publications, video presentations, conferences and continuing 
medical education programs, there had been an increase in the percentage of 
clinicians offering treatment to women with NVP. In addition, before the campaign, 
clinicians were offering Gravol (dimenliydrinate) as the first line of treatment, 
whereas after the campaign. Dilectin, which is the medicine recommended 
specifically for NVP was used by 95% of clinicians. Other treatments offered were 
herbal products, pressure bands and ginger. Lee et al (2000) put forward the argument
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that there is a definite potential role for evidence based interventions to ensure 
optimal therapy for women while protecting the unborn child. On the other hand, we 
have seen from this study and that reported by Power et al (2001) that clinicians seem 
to be well informed about the treatments available, but since there is still a lack of 
understanding regar ding the pathophysiology of this condition, effective clinical 
management cannot be found. Thus at this time improvement in management may be 
more likely to depend on efforts of researchers rather than educators.
In practice, clinicians must talce a proactive role in providing up to date information 
about NVP as well as supporting women with symptoms, thus they should stay alread 
in terms of information regar ding NVP and treatments available (Dilorio et al, 1994). 
In addition, Dilorio et al, 1994 report that many women report gaining information 
fr om mothers, family members and friends, thus it is important that there is public 
awareness about treatments available so that the women will receive safe advice. Thus 
it is preferable if the researchers and educators work together to increase awareness 
about NVP, which affects so many women and may have a large emotional and 
economic impact. In the study carried out by Gadsby et al (1993), it was found that 
out of the 363 women taking part in the study, 206 were in paid employment. Seventy 
thr*ee of these women (35%) spent a mean of 62 hours away from their paid work 
because of their symptoms, showing the socio-economic significance of this 
condition.
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4.1.7 Methods used to alleviate symptoms
In this study it was found that the most common relief measur e was eating little and 
often, followed by eating carbohydrate rich foods, ginger and rest. These relief 
measures have been observed in other studies.
Lacroix et al (2000) found that the most effective dietary methods used by women to 
alleviate symptoms were modification of diet to dry foods and carbonated drinks and 
increasing the time spent outdoors and reduction of mobility.
O’Brien et al (1997) reported that although most women reported that no intervention 
or relief measures completely relieved symptoms, almost all women reported to have 
altered their normal activities in some way, with rest being an important relief 
measure, especially lying down. Other effective measures were being outdoors or in 
water, and nutritional factors such as hydr ation and consumption of car bohydrates 
especially breads and crackers. Most women also foimd fruit such as bananas and 
oranges to be helpful. Meat was consumed less, with the main protein source being 
dairy products. This was also seen in our study where when questioned about foods 
which helped reduce symptoms of NVP, the majority of women reported 
carbohydrates. Some women also mentioned fr*uit, sweets, non-alcoholic beverages 
and dairy products; Meat was not mentioned by anyone.
In a prospective study carried out by O’Brien and Naber (1992) on 147 women, using 
open-ended questions, 120 women reported at least one teclinique to relieve 
symptoms. The most common was eating (52.8%), recumbent rest (25%), nothing 
(9.7%), vomiting (5.6%), time (4,2%), medication (2.1%) and distraction (0.7%).
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In a study on 92 pregnant teenagers, Dilorio (1985) found that the teenagers had tr ied 
a variety of measures to control NVP, the most common measur e was .lying down 
during an episode of NVP, with 46% of those who tried it reporting it to be effective 
in reducing symptoms. Twenty-three women tried eating crackers, but only 26% 
fomid this to be the most effective measure in relieving symptoms. Other measures 
mentioned were going out for air, sitting quietly, fizzy drink and anti-sickness 
medication.
It can be seen that rest has been mentioned very frequently as an effective relief 
measure for NVP. Dilorio (1985) speculates that NVP may be due to orthostatic 
hypotension, ie low blood pressure found in some patients when they stand up, as 
NVP tends to occur on getting out of bed in the morning. Lying down is thus a 
common sense approach to counteract orthostatic hypotension. O’Brien at al (1997) 
reports that by lying down, women may be trying to reduce the amount of fatigue that 
they were experiencing as many women reported being continuously tired, or they 
may have been trying to stabilise their position since some women reported that they 
often felt dizzy. More research is needed to find out whether rest or position has the 
gr eatest impact on symptom relief.
Some factors are known to exacerbate symptoms. In this study, when the women were 
asked about foods, which made symptoms worse, the most commonly avoided foods 
and drinks were “ethnic” and spicy foods, followed by stimulating drink such as tea 
and coffee. Similar findings have been reported in other studies. O’Brien et al (1997)
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foiind that the foods that made the symptoms worse were probably related to 
individual taste and food tolerance. Some women reported spicy foods, and others 
reported not being able to tolerate prenatal supplements or coffee. Other factors, 
which exacerbated symptoms, included olfactoiy stimulation such as smells, and 
some activities such as loud noises and talking on the phone.
In their study on 147 women, O’Brien and Naber (1992) found that 117 women 
reported at least one thing that exacerbated symptoms, mainly particular foods or 
beverages, not eating, physical position and olfactory stimulation. Some other 
mentioned factors were auditory stimulation, visual stimulation, heat, time of day and 
brushing teeth.
In practice, this information can help symptomatic women and their providers develop 
sti-ategies for reducing symptoms of NVP. The results cannot be generalised to the 
entire population of symptomatic women, as each woman is different; by knowing • 
what other women foimd effective, advice can be given to each women to try the 
different methods mentioned to see which method will suit that individual.
Lacroix et al (2000) found that among their sample, 20% had not tried any relief 
measure, suggesting that measures should be reviewed with women as some women 
may not know what can be done, this might prove to be beneficial in reducing 
symptoms amongst the women.
I l l
4.1.8 Effect of NVP on outcome of pregnancy
In this retrospective questionnaire study, no relationship was observed between NVP 
and outcome of pregnancy. This is supported by other studies. Jarnfelt-Samsioe et al 
(1983) found no effect of NVP on birth weight and length of gestation. Lacroix et al 
(2000) also did not find an effect of NVP on birth weight and Wiegel and Wiegel 
(1989) did not find an effect on birth weight, length, head circumference and length of 
gestation. Wiegel and Wiegel (1989) found that the only outcome associated with 
NVP was a decreased risk of miscarriage, and it was those women who vomited who 
had the decreased risk, women with nausea only had similar miscaiTiage rates as those 
women without NVP.
However, other authors have reported a protective effect of NVP on outcome of 
pregnancy. Klebanoff et al (1985) did not find an effect of NVP on birth weight, but 
they did find that those women who had vomited had a longer gestation (1.5 days) 
compared to those women who did not vomit. Brandes (1967) found that women 
without NVP had lower birth weight babies and shorted gestations than those with 
NVP. Tierson et al (1986) also found that asymptomatic women delivered a higher 
proportion of LBW babies (20%) compaied to those with nausea (6%) and vomiting 
(10%), partly as a result of lower gestational age in asymptomatic women.
It was originally speculated by Little and Hook (1979) that NVP may be protective, as 
NVP was more common among non-smokers and drinkers. However, in a later study, 
Little (1980) found that NVP was related to a higher birth weight, even after
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adjustment for maternal smoking and alcohol use. Smoking and drinking during 
pregnancy were found to be independent risk factors for LBW.
Wiegel and Wiegel (1989) suggested that the lack of agreement in findings could be 
due the fact that confounding variables which have been shown to affect birth weight 
may not have been taken into consideration in some studies. The large size of their 
study, 903 women and the fact that other studies have shown similar findings 
increases the confidence of these findings.
Flaxman and Sherman (2000) who conducted a comprehensive review of the 
literature found that women who experienced NVP were significantly less likely to 
miscaiiy than women who did not. The authors report that in contrast to the strong 
and consistent negative associations between NVP and miscarriage, NVP was not 
associated with birth weight and rate of birth defects. In addition, Flaxman and 
Sherman (2000) investigated whether alleviating the symptoms artificially would 
reduce the positive effects of NVP. However in their review of the studies conducted 
on anti-emetic use and NVP, Flaxman and Sherman (2000) did not see an increase in 
risk of birth defects in women who took antiemetics. The authors report however that 
eliminating vomiting could create a better metabolic environment for fetal 
development, or that those women with symptoms severe enough to require 
medication are bearing the healthiest embiyos, or that women with NVP may have 
developed aversions to potentially hamifiil foods, thus protecting the woman and her 
fetus. Thus we can see that for the time being, we can reassure women that NVP does 
have some protective effects and that alleviating symptoms does not stop this effect.
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Although NVP seems to have a protective effect in terms of reducing risk of 
miscarriage, it does not seem to have an effect on other pregnancy outcomes. 
However, results remain controversial, and how NVP exerts its effect is still only at 
the hypothesis level, a lot of research is needed in this area before any definite 
conclusions can be drawn.
4.2 Dietary cravings and aversions in pregnancy
4.2.1 Incidence of cravings and aversions in pregnancy
It can be seen that dietary cravings and aversions are not limited to a few isolated 
individuals but affect a sizeable fraction of pregnant women. In this study 51.3% 
reported at least one craving and 41.4% reported at least one aversion. This incidence 
is similar to that reported by other authors. Cravings have been reported to occur* in 
47%-76% of pregnant women (Dickens and Trethowan, 1971, Schwab and Axelson, 
Finley et al, 1985, Tierson et al, 1985, Wijewardene et al, 1994, 1984, Knox, 1995, 
Bayley et al, 2002) wliile aversions bave been repor*ted to occur* in 25.1%-85% of 
pregnant women (Dickens and Trethowan, 1971, Schwab and Axelson, 1984, Finley 
et al, 1985, Tierson et al, 1985, Wijewar*dene et al, 1994,, Knox, 1995, Bayley et al,
2002X
4.2.2 Foods craved and avoided during pregnancy
We have found that the most commonly craved food category was sweets, fruit, 
grains and starches followed by dairy products. In this sample, there were three 
r*epor*tings of pica, one for coal, and two for* ice-cubes. As for aversions, the most
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commonly avoided foods were stimulating drinks, followed by vegetables, and ethnic, 
strong and spicy foods.
Similar findings were reported by Finley et al (1985). The foods most commonly 
craved were sweets, milk products and finit. As for aversions, Finley et al (1985) 
reported that vegetables, gi*easy, strong tasting foods, tea, coffee and alcohol were 
most commonly avoided.
In another study carried out in the UK on 100 primiparous women by Dickens and 
Trethowan (1971), the most commonly craved foods were fruit and fruit drinks, 
sweets, chocolate and ice cream, and milk and dairy products. The most commonly 
avoided foods were tea, coffee, cocoa, vegetables, meat fish and eggs, followed by 
greasy foods.
In their review of the literatm e, Flaxman and Sherman (2000) found that the most 
commonly craved foods were fiuit and juices, sweets, and dairy products and ice 
cream. The most commonly avoided foods were meats, fish and poultry and eggs 
followed by non-alcoholic beverages then vegetables. They reported that the pattern 
of cravings and aversions were mirror images of each other.
Bayley et al (2002) also found that the most commonly craved foods were finit and 
fruit juices and sweet foods, and the most commonly avoided foods were tea, coffee, 
spicy foods and meat or high protein foods.
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Our study as well as those studies carried out by other authors have shown that fruit 
and fruit juices are commonly craved foods during pregnancy, whereas, tea and coffee 
aie commonly avoided. Dickens and Trethowan (1971) speculate that it would appear 
that women crave strong-tasting foods, whereas aversions are for those items which 
have a unique or powerful odour. They put forward the idea that pregnant women 
crave sweet, sour, savouiy or strong-tasting substances in order to try and stimulate 
and impaired sense of taste and smell brought about by pregnancy. Brown and Toma 
(1986) carried out a taste test on twenty-tln*ee pregnant women and twenty-three non­
pregnant women. They found that pregnant women were less able to discriminate 
among differing concentrations of salt solutions compared to non-pregnant women 
and preferred stronger tasting salt solutions compared to non-pregnant women. As for 
sucrose solutions, no significant difference was seen, though the authors suggest that 
larger studies aie needed to test this effect.
As for aversions, Dickens and Trethowan (1971) speculate that aversions could be 
due to heightened sense of smell, for example many women report an aversion to the 
smell of tobacco.
Aside ftom changes in olfactory and taste sensitivity in pregnancy, several other 
factors may be the cause of dietaiy cravings and aversions. The cravings for dairy 
items, sweets, chocolate and fruit could be due to the increased needs for calcium and 
calories (Hook, 1978). Although there is an increased need for protein.too, there is no 
craving for meat products, infact meat is often reported as an aversion. This could be 
due to the fact that protein consumption today is high anyway. Finley et al (1985)
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reported that while aversions to meat products and vegetables may reduce the quality 
of the diet, most women who reported an aversion to meat had a craving for dairy 
products.
Another cause which was originally put forward by Hook (1978), and has recently 
gained a lot of interest is that cravings and aversions ai e manifestations of an 
evolutionary process in which beneficial foods were chosen and craved, and aversions 
developed toward food haiinful to the fetus. In accordance with this theory is that it 
has been seen that many women report an aversion to caffeinated drinlcs. Fimieaux et 
al (2001) state that there is some evidence to suggest that caffeine consumption may 
be associated with lUGR, spontaneous abortion and adverse effects on the neonate, 
though results remain controversial. Caffeine belongs to a family of drugs known as 
methylxanthines. Caffeine is completely absorbed from die digestive tract and reaches 
all tissues, and during pregnancy, caffeine passes tlimugh the placenta and can be 
measured in fetal tissues, cord blood and amniotic fluid and breast milk.
We have also seen a high aversion to vegetables. The chemicals that give many plants 
their distinctive aromas and flavouis evolved to counter the plant’s enemies such as 
herbivorous insects and vertebrates, fungi, pathogens and parasites. These chemicals 
are known as phytochemicals, and in large quantities they can be mutagens, 
teratogens, abortifacients and allergens. For example, crude juice extiacts from 
vegetables such as cabbage or brussel sprouts contain isothiocyaiiates and other 
breakdown products of glucosinolates that can induce clnomosomal aberrations in 
mammalian cells (Flaxman and Sherman, 2000).
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Flaxman and Sherman (2000) considered thiee possible explanations for the 
association between animal products, food aversions and NVP. First, the digestive 
breakdown of animal products may create or release teratogenic or abotifacient 
substances. Categories of compounds released include dipeptides, tripeptides, 
phospholipids, sterols, amino acids, uiic acid and fat soluble vitamins, of which only 
vitamin A is laiown to cause birth defects if consumed in pharmacological doses over 
several months of gestation, thus it is unlikely that the constituents of meats in the 
normal diet will endanger a developing embryo. The second idea put forward by 
Flaxman and Sherman (2000) is that certain culinaiy practices like frying and 
smoking create mutagens and introduce phytochemicals such as those in spices.
Before the widespread availability of refrtdgeration, the use of spices or heavy salting 
were primary means of preserving animal products, so by avoidance of roasted, 
burned or smoked or heavily spiced foods, pregnant women could minimize exposure 
of their embryo to toxic chemicals. We have seen in tliis study that etlinic, spicy or 
strong tasting foods were commonly avoided during pregnancy. Although spices may 
be beneficial in the tiny quantities used in cooking, in large doses, many 
phytochemicals have deletrious effects as allergens, mutagens, carcinogens, 
teratogens and abortifacients (Flaxman and Sherman, 2000). Flaxman and Sherman 
(2000) report that the third and most likely reason for avoidance of meat products is to 
minimize exposure to foodborne illnesses and food poisoning. It has been shown that 
raw meats and meat dishes that are prepared in advance and stored at ambient 
temperatures for more than a few hours, show a high increase in bacterial and fungal 
growth. Since the pregnant women’s immune system is suppressed in order to prevent 
rejection of her own offspring, it seems that aversions aie natui'e’s way of protecting 
the mother as well as the fetus. In view of this, Flaxman and Sherman (2000)
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expanded the term “embryo protection hypothesis” to be the “fetal and maternal 
protection hypothesis”.
We found a 3% incidence of pica in the women with cravings, with ice being reported 
in two out of the tlnee cases. In other studies, the incidence of pica has been reported 
to be between 12-20%, with the majority of women consuming ice (Knox et al, 1995, 
Pope et al, 1992, Scwab and Axelson, 1984). In the study caiTied out by Knox et al 
(1995) most women attributed the craving of ice to thirst, whereas Schwab and 
Axelson (1984) state that craving for ice (pagophagia) might be a clinical sign of iron 
deficiency. In a retrospective study by Rainville (1998) on 281 women who were 
eligible for the Special Supplemental Nutrition program for women, infants and 
cliildren (WIC), it was found that women who had ice pica, had the lowest 
haemoglobin levels. However, Rainville (1998) stated that it is not known whether 
anaemia is the cause or effect of pica, as it could be that the ice could be replacing 
iron-rich foods in the diet. However, being a retrospective study, tliis could have led 
to recall bias. In addition, the results of tlie study by Rainville (1998) only apply to 
those women eligible for the WIC program, also those women may have problems 
such as alcohol use or lifestyle factors which could have played a role in these results.
4.2.3 Reasons cited for cravings and aversions
Of the women reporting cravings and aversions in pregnancy, only thirty-nine women 
gave reasons for craving or avoiding certain foods. Only endogenous reasons were 
considered in this study, as exogenous factors such as the doctor telling the women to 
avoid a certain food is not the same as a definite dislike of the food, Tierson et al 
(1985) reported that most women reported endogenous factors for cravings and
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aversions such as NVP or that the food item tasted better. In a study caiiied out in 
Scotland, Taggart (1961) found that fruit were craved because they were readily 
available, and they satisfied thirst. In a retiospective study on 250 women. Hook 
(1978) found an increase in consumption of milk, which was not totally attributable to 
concern for infant and maternal health. Neaiiy one third of women reported 
endogenous factors such as a gieater desire for the item and better taste. Endogenous 
reasons such as nausea and loss of taste for the drinks were also cited as causes for 
aversions to stimulating drinks.
In this retrospective study, the main reasons cited for cravings were to ease NVP 
(mainly by carbohydrates and fr uit) because the foods were bland (such as 
cai'bohydrates, dairy products and fr uit), and to make up for reduced tea intake 
(increasing consumption of non-alcoholic beverages, fr uit juices and dairy products).
The main reasons cited for aversions in this study was mainly due to NVP (mainly 
etlinic, sti'ong, spicy foods, vegetables and stimulating drinks such as tea and coffee), 
this was followed by the smell of the food (mainly stimulating drinks) and heailburn 
(mainly ethnic, strong, spicy foods).
4.2.4 Factors related to cravings and aversions in pregnancy
The finding that cravings and aversions were more likely to occui* together than alone 
has been reported by other researchers (Dickens and Trethowan, 1971 and Knox, 
1995). Knox et al (1995) reported that this tendency for cravings and aversions to co­
exist may well point to some common causal link.
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In this study it was observed that cravings and aversions were more likely to occur in 
women with NVP. Although many authors report that the cause of some cravings and 
aversions could be NVP, to the best of the researcher’s knowledge, statistically 
significant relationships have only be seen by tlnee authors. Vellacott et al (1988) 
reported tliat those women with cravings were more likely to have NVP. Ciystal et al 
(1999) in a study on one hundred and twenty nine women, found that severity of 
symptoms of vomiting affected aversions, whereas severity of nausea did not. As for 
cravings, although there was an increase in cravings in women who had more severe 
vomiting, this relationship did not reach statistical significance, and again severity of 
nausea did not have an effect. In a recent retrospective study by Bayley et al (2002), 
on 99 pregnant women, it was found that there was a significant relationship between 
nausea and aversions. No significant relationship was seen between nausea and 
cravings. Bayley et al (2002) put forward the idea that the relationship between 
aversions and nausea was due to a taste aversion learning mechanism where foods 
paired with illness aie subsequently avoided. Bayley et al (2002) reported that this is 
supported by the fact that food aversions and nausea tended to start during the same 
week, and also that no relationship was seen between nausea and cravings. In 
addition, in most cases, cravings were found to start two weeks after nausea, and so 
Bayley et al (2002) speculated that the cravings could have developed for foods which 
would help ease tlie nausea, and as seen earlier, the main reason cited for the cravings 
in the current study was that the food eased NVP.
In this study it was found that aversions were more likely to occui* in women with 
higher education, other authors have not reported this relationship. Seeing the strong 
relationship between aversions and NVP, and as NVP was seen to occur more often in
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women with NVP, this could explain why aversions were more likely to occui* in 
women with higher levels of education.
4.3 Factors related to pregnancy outcomes
We have found that maternal birth weight was significantly related to infant birth 
weight, length and head circumference. We did not find a relationship between 
maternal birth weiglit and PI or head circumference to length ratio. In a study earned 
out by Godfrey et al (1997) on 538 infants in Southampton, it was found that women 
who themselves had a low birth weight had infants who were lighter and thinner, they 
also had lower pondéral indices. Maternal birth weight was an independent risk factor 
for pondéral index even after taking into account of gestational age, gender, parity and 
maternal diet. This association was also independent of SEC, maternal height and 
smoking. Godfrey et al (1997) stated that the fact that maternal but not paternal birth 
weight is related to infant pondéral index is evidence against the hypothesis that 
thinness at birth and later insulin resistance are due to genetic abnormalities. Since 
low maternal birth weight was found to affect placental weight, the authors speculated 
that low growth rates in utero among female fetuses may lead to impaired 
placentation when they reproduce, probably as a result of alterations in the uterine 
vasculature, which may be determined during fetal life. This impaired placentation 
may result in failine of the fetus to achieve it frill growth potential, or may lead to 
actual fetal wasting. Thus women whose own fetal growth was retarded tend to have 
thin infants, which could explain why some women have thin babies in successive 
pregnancies (Godfrey et a l , 1997). Since thinness at birth has been shown to be 
associated with insulin resistance, NIDDM and CHD in adult life, it is important to
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promote proper intrauterine growth in this generation, to protect the next generation 
(Godfrey et al, 1997).
In this study it was seen that maternal height was related only to infant length. 
Godfrey et al (1997) found that the infants of short women were shorter and lighter 
than infants born to tall women, however maternal height was umelated to infant’s 
pondéral index. Mathews et al (1999) in their study on 693 pregnant women in 
Portsmouth also found that maternal height was related to birth weight. Using 
multiple regression, maternal height was an independent risk factor for birth weight. 
Thame et al (1997) also found that shorter women had lighter, shorter babies with 
smaller head circumferences. However maternal height was not related to infant 
pondéral index or head circumference to length ratio.
Another factor found to be related to birth outcome was maternal BMI. Thinner 
women had lighter babies. In addition there was a trend for thinner women to have 
infants with smaller head circimiferences and lower PI. Thame et al (1997) in a 
retrospective study on 2394 records of pregnant women also found that maternal BMI 
was related to infant birth weight, length and head circumference, but it was not 
related to pondéral index or head circmiiference to length ratio.
We also found that maternal pre-pregnancy weight was related to infant birth weight, 
length and head circumference. In addition, there was a trend for maternal pre­
pregnancy weight to be related to PI. Godfrey at al (1997) found that after taking into
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account maternal height, smoking and parity, maternal weight in early pregnancy was 
only weakly related to infant birth weight and not related to pondéral index.
Mathews et al (1999) also found that maternal weight pre-pregnancy was related to 
birth weight, but it was not an independent factor. Thame et al (1997) found that 
mothers who were lighter had babies who were shorter, lighter with smaller head 
circumferences and higher head circumference to length ratio. Maternal weight was 
not found to be related to pondéral index.
Maternal weight gain in pregnancy was also a significant factor in terms of infant 
birth weight, length and head circumference. In their study on 510 women in 
America, Aaronson and Macnee (1989) also found a significant relationship between 
maternal weight gain and infant birth weight. Low maternal weight gain is known to 
be a risk factor for LBW and increased perinatal mortality (British Nutrition 
Foundation, 1994). In 1990, the National Academy of Sciences Food and Nutrition 
Board in the USA made recommendations where optimal target weight gains, based 
on optimal neonatal survival were established for groups of women with different pre­
pregnancy BMI, Within these recommendations, women witli lower pre-pregnancy 
BMI were recommended to gain more weight in pregnancy compared to those of 
higher BMI (British Nutrition Foundation, 1994). In a systematic review conducted 
recently by Abrams et al (2000), they found that studies have shown that pregnancy 
weight gain within the recommendations by the National Academy of Sceinces, Food 
and Nutrition Board in the USA, is associated with the best outcomes in terms of fetal 
weight compared to those women gaining below or above these recommendations.
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We have also shown that housewives had heavier and longer babies. Similai* findings 
were found by Wiegel and Wiegel (1989). In his review of the literatuie, Pivaiiiik 
(1998) concluded that some studies have shown job related physical activity to be 
related to unfavourable birth outcomes including prematuie delivery and LBW. 
Pivarnik (1998) reports that most studies did not control for SEC nor was actual 
physical activity throughout gestation actually quantified. In addition, other unlmown 
stresses related to the job may have confounded or modified the effects of physical 
activity.
We also showed that primiparous women had infants who were lighter, shorter and 
with smaller head circumference compared to infants born to multiparous women. 
Pai’ity had no effect on either PI or head circumference to length ratio. Godfrey et al 
(1997) also found that primiparous women had infants with lower birth weights and 
shorter lengths than infants born to multipaious women, pondéral index was also 
lower.
In this study we found that father’s height was related to infant length. In addition 
there was a near association with birth weight. Father’s height was not found to be 
related to either PI or head circumference to length ratio. Godfrey et al (1997) also 
found that infants of short fathers were lighter and shorter, with a proportionately 
greater decrease in length than birth weight, thus making the pondéral index of those 
infants higher. Godfrey at al (1997) report that since father’s height was not found to 
be related to placental weight, the association between father’s height and pondéral 
index does not seem to be mediated by impaired placental development. They 
speculate that this association could be due to genetic influences, where paternal
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height promotes higher rates of skeletal giowth in the offspring, which outstrip the 
supply of nutrients for soft tissue deposition. The authors found that father’s height 
was an independent risk factor for pondéral index even after taking into account of 
gestational age, gender, parity and maternal diet. Tliis association was also 
independent of SEC, maternal height and smoking.
Father’s who tliemselves had low birth weight were found to have infants who were 
lighter, shorter and with smaller head circumferences. Father’s birth weight was not 
found to be related to either PI or head circumference to length ratio. Godfrey et al 
(1997) also found that infants of fathers who themselves had a low birth weight were 
lighter and shorter, however paternal birth weight was unrelated to infant’s pondéral 
index. Godfrey et al (1997) found that maternal birth weight and paternal height were 
independently associated with pondéral index at birth.
As these var iations in size at birth may be early markers of CHD in later life, possible 
ways of reducing these variations should be aimed at.
It is always important to remember that these measurements were provided by the 
women in the study and were not actually measured in the study, thus inaccuracies 
may have occuned. However, the fact that other authors have reported similar results 
tends to increase the confidence in these findings. In addition, Godfrey et al (1997) 
found a high level of agreement when recalled weights from the sample were 
validated against a sample of those recorded in their study.
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4.4 Dietary advice during pregnancy
It was seen that most women received infoimation about nutrition in pregnancy from 
their midwife. Anderson (2001) stated that ante-natal caie is one situation that is 
unique in providing the opportunity to reach large numbers of healthy women with 
the potential to influence the health of the next generation. For many women, 
antenatal staff may be the first trained staff to inform, advise and re-enforce health 
messages about nutrition and other lifestyle considerations. Thus it is very important 
that the midwives have a sound knowledge of nutrition, as wrong information during 
pregnancy leading to poor nutritional intake may be risking a lot of health problems in 
the future generations, as we have seen from the work of Baiker and his colleagues. 
Thus in order to optimize the women’s reproductive health, nutrition screening and 
education should be an integral pai t of health care, and midwives are in an excellent 
position to deliver nutritional cai*e as primary cai*e providers for women of 
reproductive age (Hally, 1998). Midwives should be able to screen pregnant women 
for nutritional risk factors, and in specific cases with suspected nutritional 
inadequacy, refer the women to a dietitian.
Anderson (2001) reported that dietaiy alterations aimed at entrancing the well-being 
of the mother and baby may arise from a number of stimuli including advice given 
during pregnancy by health professionals, fi'om lay individuals and information 
gathered from books, magazines and the media. In our study, we have observed 
similar findings. Other than the midwives, some women reported receiving their 
information from book, magazines, their doctor and leaflets about pregnancy.. Other 
soiu’ces of information mentioned were friends, relatives and only in 3.3% of cases a
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dietitian. Since it has been observed that dietary information is sought from different 
sour ces, it is the responsibility of nutritionist to make sure that the information being 
wr itten or presented in the media is accmate and will not harm the woman or her 
baby. In addition, the midwives should just reiterate the general guidelines of diet in 
pregnancy to make sure that each woman has the proper information.
However, it is important to remember tliat in those women witli symptoms of NVP, 
their physical symptoms are controlling their intake, and in such cases, the dietary 
changes might not be nutritionally beneficial, but may actually make the women feel a 
lot better in the short teiin. Specifically for NVP, since midwives are the main source 
of dietary information for pregnant women, it is important that tliey are aware of the 
different remedies available in order to advise tlie women about them. In addition, 
midwives should ask the women about symptoms of NVP, as it has been shown that 
many women do not report these to their car ers.
4.5 Study Limitations
This study was based on women reporting about symptoms of NVP and cravings and 
aversions, which could have taken place one year* previously. Thus it does not allow 
for a very clear* recall of what actually happened. In addition, being a questionnaire 
study, the study was based on self-recall rather than actual observations of women’s 
responses to foods or* measured severity of NVP during pregnancy. Some women may 
have responded to what they should have wr*itten rather than what actually happened 
(Flaxman and Sherman, 2000). Self reporting may only provide approximate 
indications of what is actually consumed (Knox, 1995). Another* limitation is that the 
women were not given actual definitions for NVP and cravings and aversions. Dietary
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1preferences may be interpreted as cravings or women might translate increased 
appetite in pregnancy as cravings (Knox, 1995), In addition, in terms of severity of 
symptoms, mild nausea to one women might be very severe to another. Or nausea and 
vomiting which occurs only once or twice a day, may have less of an effect on the 
woman than continuous nausea which occurs throughout the day. Finally, the study 
was based on a biased community of high income, education and SEC, where only 
white women were included.
In the analysis conducted in this study, confounding variables such as gestational age 
and infant gender were not considered, these could have affected the relationships 
seen with pregnancy outcomes.
In the light of these limitations, it was decided to undertake a prospective clinical trial 
to examine the effect of NVP on dietary intake and outcome of pregnancy, and the 
following chapters describe the trial and the outcomes.
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5. SUBJECTS AND METHODS (PROSPECTIVE STUDY)
5.1 Study Design
A prospective study was conducted to test whether NVP had an effect on pregnancy 
outcome. Two subject groups of women, one with NVP and one without NVP were 
followed up for the dui ation of pregnancy, in order to assess whether their experience 
of NVP was related to their initial status such as pre-pregnancy weight, BMI, smoking 
status, and whether the outcome of pregnancy was related to their initial status or to 
factors occurring during pregnancy such as change in diet.
The achievable outcomes the study would observe were mean differences in 
pregnancy outcome between women with NVP and women without NVP.
5.2 Subjects and Recruitment 
5. 2.1. Subject Numbers
Sample size calculations were calculated by Dr. loannis Vlachonikolis, Reader in 
Medical Statistics, University of SuiTey. These were based on mean pregnancy 
outcome and standard deviation and the expected degree of change in outcome. In this 
study these were:
1) Mean birth weight of 3500g ( SD 500g) with an effect of 150g (Mathews and 
Neil, 1998)
2) Mean placental weight of 600g (SD 120g) and an effect of 50g (Williams et al, 
1997, Godfrey et al, 1996)
3) Percentage of women suffering from NVP (70%) (Broussard and Richter, 1998).
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In order that the tests of the effect of NVP on pregnancy outcome compar ed with the 
effect of no NVP had 80% power at the 5% significance level, 45 women per group 
were required. However, the study was restricted by the time frame rather than the 
statistical power.
5.2,2, Subject Characteristics
Women with and without NVP who consented to take part were recruited from the 
Guildford area. Due to the timetable, associated with the constr aints of the preparation 
of the thesis, recruitment was curtailed after eighteen months. Women were recruited 
early on in pregnancy when NVP was likely to occur. All the women had healthy 
pregnancies, with no gestational diabetes, high blood pressur e or anaemia. The 
women were not given any incentives for taking part in the study. All the women 
taking part in the study were under the care of the Royal Surrey County Hospital, 
which covers the South West Siurey area.
5. 2.3. Exclusions
The exclusion criteria for this study were that the women should not be less than 18 
year's of age, should not have pre-existing diabetes, there should not be a language 
barrier, and the women should not suffer from mental or psychological problems. The 
midwife recommended those women who would not be suitable for the study to the 
investigator.
5.2.4. Recruitment Method
Five different methods of recruitment were used in this study. These were:
1. Antenatal clinics, a service offered at tlnee GP surgeries (Fairiands Medical 
Centre, Dapdune House Surgery and St. Luke’s Medical Centre). Women with
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and without NVP were recruited from booking in antenatal clinics (6-10 weeks 
gestation). They were approached in the waiting rooms, and the study was 
explained to them, they were given an information sheet (See Appendix VIII), 
which the women took home to think about and discuss with her partner. If the 
women consented, she was asked to sign a consent form (See Appendix IX). If 
consent was gained, an appointment for a home visit was ananged. Forty-nine of 
the fifty-seven women taking part in this study were recruited by this method.
2. Guildford National Childbirth Trust (NCT). Flyers were sent to a member of the 
Guildford NCT, who put them in the Guildford NCT magazine. If a woman was 
interested in taking pai't, she contacted the researcher, and a home visit was 
arranged. If the woman was not from die tlnee surgeries in the study, her doctor 
and midwife were contacted either by phone or by mail to ask for approval. Five 
women were recruited by this method.
3. University of Surrey web page. A notice was placed on the University web page 
and in the University of Sinrey newsletter. Two women were recruited by this 
method.
4. Radio. Tlnee radio broadcasts about the study were also conducted on the local 
radio stations; County Sounds and Southern Counties, and a request for women to 
participate in the study was given out. The radio broadcast attracted no women.
5. Community mid wives. Flyers were also sent out to community midwives in the 
Guildford area. The midwives were based at Hazleniere Hospital, Farnliam
132
Hospital and the Royal Surrey County Hospital. The midwives distributed the 
flyers when seeing the woman at home for the booking-in appointment. One 
woman was recruited tlii'ough the community midwives.
5. 3 Assessment of nutritional status during pregnancy
According to Gibson (1990), if it is suspected that nutrition affects health in some 
way, the nutritional status of a group of people can be assessed using:
1. Dietaiy methods- In this study one week food records were used.
2. Laboratory methods- Functional tests are not suitable for field surveys as they are 
too invasive and require elaborate equipment (Gibson, 1990). In this study all the 
women did not have problems with anaemia, elevated blood pressine or 
gestational diabetes. These were considered as they have been shown to have an 
effect on outcome of pregnancy (Godfi*ey et al, 1991; Steer et al, 1997).
3. Antlii'opometric methods- In this study, weight and triceps skinfolds were 
measured. Anthi'opometric measuiements have the advantage of providing 
information about past history, which cannot be obtained with equal confidence 
using other methods (Gibson, 1990).
5.3.1 Dietary Assessment 
5. 3.1.1 Method of Assessment
The total daily intake of all foods was measured using estimated food records over a 
seven-day period. Using this method, the participant is asked to record, at the time of 
consumption, all foods and beverages consumed, including detailed descriptions 
cooking methods, brand names and recipes (Gibson, 1990). Initially the aim was for
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women to keep a one-week weighed intake diaiy, and digital scales (SOEHNLE 
digita) were provided. This method is the most precise method available for 
estimating usual food intake of individuals. However, the compliance to this method 
was very poor, as the women found it veiy tedious to weigh out their entire intake for 
a whole week. The researcher was recruiting for two months, only two women were 
reci"uited, four consented and then dropped out due to the weighed intake. Thus a 
decision was made with advice from the study supervisors to use estimated food 
records instead. Although precision is greater with weighed intakes (Gibson, 1990), 
the compliance rate with the estimated records proved to be better. Seven days were 
used as it has been reported that this is sufficient to calculate energy and energy 
yielding nutrients (Margetts and Nelson, 1997). Longer periods are probably needed 
for items such as alcohol, some vitamins and minerals and cholesterol (Margetts and 
Nelson, 1997), however, this would have been to tedious for the participants.
5. 3.1.2. Assessment Protocol
Women were asked to keep a seven-day record of their intake at the time of 
recruitment, ie weeks 6-12, when NVP was likely to be, and at weeks 25-32, when 
NVP was likely to have resolved, in order to compare the diets and to assess the effect 
of NVP on nutritional intake. The women were asked to record everything they ate 
and drank in household measures. These were then converted to weights using 
published food portion sizes. Diet 5 2000 (Robert Gordon University, Aberdeen) was 
used for the computed dietary analysis.
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5. 3.1.3.Food diaries
A food diaiy was devised to assess the women’s mean daily energy and nutrient 
intake (Appendix X). The diaries had the woman’s code number only for 
confidentiality.
The diary contained an instruction sheet for diary completion, and an example of a 
typical day’s intake. In the main body of the diary, each page was divided into a 
section for the time, food or drink commodity and estimated weight. A final section 
was available for the researcher to input the actual weight in grams. Each page in the 
diary corresponded to a single day. Women with NVP were asked to record whether 
they had vomited at all during that time and to record the time that they had vomited. 
This was requested so that any meals consumed up to 2 hours before being sick 
(Mathews and Neil, 1998) could be discarded. The first and second diet diary were 
different colours; The first diet diary was blue and the second one was green, in order 
to differentiate between them.
The resear cher went tlii'ough the diaries with the women to explain how to fill them 
in, clarify any points and remove anomalies.
5. 3.2 Laboratory Assessment
A non-fasting blood sample and blood pressure measurement were taken by the 
midwife at booking-in clinic at Fairiands, and at 16 weeks at St.Lulce’s, then again at 
26 weeks at both surgeries. However, it was hard to get actual results as they were not 
usually given to the women, in most cases the women were only told if they had a 
problem.
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5. 3.3 Anthropometry 
5. 3.3.1 Weight
Portable electronic scales were used by the researcher to weigh the women at both 
home visits. The women were weighed in light clothing.
5. 3.3.2 Height
Recalled height was used in this study.
5. 3.3.3. Skinfold Thickness
Triceps skinfold measurements were measured twice, once at the first home visit and 
again at the second visit. The skinfold measures were talcen using Holtain calipers. 
This was measured on the non-dominant aim, half way between the acromion and the 
olecranon process, as described by Gibson (1990). Tlnee measurements were taken 
and the mean was calculated. Measurements from all foui* sites were not taken, as 
some women were not comfortable about this. Skinfold measurements at a single site 
are sometimes used to assess tlie total body fat or the percentage body fat. Studies 
caiTied out by Viegas et al (1987) and Claiic et al (1998) on pregnant women, both 
used triceps skinfold thickness measuiements to assess nutritional status in pregnant 
women. There is no agreement as to the best single skinfold site, however Gibson 
(1990) recommended that triceps skinfold thiclaiess has been the site most hequently 
selected site for a single, indirect measure of body fat in women. Clark et al (1998) 
reported that skinfolds change very little in early pregnancy, therefore values taken at 
18 weeks or before may be a good indicator of poor pre-pregnancy or early pregnancy 
nutritional status. Viegas et al (1987) suggested that changes in skinfold 
measurements in the second trimester probably reflects the balance of energy intake 
minus energy expenditui'e dming the trimester when the mother would be normally be
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laying down extra fat in anticipation of later fetal demands. The second measurement 
of skinfold thiclaiess in our study was thus taken at the end of the second trimester by 
the same researcher.
The measurement tecliniques of the reseai'cher were checked by experienced 
colleagues (Dr. Jane Morgan) before commencement of the study.
5,4 Assessment of NVP symptoms During Pregnancy 
5. 4.1. Method of Assessment
The duration and severity of symptoms of NVP during pregnancy was determined by 
recording symptoms on a daily basis from the time of entry into the study until the 
symptoms resolved.
5. 4.2. Assessment Protocol
The women were asked to keep a diary of their symptoms from the start of the study 
until the cessation of the symptoms. The women were asked to record their symptoms 
on a half-hourly basis and to describe whether they were nauseous or were actually 
sick. The data arising from the symptom diaiy was used to assess severity and 
duration of symptoms by calculating the number of weeks suffered and the total 
number of hours of NVP.
5. 4.3 Symptom Diaiy
A symptom diary was devised to assess the women’s symptoms (See appendix XI). 
The diary had the woman’s code number only. This diaiy was based on the symptom 
diary devised by Gadsby et al (1993). The diaiy contained an instruction sheet, and an
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example of a typical day’s symptoms. In the main body of tlie diaiy, each page was 
divided into 21 colmnns and coixesponded to 3 weeks. Methods used to alleviate NVP 
were entered on the final page.
The researcher explained how to fill in the diaiy and obtained the date of onset of 
symptoms. Up to two weeks retrospective symptoms were accepted if they could be 
remembered accurately. The women completed the diaiies until symptoms had 
ceased.
5. 5 Protocol for data collection during pregnancy 
5. 5.1 Number and timing of visits to each women
The researcher visited each woman at home twice over the cour se of her pregnancy, 
once early in pregnancy and once towards the end of the pregnancy. One of the 
purposes of the visit was to measuie the mother. At the first visit, the diet diaries and 
symptom diaries were distributed and explained. Additionally, the women’s 
background details were collected, and some details were collected about the partner. 
At the second visit, the record card for the delivery was distributed and explained.
5. 5.2 First home visit
The following protocol was followed for the first home visit.
The researcher carried out an interview with the women regarding the women’s 
background information. Questions were also asked about the partner’s background. 
These questions were based on those used from in the questionnaire survey as no 
problems were encountered in the retrospective study (See Appendix XII). The 
women were also asked about their gestational age and expected date of delivery. This 
was based on last menstrual period. This was confirmed and corrected by an ultra
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sound scan. If the due date was different to that given to the researcher at the first 
home visit, the women notified the researcher at the second home visit.
Each woman was given the food diary and the researcher explained the method of 
completion. Symptom diaries were distributed and explained to those women with 
NVP. Each woman was given pre-paid envelopes to return the diaries. The woman 
was weighed and triceps skinfold measurements were canied out.
5. 5.2. Second home visit
The second visit was made after the women returned the completed second diet diaiy, 
this was usually at ai’oimd 30-32 weeks gestation. Women were not seen later in 
pregnancy due to the risk of a missed appointment because of premature labour. The 
women were weighed and triceps skinfold measurements canied out.
The women were given an A5 sized card to give to the midwife at delivery. The card 
asked the midwife to record the endpoints of the pregnancy that the study required. 
Attached to the card was the blood bottle for the collection of the cord blood sample. 
Women were also given a card for them to record the baby’s length and head 
circumference once the health visitor had measured them after ten days. A pre-paid 
envelope was provided to send the cai'd back to the researcher.
At the end of the visit, each woman was thanked for paiticipating in the study. No 
incentive was offered to the women.
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5. 6 Assessment of outcome of pregnancy 
5. 6.1 Anthropometiy 
5. 6.1.1 Birth weight
At birth the babies were weighed to the nearest gram by the midwives using electronic 
scales (Weylux Scales).
5. 6.1.2 Length
The health visitor measured the length of the babies at ten days of age, as length is not 
routinely measured at birth. The length was measui'ed with the baby supine, using a 
measuring mat provided to the health visitors by the Child Growth Foundation.
5. 6.1.3 Head circumference
The health visitor measured the head circumference of the babies at ten days of age, 
as head circumference is not routinely measm*ed at birth. Head circumference was 
measured midway between the eyebrows and the hairline at the front of the head and 
the occipital prominence at the back using a tape measure provided to the health 
visitors by the Child Growth Foundation.
5.6.2. Biochemical Analysis
5. 6.2.1 Blood Sampling Method
The midwife took cord blood samples after the cord had been clamped. Once this had 
been done, the researcher was contacted, and collected the sample as soon as possible 
to prevent haemolysis of the IGF-1. The blood was collected in a plain tube, 
containing no additives. Each tube had the women’s code number marked on it. The 
sample was taken to the School of Biomedical and Life Sciences, University of
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Suixey. The sample was allowed to clot then centrifuged at 30001'pm for 10 minutes. 
The semm was removed and frozen at -20 C, until the end of the study. Dr. Derek 
Teale, Royal Surrey County Hospital was responsible for the biochemical analysis of 
the cord blood.
5. 6.2.2. IGF-1 Assay
The serum was transported to the Royal Surrey County Hospital at the end of the 
study. IGF-1 was analysed using the Nichols Advantage IGF-1 Assay, which is a two- 
site chemiluminescence immunoassay used for the measui*ement of IGF-1 in human 
serum. The antibody to the C-terminal with the amino acid sequence of 62-70 was 
biotinylated for captine and the antibody to tlie amino acid sequences of 1-23 and 42- 
61 was labelled with acridinium ester for detection. The sample was acidified to 
sepai'ate IGF-1 from IGFBFs. Then, excess IGF-II was added in the assay to block the 
IGFBP binding sites from recombining with the released IGF-I. The acidified sample 
was incubated simultaneously with the biotinylated capture antibody, excess IGF-II 
and the acridinium ester labelled tag antibody. During the first incubation period, 
strepatavidin coated magnetic paiticles were added to the reaction mixture and a 
second incubation followed. The streptavidin coated magnetic particles allow for a 
highly specific and efficient means of binding the sandwich complex to the solid 
phase via the high affinity interaction between biotin and the streptavidin. Free 
labelled antibody was separated from the labelled antibody boimd to the magnetic 
paificles by aspiration of the reaction mixtuie and the subsequent washing. The wells 
containing the washed magnetic particles were transported into the system 
luminometer, which automatically injects Trigger 1 and Trigger 2, initiating the 
chemiliuninescence reaction. Acridinium esters emit light upon treatment with 
hydrogen peroxide and an alkaline solution. The trigger 1 solution contains hydrogen
141
peroxide in dilute acid and Trigger 2 solution contains dilute sodium hydroxide. 
Trigger 1 and Trigger 2 oxidise the acridinium ester, which becomes in an excited 
state. The subsequent return to gromid state results in the emission of light, which was 
quantified in 2 seconds and was expressed in relative light units (RLU) by the 
integrated system luminometer. The amount of bound-labelled antibody is directly 
proportional to the concentration of IGF-1 in the sample.
5. 6.3 Associated data collection
5. 6.3.1 Placental weight
The placenta was weighed to the nearest gram by the midwives using digital scales 
(Soelmle digita) provided by the researcher. Placental weights were recorded wet, 
without trimming the membranes or cord. Trimmed placental weight was not used as 
it was apparent that this would be too troublesome for the midwives.
5.6.3.2 Gestational age
Gestational age was recorded by the midwife, based on routine clinical obstetric data; 
the last menstrual period (LMP) and ultra sound scan.
5.6.3.2 APGAR scores
The midwife recorded the APGAR scores of the infant, on the car d provided by the 
paiticipant. APGAR scores assess the infant heart rate, respiratory effort, muscle tone, 
reflex irritability and colour, and ar e a score out of ten.
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5. 7 Data Analysis
The strictest rules of confidentiality and anonymity were observed in all data 
handling. All subjects were assigned a code number upon joining the study. All 
information relating to the subjects was stored, by number only, in a secured personal 
computer, which was accessed by the researcher only. Hard copies of data were 
similaiiy denoted, and stored in a locked cabinet.
SPSS version 10.0 was used for data storage and statistical analysis. The data from the 
two groups was analysed using appropriate observational and comparative statistics. 
In this study, the severity of NVP was categorised using tliree different methods. 
Firstly, type of NVP (none, nausea only or both nausea and vomiting), horns of NVP 
and dmation of NVP. When looking at factors related to NVP, Spearman Rank 
correlations were used to correlate between the continuous factors such as maternal 
age and hours and duration of NVP. As for the categorical variables, the Mann 
Whitney test was used. ANOVA was used to find the relationship between the 
continuous variables and type of NVP. For the categorical variables, the Chi squar e 
test was used.
The pearson product moment correlation was used to find the relationship between the 
continous maternal factors and pregnancy outcomes. As for the categorical variables 
with two variables, such as smoking status, either the independent t-test or the Mann 
whitney tests were used. For categorical variables with more than two variables, such 
as socio-economic status, ANOVA or the Kruskall Wallis test was used.
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As for the effect of NVP on outcome of pregnancy, the relationship between the 
duration and hours of NVP and pregnancy outcome was assessed using Spearman 
correlations. As for the type of NVP, ANOVA or the Kiuskall Wallis test was used.
For cravings and aversions, their effect on pregnancy outcome was assessed using the 
independent t-test or the Mann-whitney test.
For the effect of NVP, cravings and aversions on nutritional intake, the independent t- 
test was used. As for the effect of maternal factors, the effect of the continous factors 
on nutritional intalce was tested using the Pearson correlation, whereas ANOVA was 
used for the categorical vai iables.
The effect of nutritional intake on pregnancy outcome was tested using either the 
Pearson or Spearman coixelations.
The results of the statistical tests were considered significant at p<0.05.
For the open questions, such as types of foods craved and avoided, only descriptive 
statistics could be canied out. Frequency tables were generated and graphs produced.
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5. 8 Ethical Approval 
5. 8.1 Main Study
The study protocol, together with the infonnation letter for the women, the consent 
form, a copy of the diet diaiy and symptom diaiy, the project’s time frame, 
permission letters from the head of midwifery, head of obstetrics and gynaecology 
and Dr. Jolm Nichols (Faiiiands Medical Centre), and the questions to be asked at the 
home visit were all submitted along with the application form to the South West 
Surrey Local Reseai'ch Ethics Committee on 28.03.00. Permission was granted on
16.05.00. See Appendix XIII. The reference number of this study was EC51/00
5. 8.2 Amendment
An application for an amendment to the study was made on 04.07.00 to the South 
West Surrey Local Research Committee. The amendment requested permission to 
recruit women from another two surgeries in Guildford, Dapdmie House Surgeiy and 
St.Luke’s Surgery. This amendment was requested in order to increase the sample 
size of the study. The Chairman of the Ethics Committee approved the amendment 
subject to ratification by the full committee. This was granted on 12.08.00. See 
Appendix XIV.
A further amendment was requested on 07.08.00. The amendment requested 
permission to recruit women via the local radio stations, local papers and via the 
Guildford branch of the National Childbiifh Trust. Permission was granted on
23.09.00.
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5. 8.3 University of Surrey
An application for an endorsement of the approval for the prospective study was made 
to the advisory committee on ethics of the University of Suixey in May 2000. The 
committee made some coimnents. Once the appropriate changes were made, the 
advisoiy committee approved the study on 05.07.00 (See Appendix XV). The 
reference number of the study was ACE/2000/52/EIHMS.
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6. RESULTS OF PROSPECTIVE STUDY
6,1 Study Population, including a comparison with the non-responders
A total of one hundred and fifty women were seen in clinics between May 2000 and 
August 2001. Eighty-two women agreed to take part in the prospective study, 
however, of those thirty women dropped out, leaving a study population of fifty-two 
women.
Of the 30 women who did not take part in the study, five women dropped out even 
before the first home visit as they stated that they were too busy to talce part. Tluee 
women who had consented to take pait and aixanged a time for the first home visit 
missed the visit and did not answer the reseaicher’s calls to rearrange the meeting. 
One woman miscarried before the first home visit.
Twenty one women of the thirty were visited by the researcher, of those sixteen then 
did not send the diaries back to the reseai'cher, and when the researcher called them to 
remind them, they asked to be dropped from the study. Two of the women visited by 
the researcher moved away from the reseai'ch area. Thiee women visited then had 
miscarriages and were withdrawn from the study.
Of the thirty women who dropped out, information was only available about twenty- 
one of them, whom the reseai'cher actually visited, and the demographic information 
for these women is compared with the study population.
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The mean age of the women who did not take paif in the study was 31.14 years (SD 
5.30), the youngest women being eighteen and the oldest thirty-eight. Independent t- 
tests were cai'ried out to test whether there was a statistical difference between the 
mean age of the women in the study population compared to the non-responders. No 
significant difference was found (p = 0.195), The mean pre-pregnancy weight of the 
women in the non-response group was 61.99kg (SD 9.22), the minimum weight being 
44.5 kg and the maximum weight 90.7kg. There was no significant difference in the 
mean weight of the non-responders compared to the women in the study population.
More than half of the women who did not talce part in the study had a household 
income of more than £40,000. The Chi-Square test to compare the study population 
with the non-responders could not be cairied out as more than 20% of the cells had an 
expected count less than 5.
In addition in this group, more than half the women had obtained a degree or a post 
degree. There were no significant differences between the proportion of women at 
each level of education between both groups (p=0.795)
Seventy five percent of the non-responders were of social classes I and II. Chi square 
tests could not be carried out as more than 20% of cells had an expected frequency 
less than 5.
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The majority of the women who dropped out did not smoke either pre-pregnancy 
(81%) or dui'ing pregnancy (85.7%). Again, Chi square tests could not be carried out 
for smoking status.
As for alcohol intake, 61.9% of the non-response group did not drink alcohol pre­
pregnancy. Figure 6.1.a below shows how the study group compares with those who 
dropped out of the study.
Figure 6.1.a Alcohol intake in the study group compared to the non-responders
CL 30
[ t Study Group 
Noivrespoirdsrs
Alcohol pre-pregnancy
There was a significant difference between the proportion of women who drank 
alcohol pre-pregnancy in the study group compared to the non-responders, where 
women in the study gr oup were more likely to consume alcohol pre-pregnancy 
compared to those in the non-response group (Chi Squared p=0.04).
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IAs for alcohol intake during pregnancy, the majority of women (95.2%) in the non- i
response group did not drinlc during pregnancy. Chi square tests could not be canied 
out in this case due to the small numbers involved
Wlien asked about nutritional supplement use pre-pregnancy, more than half (52.4%) 
of the women who dropped out did not consume any nutritional supplements, 
whereas, in the study population, only 28.8% of the women did not consimie 
nutritional supplements pre-pregnancy. Chi square tests showed that this difference 
was not significant {p -  0.066).
As for supplement use during pregnancy, a minority of women (9.5%) did not take 
nutritional supplements during pregnancy. Again, Chi square tests could not be 
carried out due to the small numbers involved
More than half of the non-responders (57.1%) were either in full-time or part-time 
occupation. There was no significant difference in the proportion of women in each 
type of occupation between the two groups {p  = 0.37).
As for the number of children, 28.6% of the women were first time mothers. Equally,
28.6% were second time mothers, and another 28.6% were third time mothers. 9.5% 
of the women had tln*ee children already and 4.8% had four' children. There were no 
significant differences between the number of children the women had in the non­
response group compared to the study population (p=0.21).
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6.1.1. Descriptive Characteristics of the study population
The mean age of the women at the time of delivery was 32 yeai's (SD 4.19), the 
yoimgest women being 20 years and the oldest forty-two years. One hundred percent 
of the women were manied or living with their partners. Twenty-five women (48.1%) 
were first time mothers.
Four women (7.7%) reported smoking pre-pregnancy and one woman (1.9%) reported 
smoking during pregnancy. As for alcohol intake, thirty-four women (65.4%) reported 
drinking pre-pregnancy and six women (11.5%) reported drinking during pregnancy. 
Nutritional supplements were consumed pre-pregnancy by thirty-seven women 
(71.2%), and during pregnancy by forty-one women (78.8%).
Thirty-two women (61.5%) were degree or postgraduate degree holders. Thirty eight 
women (73%) were in full-time or part-time occupation. Similarly to the previous 
study, reported in chapter 3, the majority of women (82.9%), were in social classes I 
and II. In addition, the majority of women (67.5%) had a reported aimual household 
income of 40,000 pomids or higher. See Tables 6.1.a and 6.1 .b for the descriptive 
characteristics of the study population.
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Table 6.1.a Categorical characteristics of study population
Characteristic n (%)
Marital status 52
Living with husband/partner 52(100)
Vegetarian 52
Yes 8(15.4)
No 44 (84.6)
Smoking pre-pregnancy 52
Yes 4(7.7)
No 48(92.3)
Smoking during pregnancy 52
Yes 1(1.9)
No 51(98.1)
Alcohol pre-pregnancy 52
Yes 34(65.4)
No 18(34.6)
Alcohol during pregnancy 52
Yes 6(11.5)
No 46(88.5)
Supplements pre-pregnancy 52
Yes 37(71.2)
No 15(28.8)
Supplements during pregnancy 52
Yes 50(96.2)
No 2(3.8)
Number o f children 52
None 25(48.1)
One 20(38.5)
Two 6(11.5)
Six 1(1.9)
Income 40
<9,999 1(2.5)
10,000-19,999 1(2.5)
20,000-29,999 3(7.5)
30,000-39,999 8(20)
>40,000 27(67.5)
Education 52
None 1(1.9)
GSCE 12(23.1)
A-Level 7(13.5)
Degree 19(36.5)
Post degree 13(25)
Socioeconomic status 47
HIM 2(4.3)
IIIN 6(12.8)
II 23(48.9)
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I 16(34)
Occupation 52
Full-time 19(36.5)
Part-time 19(36.5)
Housewife 14(26.9)
Table 6.1.c Continuous characteristics of study population
Characteristic Min . Max X Mean (SD)
Pre-pregnancy 
weight (kg)
49 47.0 90.7 62.3 (9.4)
Age (years) 52 20.0 42 32.7 (4.2)
Women’s birth 
weight (kg)
43 1.8 4.4 3.3 (0.5)
Height (m) 51 1.6 1.9 1.7 (0.1)
BMI (kg/m2) 48 17.7 32.1 22.7(3.2)
6.1.2. Anthropometric Assessment
The mean pre-pregnancy weight of the women was 62.3kg, and a mean BMI of 22.7 
kg/m^. At the first meeting, when the women were between six and ten weeks 
gestation, the mean weight was 65.2kg, and the mean triceps skinfold thickness was 
26mm. At the second meeting, when the women were between 26-30 weeks gestation, 
the mean weight was 75.9kg, and the mean triceps skinfold thickness was 28mm.
6.2 NVP
6.2.1 Symptoms of NVP
Of the fifty-two women in this sample, forty-one (78.8%), reported having 
experienced NVP. Of those, twenty-four women had nausea only and the remaining 
seventeen women had both nausea and vomiting. In four women (9.8%), the NVP was
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severe enough to cause weight loss in the women. In all the women in this study, 
symptoms of NVP had started before the initial interview at 6 to 10 weeks gestation.
6.2.2 Onset and cessation of NVP
In all the women, episodes of nausea occurred before the initial interview. The mean 
week for NVP to start was 5.2 (SD 1.9, median 6 weeks, range 1 to 9 weeks), in all 
the women with symptoms, episodes of NVP had started by 9 weeks gestation. See 
Figure 6.2.a.
Figure 6.2.a Distribution of week of onset of NVP
NVP started (weeks)
The mean week for cessation of symptoms was 14.3 (SD 5.12, median 13 weeks, 
range 6 to 33 weeks). 87.2% of women with symptoms ceased having symptoms by 
week 20. In one woman, symptoms persisted until week 33. See Figure 6.2.b.
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Figure 6.2.b Distribution of week of cessation of NVP
6 8 9 10 11 12 18 14 15 18 17 19 20 21 22 2S U
NVP ended
6.2.3 Symptom severity
Two measures of symptom severity were used in this study- the total number of hours 
of nausea during pregnancy and the duration of symptoms in weeks from the start of 
symptoms. The median total number of hours of symptoms was 80 hours (range 24 to 
1177 hours). These symptoms lasted for a median of 8 weeks (range 2 to 25 weeks).
6.2.4 Episodic Nature of Symptoms
The total number of episodes of NVP recorded was 1130. The times throughout the 
day when episodes of nausea occurred are shown in table 6.2.a. The most common 
three hour period for symptoms of nausea was between 06:00-09:00. The three hour 
periods between 09:00-12:00, 12:00-15:00 p.m, 15:00-18:00 and 18:00-21:00 each 
had a similar percentage of symptoms of nausea. The least time for symptoms to 
occur were between 21:00-00:00, 00:00-03:00and 03:00-06:00.
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Of the seventeen women reporting vomiting, recorded episodes were available for 
only 13 of them, with the number of episodes ranging from 1-130. 266 episodes were 
recorded, with the most common time of occurrence being either 06:00-09:00a.m or 
18:00-21:00. 09:00-12:00and 12:00-15:00 were also common times for the episodes 
of vomiting. This was followed by 15:00-18:00and 21:00-00:00 and 03:00-06:00. 
Vomiting did not occur between 12:00-15:00.
T able  6.2.a D istribu tion  o f tim ing  o f episodes o f nausea and  vom iting
Time i Nausea (n=l 130)^% V@mhmg (n=266) 
(%«l)isodes)
06.00-08.59 32 26
09.00-11.59 20 14
12.00-14.59 10 19
15.00-17.59 13 6
18.00-20.59 12 27
21.00-23.59 6 7
00.00-02.59 2 0
03.00-05.59 5 1
6.2.5 N um ber and  length  o f episodes p e r  day
Of the women with NVP, a total of 19 women (90.5%) experienced days with only 
one episode of nausea, and 18 women (85.7%) experienced days with two episodes of 
nausea. 17 women (81 %) experienced episodes, which lasted three or more hours at 
some time during their pregnancy. Of the 1396 episodes in which length of NVP was 
stated, 72% lasted between half an hour to two hours. 17.9% lasted more than two 
hours with 3.8% of episodes lasting more than 10 hours at some time during the 
pregnancy.
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6.2.6 Factors that alleviate and worsen symptoms
At the initial interview and in the symptom diary women were asked about measures 
used to alleviate symptoms of NVP. It was observed as shown in Figure 6.2.c that 
eating little and often, carbohydrate rich meals, ginger and rest were reported to be the 
most effective methods for reducing symptoms of NVP.
Figure 6.2.C Methods used by women to alleviate symptoms of NVP
□  Eating
■  CHO
□  Ginger
□  Rest 
■Water
□  Eating in a.m
■  acupuncture
□  sweet foods
■  homeopathy
■  lemon
□  exercise
□  keeping busy
■  peppermint 
■wrist bands
■  antisickness
■  milk
(Numbers by the pie chart denote number of women who reported effectiveness of 
method)
When asked about factors that made symptoms of NVP worse, it was found that both 
smells and tiredness were equally reported by the majority of women complaining of 
symptoms of NVP. See Figure 6.2.d.
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Figure 6.2.d Factors reported to exacerbate symptoms of NVP
□  Smells
■  Tiredness
□  Hungriness
□  Brushing teeth
■ Travel
(Numbers by the pie chart denote number of women who reported factor to worsen 
symptoms of NVP)
6.2.7 Factors related to NVP
In this study, three different methods were used to assess factors related to NVP. The 
first was type of NVP; none, nausea only or both nausea and vomiting. Second was 
hours of NVP during pregnancy and third was duration of NVP.
For the continues variables and hours and duration, Spearman correlations were used, 
as the hours and duration of NVP were not normally distributed. For the continuous 
variables and type of NVP, ANOVA was used as all the continuous variables were 
normally distributed. The results of the tests are shown in Table 6.2.b. Women’s age 
has an effect on both duration of NVP and type of NVP. Tukey post hoc analysis 
showed that there was a significant difference in age between those women without 
NVP and those with both nausea and vomiting. See Figure 6.2.e. The mean age of
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women without NVP was 35.2(3.5) whereas women with both nausea and vomiting 
were 31.8(4.0) years old.
Table 6.2.b Effect of continuos maternal factors on duration, number of hours 
and type of NVP
Factor Duration Hours Type
Weight 1 P -0.774 P=0.747 P^O .855
Skin fold 1 P=0.731 P=0.737 P-0.241
Weight 2 P=0.666 P=0.717 P=0.647
Skinfold 2 P=0.726 P=0.333 P=0.545
Pre-pregnancy weight P=0.789 P=0.736 P=0.917
Women’s birth weight P=0.674 P=0.446 P=0.234
Women’s height P=0.100 P=0.543 P=0.310
Women’s age P=0.023* P=0.536 P=0.076
Women’s BMI P=0.936 P=0.964 P=0.984
Weight gain P=0.133 F=0.390 P=0.391
Change in skinfolds P=0.909 P=0.773 P=0.761
(In the table, weight 1 and skinfold 1 refer to measurements made at the first home 
visit. Weight 2 and skinfold 2 refer to measurements made at the second home visit. 
Skinfold measures where only taken at the triceps. * denotes significant value)
Figure 6.2.e Effect of women’s’ age on type of NVP
Type of NVP
As for the results of the categorical variables, these were statistically explored using 
the Mann Whitney test for duration and hours of NVP and using Chi square test for
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Type of NVP. However in the case of type of NVP, many of the tests could not be 
carried out as the sample size was too small. See Table 6.2.C.
Table 6.2.c Effect of categorical maternal factors on duration, number of hours 
and type of NVP
Factor Duration Type o f NVP
Smoking pre-pregnancy P=0.140 P-0.190 -
Smoking during 
pregnancy
P=0.154 - -
Alcohol pre-pregnancy P=0.352 P-0.223 P=0.126
Alcohol during 
pregnancy
P-0.464 P=h0.114 -
Dietary restrictions P-0.105 P-0.062 -
Supplements pre­
pregnancy
P=0.180 P-0.517 -
Supplements during 
pregnancy
P=0.256 - -
Exercise pre-pregnancy P=0.780 P=0.519 -
Exercise during 
pregnancy
P=0.530 P=0.972 P=0.264
Cravings P=0.387 P=0.423 P=0.905
Aversions P=0.989 P=0.590 -
Education P=0.396 P=0.159 -
Income P=0.151 P-0.435 -
Occupation P=0.832 P=0.644 -
SEC P=0.546 P-0.791 -
Husband smoking P=0.407 P=0.467 -
(- denotes statistical analysis could not be carried out)
Type of NVP was significantly related to both duration of NVP (P=0.009) and 
number of hours of NVP (P=0.003), where women who had both nausea and 
vomiting had more hours of NVP, and the symptoms lasted for longer. See Figures
6.2.f and g.
1 6 0
Figure 6.2.f Effect of type of NVP on duration of NVP
NAUSEA NAUSEA AND VOMITING
Type of NVP
Figure 6.2.g Effect of type of NVP on number of hours of NVP
NAUSEA NAUSEA AND VOMITING
Type of NVP
6.2.8 Cravings and aversions in pregnancy
During the initial interview, the women were asked whether they had any cravings 
and /or aversions during pregnancy. In addition, some women mentioned further 
cravings and aversions in their food diaries. It can be seen that the most commonly 
craved foods were fruit, grains and starches, sweets and dairy products. See Figure
6.2.h.
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Figure 6.2.h Types of foods craved by women
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Types of food
Food category abbreviations: Sweets” is sweets, desserts and chocolate, “Fruit” is 
fruits andfruit juices, “G&S” is grains and starches, “Dairy” is dairy products and 
ice-cream, “Meat” is meats, fish, poultry, eggs and meat alternatives, “Veg” is 
vegetables, “Other ” is for foods that do not fit into the categories,
“N-A ” is nonalcoholic beverages, “Fried” is friedfoods and junkfoods, “Stim ” is 
stimulating drink such as tea, coffee, “Alcohol” is alcoholic beverages, “ESS” is 
ethnic, strong and spicy foods.
As for the aversions, the most commonly avoided foods were stimulating drinks such 
as tea, coffee, meats, sweets, vegetables, ethnic and spicy foods. See Figure 6.2.i.
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Figure 6.2.i Types of foods avoided by women
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Types of food
Food category abbreviations: “Sweets ” is sweets, desserts and chocolate, “Fruit ” is 
fruits andfruit juices, “G&S” is grains and starches, “Dairy” is dairy products and 
ice-cream, “Meat” is meats, fish, poultry, eggs and meat alternatives, “Veg” is 
vegetables, “Other ” is for foods that do not fit into the categories,
“N-A ” is nonalcoholic beverages, “Fried” is friedfoods and junk foods, “Stim ” is 
stimulating drink such as tea, coffee, “Alcohol” is alcoholic beverages, “ESS” is 
ethnic, strong and spicy foods.
6.3 Pregnancy outcomes
Of the fifty-two infants bom, twenty-two (42.3%) were male and thirty were female 
(57.5%). Male infants had a mean birth weight of 3.5kg (SD 0.6), a mean length of 
53.3cm (SD 2.6), a mean head circumference of 36.3cm (SD 1.7), a mean gestational 
age of 38.82 weeks (SD 2.44) and a mean placental weight of 0.7kg (SD 0.1). Male 
infants had a mean APGAR score of 9 and a mean cord blood IGF-1 concentration of
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9.7 nmol/1 (SD 2.6). Female infants had a mean birth weight of 3.6kg (SD 0.5), a 
mean length of 51.7cm (SD 2.8), a mean head circumference of 35.8 cm (SD 1.2), a 
mean gestational age of 39.8 weeks (SD 1.2) and a mean placental weight of 0.7kg 
(SD 0.5). Mean APGAR scores in female infants was 9 and the mean cord blood 
concentration of IGF-1 was 10 nmol/1 (SD 4.5). There were no significant differences 
between the males and females in any of the measurements except with pondéral 
index (PI)(p=0.006) where male infants (n=16) had PI of 23.6 kg/m^(SD 2.59) and 
female infants (n=28) had a PI of 25.7 (2.1). For pregnancy outcomes see Table 6.3.a.
Table 6.3.a Pregnancy outcomes
-
Birth weight (kg) 52 1.7-4.6 3.5(0.5)
Placental weight (kg) 29 0.5-I.0 0.7(0.2)
Head circumference 
(cm)
44 32.0-39.5 36.0(1.4)
Length (cm) 44 44-58 52.3(2.8)
PI (kg/m’) 44 17.9-29.4 24.9(2.5)
Hc:l 42 0.6-0.8 0.7(0.0)
APGAR 34 l-IO 8.9(1.7)
IGF-1 16 4.5-15 9.8(1.7)
Gestational age (weeks) 50 31-42 39.4(1.9)
The relationship between birth weight, length, head circumference, placental weight, 
IGF-1 and gestational age was investigated for both sexes combined, using Pearson 
Product moment correlation coefficient. Preliminary analyses were performed to 
ensure no violation of the assumptions of normality, linearity and homoscedasticity. 
There was a strong positive correlation between birth weight and length (r = 0.765, p 
<0.001) (Figure 6.3.a), head circumference (r = 0.657. p < 0.001) (Figure 6.3.b) and 
placental weight (r = 0.626,/? < 0.001) (Figure 6.3.c) and gestational age. There was
164
no correlation between birth weight and both IGF-1 ( r = -0.068, p  = 0.802) and PI 
(r=0.192,/7=0.212). As for head circumference to length ratio (hc:l), ( r =-0.488,/> 
0.001), although there was a significant negative correlation, the strength of the 
correlation was not very high (Figure 6.3.e).
Figure 6.3.a Relationship between infant birth weight (kg) and length (cm)
gender
baby's weight
Figure 6.3.b Relationship between infant birth weight (kg) and head 
circumference (cm)
gender
baby's weight
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Figure 6.3.c Relationship between infant birth weight (kg) and placental weight 
(kg)
gender
0.0 .5 1.0 1.6 2.0 2.5 SO S.S 4.0 4.6  6.0
baby's weight
Figure 6.3.d Relationship between infant birth weight (kg)and gestational age 
(weeks)
2  36
gender
baby's weight
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Figure 6.3.e Relationship between infant birth weight (kg) and head
circumference:length ratio
gender
2.0 2.6
baby's weight
Length and head circumference also showed a strong positive correlation ( r = 0.589, 
p  < 0.001). Length was also positively correlated with gestational age ( r = 0.424, p= 
0.005). There was no correlation between length and IGF-1 ( r = -0.765,/? = 0.250) or 
between length and placental weight ( r = 0.346,/? = 0.091). However, length was 
also strongly related to pondéral index and head circumference to length ratio 
(r=-.477,/? =0.001) and (r =-.770,/?<0.001) respectively.
As for head circumference, there was a strong positive correlation with placental 
weight ( r = 0.575, p < 0.001), and with gestational age ( r = 0.568, p< 0.001). There 
was no correlation between head circumference and IGF-1 ( r = -0.344,/? = 0.330). 
Head circumference was not related to either PI or hc:l (r=-.148,/?=.348) and (r=.059, 
/?=.709)
There was no correlation between placental weight and gestational age ( r = 0.343, p  
0.074). In addition, placental weight was not related to either PI or hc;l (r= .227,/? = 
.274) and (r=.108,/?=.615)
167
There was no correlation between placental weight and gestational age ( r = 0,343,/? = 
0.074). In addition, placental weight was not related to either PI or hc:l (r= .227,/? = 
.274) and (r=.108,/?=.615)
As for APGAR scores, they were not correlated with any of the other pregnancy 
outcomes, including head circumference (r = -0.088, p = 0.643), length (r = -0.008,/? 
= 0.967), IGF-1 (r = 0.462,/? = 0.130), weight ( r = -0.048,/? = 0.787), placental 
weight ( r = -0.075,/? = 0.768) and gestational age ( r = -0.072,/? = 0.696). In 
addition, APGAR scores were not related to either PI or hc:l (i-.OOO, /? = .998) and 
(i~-.097,/?=.610).
IGF-1 was not related to either PI or hc:l (i-.256,/? =,447) and (r=-.71,/?=,848). In 
addition, gestational age was not related to either PI or hc:l (r=-.005,/? =.975) and (i*=- 
.153,/?=.345). In this study, the majority of women had normal deliveries, thus the 
effect of mode of delivery on IGF-1 concentrations could not be assessed. Both Hc:l 
and PI were strongly related to one another (r=.470,/?=0.002)
6.3.1 Effect of maternal factors on pregnancy outcomes
Independent sample T-tests were used to test whether smoking and alcohol intake, 
had any significant relationships with the baby’s weight, placental size, lengtli, head 
ch'cumference, cord IGF-1, pondéral index or head circumference to length ratio. As 
for gestational age and APGAR scores, the Mami Whitney test was used. For level of 
education, occupation, level of income and socio-economic status, ANOVA and the 
Kruskall Wallis tests were used. The /? values of the tests ai'e shown in Table 6.3.b.
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Table 6.3.b Results of statistical analysis of the relationship between categorical 
maternal factors and pregnancy outcomes
PI HC:L WT PWT.% ÎJENG APG IGF-1 GEST
Smoke
pre-prcg
0.655 0.006* 0.378 0.611 0.159 0.045* 0.857 0.924 0.105
Smokeduring 0.357 0.494 0.533 - 0.489 0.242 0.857 - 0.760
Etoh
pre-
preg
0.183 0.177 0.718 0.794 0.303 0.084* 0.905 0.741 0.556
Etohduring 0.425 0.612 0.934 0.576 0.220 0.874 0.264 0.723 0.850(%cup 0.518 0.033 0.188 0.106 0.339 0.097 0.937 0.651 0.934
SEC 0.960 0.970 0.662 0.872 0.115 0.160 0.104 0.368 0.180
Educat 0.482 0.828 0.540 0.941 0.948 0.841 0.501 0.790 0.982
incom 0.369 0.185 0.283 0.376 0.487 0.213 0.276 1.000 0.354
(  Abbreviations: PI is pondéral index, HC:L is head circumference to length ratio,
WT is birth weight, PWT is placental weight, HC is head circumference, LENG is 
length, APG id APGAR, IGF-1 is cord blood IGF-I levels and GEST is gestational 
age, ETOH is alcohol, OCCUPAT is maternal occupation, SEC is fam ily socio­
economic status, educat is maternal level o f  education and incom is level o f  family 
income)
It can be seen that there was a relationship between smoking pre-pregnancy on length 
at birth (p=0.045) where babies bom to women who were non-smokers pre-pregnancy 
were longer than babies bom to women who smoked pre-pregnancy (Figure 6.3.f). 
Smoking pre-pregnancy was also related to the ratio between head circumference and 
length (p=0.006), where women who smoked pre-pregnancy had babies with higher 
hc:l compared to those who did not smoke pre-pregnancy (Figure 6.3.g).
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Figure 6.3.f Relationship between maternai smoking pre-pregnancy and baby’s
length
Did woman smoke pre-pregnancy
Figure 6.3.g Relationship between maternal smoking pre-pregnancy and head 
circumference to length ratio
Did woman smoke pre-pregnancy
As for the continues maternal characteristics, these were examined for any significant 
relationships with the pregnancy outcomes using either Pearson correlations for birth 
weight, placental weight, head circumference, length, IGF-1, hc;l and PI, and
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weight, placental weight, head circumference, length, lGF-1, hc:l and PI, and 
Spearman correlations for gestational age and APGAR scores. The results of the 
correlations are shown in Table 6.3.c. The table also included two paternal factors: 
father’s height and birth weight.
Table 6.3.C Results of statistical analysis to assess relationship between continous 
maternal and paternal characteristics and pregnancy outcomes
Bwt Pwt Fk À Lem APG Hc:l PI
Wtl R=.246
P=.082
R=.200
P=.307
R=.037
P=.815
R=.082
P=.600
R=.197
P -.174
R=-.316
P=.233
R=-.313
P-.068
R=-.046
P=.774
R=.199
P=.200
Skin I R=.051 
P=.728
R--.179
P=.393
R=-.081
P=.615
R=-.075
P=.643
R=-.052
P = J 3 3
R=-.443
P=.129
R=-.281
P=.119
R=-.002
P=.990
R=.190
P=.235
Wt2 R=.239
P=.098
R=.311 
P-.lOO
R=-.122
P=.442
R=-.047
P = J 6 7
R=-.265
P -.072
R=-.135
P=.619
R=-.256
P=.150
R=.059
P=.716
R =388
P=.010*
Skin2 R=-.017
P=.914
R=.234
P-.261
R=-.049
P-.777
R=-.271
P-.105
R=.112
P -.497
R=-.250
P=.458
R=-.087
P=.668
R=.335
P=.049*
R=.414
P -.O ll*
wtchan R=.102
P=.989
R=.273
P =1 6 1
R=-.105
P-.513
R=-.094
P=.552
R=.338
P-.022*
R=.364 
P=. 166 R=.018P=.919 R=.072 P = .6 6 1 R=.271P=.083
skincha R=-.096
P=.562
R-.076
P =.73\
R=.144
P=.416
R=-.073
P-.678
R=.043
P=.800
R=.230
P=.524
R=-.072
P=.725
R=.143
P=.428
R-.OOl
P=.997
Pre-
pXQg
R=.243
P=.093
R=.194
P^.332
R=.116
P=.470
R=-.027
P=.869
R=.199
P=.180
R=-.190
P =A 97
R=-.172
P-.348
R=-.010
P=.950
R=.373
P=.017*
Bwtm R=.317
P-.039*
R=.467
P=.018*
R=.077
P=.650
R=.229
P-.179
R=.271
P=.083
R--.147
P=.616
R=-.131
P=.489
R=-.194
P=.264
R=. 170 
P=.321
Htm R=.222
P=.117
R=.300
P ^ .\2 \
R=.131
P=.398
R=.207
P -.177
R=.150
P -.304
R=.177
P=.528
R=.054
P=.756
R=-.142
P-.370
R=-.087
P=.573
Age R=-.006
P=.964
R=.170
P=.377
R=-.082
P=.596
R=-.067
F=.668
R=-.022
P=.878
R--.017
P=.949
R=.159
P-.360
R=-.036
P=.819
R=.066
P=.672
BMI R=.127
P=.389
R=.097
P=.638
R=-.175
P=.274
R=.136
P=.395
R=.131
P=.385
R=-.450
P=.106
R=-.200
P=.274
R=.086
P=.604
R=.422
P=.006*
Bwtf R=-.039
P=.870
R -.050
P=.S77
R=-.137
P=.62S
R=.127
P=.652
R=-.225
P=.341
R=-.272
P-.602
R=-.399
P=.141
R=-.286
P -.322
R=.036
P=.897
htf R=-.048
P-.738
R=.308
P = .l l l
R=.076
P=.622
R=.050
P=.749
R=.103
P=.482
R=-.245
P=.379
R=-.283
P=.100
R=.097
P=.540
R=-.029
P=.850
(Abbreviations: Wt 1 is maternal weight at the first home visit, skin 1 is triceps 
skinfold thickness at the first home visit, wt 2 is maternal weight at the second home 
visit, skin 2 is triceps skinofld thickness at the second home visit, wtchang is 
difference in weight betM>een the first and second home visit, skincha is the difference
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in tricpes skinfold thickness between the first and second home visit, pre-preg is 
maternal pre-pregnancy weight, bwtm is maternal birth weight, htm is maternal 
height, age is maternal age, BMI is maternal body mass index, bwAf is paternal birth 
weight, h tf is paternal height, bwt is infant's birth weight, pw t is placental weight, he 
is infant’s head circumference, leng is infant’s length, gest is gestational age, IGF-1 
is cord bloodlGF-1 concentj'ations, APG is infant’s APGAR scores, hc:l is infant’s 
head circumference to length ratio and PI is infant’s pondéral index) denotes 
statistical significance)
It was found that maternal weight (wt2) at the second meeting (ie in the third 
trimester) was significantly positively coiTelated with the infant’s PI (p=0.01). 
Maternal skinfold thickness at the second meeting (skin2) was also positively 
correlated with both PI and hc:l (p=0.01) and (p=0.05) respectively.
It was also found that maternal weight gain between the first visit and the second had 
a significant positive correlation with the length of gestation (p=0.02), ie the greater 
the weight gain, the longer the pregnancy.
Maternal pre-pregnancy weight was significantly positively correlated with the 
infant’s PI (P=0.02).
Maternal birth weight was also positively correlated with both the infant’s birth 
weight and placental weight, (p=0.039) and (p=0.018) respectively. However, when 
paitial correlations were carried out between placental weight and maternal birth 
weight, controlling for the baby’s birth weight, the relationship ceased to be
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significant (/?=0.080, r-0.364). Thus the effect the relationship between maternal birth 
weight and placental weight is probably due to the effect of the baby’s birth weight. 
Finally, maternal BMI was significantly positively correlated with PI (p=0.006).
However, in all these correlations, the strength of the relationship was not strong, as 
the r-value in all of the correlation was less than 0.5 (Pallant, 2001).
Neither of the paternal factors tested were found to have an effect on any of the 
factors examined.
6.3.2 Effect of NVP on pregnancy outcome
The differences in pregnancy outcomes between babies bom to women with NVP and 
women who did not experience NVP are shown in Table 6.3.d.
Table 6.3.d Pregnancy outcomes in women with and without NVP
Outcome Meap.f^D)
N o  NVP
Gestational age (weeks) 39.48(1.52) (n=40 38.90(3.07) (n=10)
Birth weight (kg) 3.55(0.49) (n=41 ) 3.48(0.70) (n = ll)
Placental weight (kg) 0.72(0.14) (n=21) 0.75(0.19) (n-8)
Length (cm) 52.14(2.94) (n-35) 52.83(2.28) (n=9)
Head circumference (cm) 35.88 (1.14) (n=35) 36.33(2.20) (n=9)
APGAR 8.78(1.85) (n=27) 9.13(0.35) (n=8)
lGF-1 (nmol/1) 9.68(3.2) (n=10) 10.05(3.74) (n=6)
To assess the effect of NVP on the outcome of pregnancy, three different methods 
were used, first type of NVP, second duration and third number of hours of NVP. For 
type of NVP and the continuous variables, ANOVA was used or the Kruskall Wallis
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test in the case of APGAR scores and gestational age as they were not normally 
distributed. As for the categorical variables, Chi square was used. With duration of 
NVP and hours of NVP, Spearman correlations were used. The results of the analysis 
are shown Table 6.3.e.
Table 6.3.e Relationship between NVP and pregnancy outcomes using three 
different measures of symptom severity
Outcome measure Type ofNVP Duration %oursofNVP
Gestational age (weeks) 0.911 0.789 0.791
Baby’s weight (kg) 0.725 0.273 0.760
Placental weight (kg) 0.810 0.147 0.238
Head circumference (cm) 0.259 0.807 0.654
Length (cm) 0.636 0.962 0.561
APGAR 0.459 0.180 0.075
PI 0.992 0.500 0.504
Hc:l 0.669 0.505 0.590
Gender 0.972 0.601 0.268
Placental ratio 0.949 0.011* 0.502
IGF-1 (nmol/1) 0.044* 0.940 0.103
[Abbreviations: PI is pondéral index, hc:l is infant head circumference to length ratio, 
type o f  delivery is either normal or casearian, and IGF-1 is cord blood lGF-1 
concentrations) (* denotes statistical significance)
It was found that there was a negative relationship between placental ratio and 
duration of NVP, where women with longer duration of NVP having the lowest 
placental ratios (See figure 6.3h)
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Figure 6.3.h Relationship between duration of NVP and placental ratio
10 20 
D u r a t io n  o f  N V P  ( w e e k s )
There was a also a significant difference between the cord blood IGF-1 concentrations 
in babies bom to women with varying degrees of NVP. Tukey tests established that 
there was a significant difference between women with no NVP and those with both 
nausea and vomiting 10.05nmol/l ( SD 3.74) compared to 12.72 nmol/1 
(SD1.52) (Figure 6.3.j)
Figure 6.3.1 Relationship between type of NVP and IGF-1 concentrations
NOnvp NAUSEA NAUSEA AND VOMITING
Type of NVP
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6.3.3 Effect of cravings and aversions on pregnancy outcomes
Independent t-tests were used to test whether cravings and aversions had an effect on 
birth weight, placental weight, IGF-1, length, head circumference, pondéral index and 
head circumference to length ratio. The equivalent non-parametric test, the Mann 
Whitney U test was used to test the effect on gestational age and APGAR scores as 
these were not normally distributed.
To test the effect on gender, chi square tests were used. The p values of the statistical 
tests are shown in Table 6.3.f
Table 6.3.f Relationship between both aversions and cravings and pregnancy 
outcomes
Outcome Aversions Cravings
Birth weight (kg) P=0.681 P=0.192
Placental weight (kg) P-0.161 P=0.424
Head circumference 
(cm)
P=0.770 P=0.399
lGF-1 (nmol/1) P=0.238 P=0.231
Length (cm) P=0.916 P=0.772
HCL P=0.238 P=0.283
PI P=0.729 P=0.157
Gender P=0.195 P=0.982
Gestation (weeks) F=0.973 P=0.100
APGAR P=0.803 P=0.987
As can be seen, neither the occurrence of cravings nor aversions showed any 
significant relationships with the pregnancy outcomes.
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6.4 Nutritional intake in early pregnancy
6.4.1 Effect of NVP on nutritional intake in early pregnancy
The effect of NVP on nutritional intake in early pregnancy was tested using 
independent sample t-tests. The intakes of both women with NVP and without NVP 
ar e shown Table 6.4.a. These intalces ar e not inclusive of nutritional supplements.
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Table 6.4.a Effect of NVP on nutritional intake in early pregnancy
Nutrient DRV y N V P („ -3 3 ) N o NVP (n= 10) P  value
Energy (kj) 8100 7094(1682.23) 7936(1479.60) 0.163
Energy (kcals) 1940 1687(401.04) 1887 (353.19) 0.163
Fat (g) 77 65.94 (21.65) 77.78(19.38) 0.129
CHO (g) 50% E 224.53(55.26) 241.44 (49.10) 0.930
Protein (g) 51 61.55(13.17) 68.03 (11.32) 0.168
Thiamin (mg) 0.8 1.58(1.12) 1.88(0.50) 0.457
Riboflavin (mg) 1.4 1.25(0.37) 1.53 (0.44) 0.050*
Niacin (mg) 13 30.10(7.31) 32.04 (7.59) 0.469
Vitamin B6 (mg) 1.2 1.74 (0.46) 2.04 (0.46) 0.075
Vitamin B12 (ug) 1.5 2.42(1.33) 2.96 (0.97) 0.246
Folate (ug) 300 231.09 (80.02) 270.00 (57.97) 0.162
Vitamin C (mg) 40 107.14 (72.69) 122.02 (28.13) 0.342
Vitamin D (ug) 10 2.33 (1.55) 2.59(1.07) 0.631
Vitamin A (ug) 700 650.64 (409.00) 734.50 (278.55) 0.549
Calcium (g) 700 678.76 (222.40) 858.100 (112.72) 0.002*
Iron (g) 14.8 11.67 (4.92) 11.40(1.99) 0.803
Phosphorus (mg) 550 1024.45 (228.36) 1203.00(154.97) 0.022*
Magnesium (mg) 270 211.06 (54.19) 262.50(41.83) 0.009*
Sodium (mg) 1600 2622.58 (740.68) 2564.10(505.38) 0.817
Potassium (mg) 3500 2310.11 (581.72) 2794.40 (337.78) 0.017*
Chloride (mg) 2500 3890.55 (1011.48) 3896.80 (733.07) 0.986
Zinc (mg) 7 6.27(1 .52) 7.37(1.13) 0.042*
Copper (mg) 1.2 0.90 (0.21) 1.10(0.22) 0.014*
Selenium (ug) 60 48.91 (16.99) 51.00 (24.38) 0.760
denotes statistical significance)
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As can be seen, women with NVP consumed less riboflavin (p=0.005) (Figure 6.4.f), 
calcium (p=0.002) (Figure 6.4.a), magnesium (/t=0.009) (Figure 6.4.b ), potassium 
(/?=0.017) (Figure 6.4.c), zinc (p=0.042) (Figure 6.4.d )and copper (/?=0.014) (Figure
6.4.e) compared to women without NVP.
Figure 6.4.a Relationship between NVP and riboflavin intake
Did woman suffer from NVP
Figure 6.4.b Relationship between NVP and calcium intake
Did woman suffer from NVP
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Figure 6.4 c Relationship between NVP and magnesium intake
5  230
Did woman suffer from NVP
Figure 6.4.d Relationship between NVP and potassium intake
Did woman suffer from NVP
Figure 6.4.e Relationship between NVP and zinc intake
Did woman suffer from NVP
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Figure 6.4.f Relationship between NVP and copper intake
Did woman suffer from NVP
As for the effect of the severity of NVP on nutritional intake in early pregnancy, three 
methods of measuring severity were used in the analysis; total hours of nausea, 
duration of NVP and type of NVP. The results of the analysis are shown in Table
6.4.b.
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Table 6.4.b Effect of NVP on nutritional intake using three different measures of 
severity
Nutrient Hours of NVP Type
Energy (kcals) R=-0.014,/? =0.952 R=-0.131,/? = 0.473 P= 0.337
Fat(g) R=-0.128,/? =0.591 R=-0.142,/? = 0.439 P = 0.214
Protein (g) R=-0.216,/? =0.359 R=-0.211,/? =0.246 f =0.23 7
CHO R=.105,P=.661 R=.003, P=.987 P=.686
Thiamin (mg) R=0.196,/? =0.407 R=0.015,/? =0.936 P=0.328
Riboflavin (mg) R=0.024,/?=0.917 R=-0.182,/?=0.318 P=0.151
Niacin (mg) R=-0.209,/?=0.377 R=-0.191,/?=0.295 ?=0.531
Vitamin B6 (mg) R=-0.062,/?=0.796 R=-0.229,/?=0.207 f=0.194
Vitamin B12 (ug) R=-0.060,/?=0.801 R=-0.083,/?=0.653 f=0.473
Folate (ug) R=0.053,/?=0.824 R=-0.166,/?=0.363 P=0.308
Vitamin C (mg) R=-0.135,/?=0.571 R=0.034,/?=0.853 P=0.825
Vitamin A (ug) R=0.062,/?=0.796 R=0.157,/?=0.390 f=0.750
Calcium (g) R=0.015,/?=0.950 R=-0.020,/?=0.913 f=0.066
Iron (g) R=0.280,/?=0.231 R=0.015,/?=0.935 P=0.986
Magnesium (mg) R=0.031,/?=0.897 R=-0.101,/?=0.582 P=0.033*
Sodium (mg) R=-0.016,/?=0.947 R=-0.107,/?=0.559 P=0.824
Potassium (mg) R=-0.118,/?=0.620 R=-0.147,/?=0.423 P=0.057
Zinc (mg) R=-0.036,/?=0.881 R=-0.245,/?=0.176 P=0.045*
Copper (mg) R=0.379,/?=0.099 R=-0.018,/?=0.920 P=0.046*
Selenium (ug) R=0.094,/?=0.693 R=-0.019,/?=0.919 f=0.913
denotes statistical significance)
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For total number of hours and duration of NVP, no significant relationships were 
seen. As for type of NVP, significant differences were seen for magnesium (/?=0.033), 
zinc (p=0.045) and copper (p=0.046) intake between women in the three different 
severity groups.
Post-hoc Tukey tests were carried out to identify the groups between which 
significant differences were detected. The results of the tests are shown Table 6.4.c.
Table 6.4.c Results of Post-hoc Tukey tests for relationship between NVP and 
intake of magnesium, zinc and copper
Nutrient No nausea and nausea No nausea and NVP Nausea and NVP
Magnesium 0.050* 0.045* 0.973
Zinc 0.345 0.036* 0.320
Copper 0.042* 0.117 0.920
(* denotes statistical significance)
Both women with nausea and those with nausea and vomiting consumed significantly 
less magnesium compared to women without NVP (Figure 6.4.g). For zinc, women 
with both nausea and vomiting had significantly lower values compared to women 
without (Figure 6.4.h). As for copper, women with nausea had significantly lower 
values compared to women with out NVP (Figure 6.4.i).
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Figure 6.4.g Relationship between type of NVP and magnesium intake
N A U S E A  N A U S E A  A N D  V O M IT I N G
Type of NVP
Figure 6.4.h Relationship between type of NVP and zinc intake
N O n v p  N A U S E A  N A U S E A  A N D  V O M IT I N G
Type of NVP
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Figure 6.4.i Relationship between type of NVP and copper intake
N A U S E A  N A U S E A  A N D  V O M IT I N G
Type of NVP
6.4.3 Effect of cravings and aversions on nutritional intake in early pregnancy
The relationship between both cravings and aversions were tested against markers of 
nutritional intake using independent sample t-tests. The results of the tests are shown 
in Table 6.4.d.
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Table 6.4.d Relationship between both cravings and aversions and nutritional 
intake in early pregnancy
Nutrient Cravings
•
Aversions
Energy (kcals) 0.382 0.168
Fat (g) 0.102 0.974
Carbohydrate 0.736 0.016*
Protein (g) 0.304 0.080
Thiamin (mg) 0.583 0.965
Riboflavin (mg) 0.547 0.011*
Niacin (mg) 0.175 0.155
Vitamin B6 (mg) 0.274 0.070
Vitamin B12 (ug) 0.788 0.164
Folate (ug) 0.528 0.204
Vitamin C (mg) 0.905 0.822
Vitamin A (ug) 0.252 0.650
Calcium (g) 0.683 0.063
Iron (g) 0.870 0.003*
Magnesium (mg) 0.446 0.121
Sodium (mg) 0.637 0.315
Potassium (mg) 0.861 0.192
Zinc (mg) 0.718 0.052
Copper (mg) 0.844 0.067
Selenium (ug) 0.076 0.928
denotes statistical significance)
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intake (p=0.016) (Figure 6.4.j), riboflavin intake (p=0.011) (Figure 6.4.k) and iron 
intake (p=0.003) (Figure 6.4.1 ), where women with aversions consumed less of each 
of these nutrients compared to women who had no aversions.
Figure 6.4.j Relationship between aversions and carbohydrate intake (g/d)
c  260
Aversions
Figure 6.4.k Relationship between aversions and riboflavin intake (mg/d)
Aversions
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Figure 6.4.1 Relationship between aversions and iron intake(g/d)
6.4.4 Effect of nutritional intake in early pregnancy on pregnancy outcomes
Both pearson correlations and spearman correlations were used to assess any 
relationships between the intakes of various nutrients and the pregnancy outcomes. 
The results are shown in Table 6.4.e.
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Table 6.4.e Relationship between nutrient intake in early pregnancy and
pregnancy outcomes
Nutrient Bwt Pwt He A m Hc:l PI
Energy
(kcals)
R--.133
P = 3 9 5
R=.069
P-.750
R=.016
P=.925
R=-.106
P=.540
R=.247
P^.395
R =057
P =.72\
R=.015
P=.939
R=.045
P =.80\
R=.026
f= .880
Fat (g) R=-.106
P=.499
R=.070
P=.1A6
R=-.087
P = .6 \5
R=-.198
f = J 4 0
R=.224
P=.442
R=.086
P=.595
R=-.025
P=.897
R=.051
P-.776
R=.151
P =.38\
Protein
(g)
R=-.178
P = 2 5 3
R=.098
P=.650
R^.Oll
P=.951
R=.092
P=.594
R - 108 
P=.712
R=-.244
P ^A 24
R=-.056
P=.773
R=-.239
P=.174
R=-.189
P^.269
CHO R=-.089
P=.512
R=.048
P=.S22
R=.117
P=.497
R=-.013
P=.941
R=.246
P ^.397
R=.096
P=.552
R=.061
P=.755
R-.075
P=.672
R=-.035
P=.841
Thiami
n(mg)
R=-.032
/’=.838
R=.473
P=.020*
R=.122
P -.479
R=-.054
P=.753
R=-.040
f = 8 9 3
R=-.044
P = J 8 4
R=.045
P=.818
R=.194
f - 2 7 1
R=.070
P = M 2
Ribofla
vin
(mg)
R=.153
P -.328
R=.316
P=.133
R - 179 
P=.295
R=.281
P=.096
R=.300
P=.297
R=.070
P=.663
R=-.116
P=.550
R=-.162
P=.359
R=-0.67
P-.698
Niacin
(mg)
R=-.020
P=.S96
R=.255
P=.291
R=.196
P ^ .25 \
R=.243
P =A 53
R=.157
P-.591
R=-.190
P=.233
R=.011
P=.996
R=-.274
P=.116
R=-.246
P=.148
Vitamin
B6
(mg)
R=.054
P=.129
R=.373
P=.072
R=.272
109
R=.353
P=.034*
R=.427
P -.128
R=-.090
P=.575
R=.027
P=.888
R=-.144
/"=.415
R=-.268
P=.114
Vitamin
B12
(ug)
R=.043
P =.1M
R=.008
P-.971
R=.022
P=.900
R=.290
P=.086
R=-.089
P=.761
R=-.110
P=.494
R=-.405
P=.029*
R=-.306
f=.078
R=-.068
P=.693
Folate
(ug)
R=.065 
P=.681
R=.407
P=.048*
R=.023
P=.892
R=.228
P^A80
R=.273
P=.344
R -.026
P=.872
R=.119
f = J 3 9
R=-.194
P=.272
R=-.126
P^.466
Vitamin 
C (mg)
R--.126
P=.422
R=.032
P=.880
R=-.117
P =A 95
R-.138
?=.422
R=-.011
P =.970
R=.056
P = J 2 8
R=.208
P=.279
R=-.232
P=^A87
R=-.350
P=.036*
Vitamin 
A (ug)
R=-.219
P -.157
R=.121
P-.572
R=-.235
P=A 6S
R=.045
P-.796
R=.431 
P=.124
R=.033
P=.840
R=.072
P=.709
R=-.123
F=.489
R=-.044
P=.798
Calciu
m (g)
R=-.033
f= .834
R--.036
P=.868
R=-.102
P =.556
R=-.010
P=.955
R=.017
P ^.954
R=.084
P=.603
R=-.173
P ^.37\
R--.066
P=.709
R=.071
P=.681
Iron (g) R=.271
f= .079
R=.430
P=.036*
R=.074
P=.66S
R=.377
P=.023*
R=. 113
P=.702
R=.107
P=.506
R=.161
f*=.404
R=-.153
P=.387
R=.004
P=.982
Magnes
ium
(mg)
R=-.157
P=.314
R=.138
P=.519
R=-.105
P=.544
R=.067
P=.697
R=.031
P = .9 \7
R=.061
P=.706
R=.070
P = .7 \6
R=-.101
P=.570
R=-.171
P =.320
Sodium
(mg)
R=.031 
P=.842
R=-.073
P = J 3 5
R=-.072
P=.676
R=.068
f= .694
R=-.078
f= .790
R-.031
P=.846
R=-.186
P^.333
R=-.328
P-.058
R=.052
P =.76\
Potass iu 
m (mg)
R=-.137
P=.380
R=.090
P=.676
R=-.036
P-.835
R=.239
P -= A 6 \
R=.213
f= .466
R=-.041
P = J 9 9
R -.069
P^.722
R=-.234
P=.183
R=-.360
P=.031*
Zinc
(mg)
R=-.151
f= J 3 3
R=.134
P -.534
R=-.068
P -.694
R=.047
P=.785
R=-.004
P=.990
R=-.198
P = .2 \6
R=.023
P=.904
R=-.115
P = .5 l6
R=-.049
P=.774
Copper
(mg)
R=-.241
P = \2 Q
R -.149
P ^ M 7
R=-.110
P=.524
R=.002
f= .989
R=.270
P=.351
R=.001
f= .994
R=.179
P=.354
R=-.014
P=.938
R=-.121
P=.481
Selenlu
m (ug)
R=-.372
P-.014*
R=-.197
P ^.356
R=-.173
P = .3 \3
R=.061
P^.724
R=.057
P = M 7
R=-.334
P=.033*
R=.031 
P=.872
R=-.153
P=.387
R=-.240
P-.159
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(  Abbreviations: PI is pondéral index, HC:L is head circumference to length ratio, 
WT is birth weight, PWT is placental M>eight, HC is head circumference, LENG is 
length, APG is infant’s AP GAR scores, IGF-1 is cord blood IGF-1 levels and GEST 
is gestational age) denotes statistical significance)
It can be seen that thiamin and folate were significantly positively correlated with 
placental weight. Vitamin Bg was significantly positively correlated with length. 
Vitamin Bn, was significantly negatively correlated with APGAR scores. Vitamin C 
and potassium were negatively correlated with pondéral index. As for iron, it was 
positively coiTelated witli both placental weight and length at birth. Finally, selenium 
was found to be negatively correlated with both birth weight and gestational age. 
However, it is important to note that in all these correlations the strength of the 
relationship was not high, as shown by an r value of less than 0.5 (Pallant, 2001).
The effect of nutritional intalce in early pregnancy was then investigated, taking NVP 
into account. See Table 6.4.f.
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Table 6.4.f Relationship between dietary intake in early pregnancy and
pregnancy outcomes in women with NVP
Nutrient Bwt Pwt He L e n ^ Gest APG Hc:l PI
Energy
(kcals)
R=-.170
P=.346
R=-.090
P=.132
R=-.023
P=.908
R=-.108
P=.586
R=-.298
P-.436
R=.167
P=.361
R=.099
P=.661
R=.029
P=.886
R=-.011 
P=.957
Fat (g) R=-.187
P=.298
R=-.165
P = 5 2 6
R=-.178
P=.363
R--.205
P=.295
R=-.207
P=.593
R=.116
P=.529
R=.182
P=.418
R=.017
P = 9 3 2
R = .ll l
P=.574
Protein
(g)
R=-.122
P=.500
R=.109
P=.616
R=.036
P=.856
R=.088
P=.656
R=-.546
P=.128
R=-.165
P=.367
R—-. 151 
P-.503
R=-.255
P=.200
R=-.202
P=.302
CHO R—-.086 
P=.632
R=-.032
P=.903
R=.116
P=.559
R=-.012
P=.951
R=-.278
P=.470
R=.239
P=.187
R=.101
P=.655
R-.076
P=.706
R=-.057
P^.774
Thiami
n(m g)
R--.073
P=.685
R=.279
P=.278
R=.l41
P^.474
R=-.110
P=.579
R=-.075
P=.848
R--.026
P=.889
R=.043
P=.850
R=.197
P=.324
R=.073
P=.711
Ribofla
vin
(mg)
R=.237
P-.184
R=.325
P-.204
R=.005
P=.780
R=.296
P=.126
R=-.130
P = J 3 9
R=.039
P=.831
R=-.040
P=.859
R=-.261
P-.189
R=-0.69
P=.728
Niacin
(mg)
R=-.021
P =.906
R=.292
P=.255
R=.158
P=.421
R=.222
P=.256
R=-.239
P=.536
R=-.199
P=.274
R=-.108
P=.634
R=-.262
P=.186
R=-.250
P=.200
Vitamin
B6
(mg)
R=.026
P=.888
R=.315
P=.217
R=.199
P=.309
R=.334
P=.082
R=.245
P=.509
R=-.213
P=.242
R=-.112
P = 6 I9
R=-.208
P=.298
R=-.373
P=.051
Vitamin
B12
(ug)
R -. 186
P=.299
R=.037
P = M 7
R=.041
P=.S35
R=.364
P -.057
R=-.606
P=.084
R=-.I54
P=.399
R=-.301
P=.174
R=-.389
P=.045*
R=-.045
P=.820
Folate
(ug)
R=.083
P=.646
R=.390
P -.122
R=-.095
P=.631
R=.215
P=.271
R=.205
P -.596
R=.042
P =.820
R=.243
P -.276
R=-.294
P=.137
R=-.194
P=.322
Vitamin 
C (mg)
R=-.096
P=.594
R=.081
P^.737
R=-.183
P = 3 5 2
R=.117
P=.552
R=.045
P=.909
R=.156
P = J94
R=.224
P=.316
R=-.242
P=.225
R=-.351 
P =.067
Vitamin 
A (ug)
R-.004
P=.983
R=-.181
P=.486
R=-.283
P -.144
R=.023
P=.908
R=.394
P=.294
R=.082
P^.657
R=.278
P=.210
R=-.195
P =330
R=-.116
P=.556
Calciu
m (g)
R=.067
P=.709
R=-.092
P=.724
R--.183
P-.352
R—.046 
P=.816
R=-.290
P=.419
R=.210
P=.249
R—-.082 
P=.716
R=-.118
P=.558
R=.145
P=.461
Iron (g) R=.397
P=.022*
R=.565
P=.018*
R=.113
P=.568
R=.428
P=.023*
R=-.210
P=.587
R=.041
P=.824
R=.098
P=.665
R--.172
P=.392
R=-.018
P=.930
Magnes
ium
(mg)
R=-.024
P=.895
R=253
P^.326
R=.003
P=.987
R=.099
P = .6 \6
R--.158
P=.685
R=.276
P=.126
R=.116
P=.606
R=-.151
P-.452
R--.216
P=.269
Sodium
(mg)
R-.077
P = M 9
R=-.091
P-.728
R=-.055
P^.779
R=.137
P=.486
R=-.484
P=.187
R=-.028
P=.880
R=-.087
P=.701
R=-.331 
P=.091
R=.035
P=.860
Potassiu 
m (mg)
R=-.019
P=.915
R-.063
P=.809
R=.034
P=.864
R=.290
P-=.134
R=-.025
P=.948
R=.117
P -.524
R=.070
P=.756
R=-.309
P=.116
R=-.453
P=.016*
Zinc
(mg)
R=-.069
P=.704
R=.l 16 
P=.659
R=-.024
P=.904
R=.041
P=.837
R=-.306
P=.423
R=-.080
P = M 5
R=.026
P -.910
R=-.115
P=.442
R=-.083
P=.673
Copper
(mg)
R=-.200
P -.264
R=.001
P=.996
R=-.055
P=.782
R=-.023
P=.906
R=-.081
P=.835
R=.306
P=.089
R=.243
P=.275
R=-.035
P -.862
R--.209
P=.287
Seleniu
m (ug)
R=-.299
P=.091
R=-.149
P=.568
R=-.089
P=.653
R=-.165
P=.402
R=-.553
P=.123
R=-.214
P -.240
R=-.161
P -.474
R=-.040
P=.842
R=-.056
P=.776
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( Abbreviations: PI is pondéral index, HC:L is head circumference to length ratio,
WT is birth weight, PWT is placental weight, HC is head circumference, LENG is 
length, APG is infant’s APGAR scores, IGF-I is cord blood IGF-I levels and GEST 
is gestational age) C* denotes statistical significance)
As can be seen, in women with NVP, vitamin B12 was negatively correlated with hc:l. 
Iron was positively correlated with birth weight, placental weight and length. As for 
potassium, it was negatively correlated with pondéral index.
As for women without NVP, Table 6.4.g shows the relationship between intalce and 
pregnancy outcomes in these women.
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Table 6.4.g Relationship between dietary intake in early pregnancy and
pregnancy outcomes in women without NVP
Nutrient Bwt Pwt He Lengtt» M G Hc:l PI
Energy
(kcals)
R=.068
P=.852
R=.215
P=.643
R=.176
P=.676
R=-.101
P=.812
R=.947
P=.014*
R=-.321
P -.400
R=-.204
P=.661
R=-.280
P=.542
R=.132
P=.755
Fat (g) R=.219
P=.542
R=377
P=.404
R=.145 
P =.731
R=-.212
P=.614
R=.788
P=.114
R=-.101
P=.795
R --.408
P=.363
R=-.165
P=.724
R-.307
P -.459
Protein
(g)
R=-.224
P=.533
R=.021
P -.964
R=-.018
P=.967
R=. 133 
P=.753
R =.831
P=.082
R=-.413
P -.270
R=-.206
P=.658
R=-.777
P=.040*
R=-.192
P=.650
CHO R=-.023
P=.949
R=.087
P=.853
R=.189
P=.655
R=-.006
P=.988
R=.951
P=.013*
R=-.346
P=.362
R=.000
P^l.OO
R=-.202
P=.664
R=-.028
P=.947
Thiami 
n (mg)
R=.281
P=.431
R=.745
P=.055
R=.164
P = .69S
R=.454
P=.259
R=-.238
P =JQ O
R=.250
P=.516
R=-.412
P=.358
R=.1I0
P=.814
R=.038
P=.930
Ribofla
vin
(mg)
R=.202
P=.576
R=.260
P=.573
R=.544
P=.163
R=.345
P=.403
R=.759
P=.137
R=.236
P=.540
R=-.408
P=.363
R=-.278
P=.546
R=-.115
P=.785
Niacin
(mg)
R=.046
P=.900
R=.103
P=.826
R=.374
P=.361
R=.341
P=.408
R=.785
P=.116
R=.127
P -.746
R=-.412
P=.358
R=-.699
P=.081
R=-.260
P=.534
Vitamin
B6
(mg)
R=.304
P=.394
R=.446
P=.3I6
R=.531
P=.176
R -.512
P=.195
R=.599
P = .2 8 6
R=.329
P=.387
R=.204
P=.661
R=-.254
P=.582
R=-.023
P=.958
Vitamin
B12
(ug)
R=-.222
P=.539
R=-.142
P-.761
R=.021
P=.961
R=.013
P=.975
R=.587
P=.298
R=.177
P=.648
R—-.408 
P-.363
R=-.356
P=.433
R=-.206
P=.624
Folate
(ug)
R=.214
P-.553
R=.632
P=.127
R=.407
P=.317
R=.352
P=.393
R=.421
P-.481
R=.363
P=.337
R=-.204
P=.661
R=.101
P=.830
R=.I33
P=.754
Vitamin 
C (mg)
R=-.294
P -.409
R=-.252
P=.586
R=-.199
P=.637
R=.440
P=.276
R=-.289
P=.638
R=-.194
P=.617
R=.612 
P=. 144
R=-.342
P=.453
R=-.555
P=.154
Vitamin
A (ug)
R=-.149
P=.682
R=.588
P=.165
R=-.149
P-.725
R=.154
P=.716
R=.662
P -.224
R—-.380 
P=.313
R=-.612
P=.144
R=-.069
P=.884
R=.167
P=.692
Calciu
m (g)
R=-.081
P=.824
R=-.136
P=.772
R=-.205
P=.626
R=.295
P=.478
R=.786
P=.115
R=-.017
P=.966
R=-.204
P=.661
R=-.395
P=.380
R=-.435
P=.282
Iron (g) R=-.164
P=.650
R=.131
P=.779
R=-.080
P=.850
R=-.019
P=.964
R=.884
P=.046*
R=-.051
P=.897
R=-.408
P=.363
R=-.243
P=.599
R=.182
P=.665
Magnes
ium
(mg)
R=-.310
P-.383
R=-.281
P -.542
R=-.374
P=.361
R=-.007
P=.988
R=.468
P=.427
R=-.380
P=.313
R=-.204
P=.661
R=-.409
P=.362
R=-.145
P=.733
Sodium
(mg)
R— 133 
P=.713
R=-.053
P=.910
R=-.173
P=.683
R=-.314
P=.449
R=.913
P-.031*
R=-.017
P=.966
R=.000
P=1.00
R=-.407
P=.365
R=.144
P=.734
Potassiu 
m (mg)
R=-.326
P=.358
R=-.016
P=.973
R=-.289
P=.487
R=.060
P-=.887
R=.664
P = .2 2 \
R=-.498
P=.173
R=0.00
P=1.00
R=-459
P=.300
R=-.095
P=.824
Zinc
(mg)
R=-.218
P-.545
R =088
P=.852
R--.208
P=.620
R=.124
P=.771
R=.859
P=.062
R=-.209
P=.590
R=-.104
P=.825
R=-.496
P=.258
R=.033
P=.937
Copper
(mg)
R— 177 
P=.625
R-.248
P=.592
R=-.219
P=.603
R=.115
P=.787
R=.833
P=.080
R=-.565
P=.113
R=-.204
P=.661
R=-.406
P=.366
R=.026
P=.952
Seleniu
m (ug)
R=-.479
P=.162
R=-.244
P=.598
R=-.290
P=.486
R=.196
P=.642
R=.668
P=.218
R=-.633
P=.067
R=-.408
P=.363
R=-.690
P -.086
R=-.659
P=.076
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(  Abbreviations: PI is pondéral index, HC:L is head circumference to length ratio, 
WT is birth weight, PWT is placental weight, HC is head circumference, LENG is 
length, APG is infant’s APGAR scores, IGF-1 is cord blood IGF-I levels and GEST 
is gestational age) denotes statistical significance).
In women without NVP, energy, carbohydrate, iron and sodium intake were all 
positively correlated with IGF-1 levels. In addition, protein intalce was negatively 
correlated with hc;l.
6,5 Nutritional Intake in late pregnancy
6.5.1 Effect of NVP on nutritional intake in late pregnancy
The intake of the women in the last trimester was assessed using the second food 
diary. The intakes of women both with and without NVP are shown in Table 6.5.a.
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Table 6.5.a Intakes in the third trimester of women both with and without NVP
Nutrient DRV N V P(n=33) N oN V P(n=10) P  value
Energy (kj) 8900 6939.56(1536.84) 7750.50 (977.55) 0.119
Energy (kcals) 1940
(+200)
1648.41 (366.44) 1842.00 (232.95) 0.119
Fat (g) 84 62.45 (19.01) 70.92 (16.25) 0.201
CHO (g) 50% E 220.32 (49.42) 243.56 (35.95) 0.169
Protein (g) 51 63.69(12.15) 68.25 (13.28) 0.301
Thiamin (mg) 0.9 1.58 (0.92) 1.66 (0.28) 0.801
Riboflavin (mg) 1.4 1.41 (0.45) 1.58 (0.46) 0.273
Niacin (mg) 13 31.41 (7.36) 32.50 (7.83) 0.681
Vitamin B6 (mg) 1.2 1.95 (0.50) 2.16(0.66) 0.281
Vitamin B12 (ug) 1.5 3.17(1.62) 3.05 (0.75) 0.830
Folate (ug) 300 234.17(70.94) 264.70 (65.80) 0.222
Vitamin C (mg) 50 103.64 (44.36) 118.55 (54.87) 0.367
Vitamin A (ug) 700 559.85 (234.35) 585.60 (233.94) 0.757
Calcium (g) 700 745.10(266.17) 807.40 (203.24) 0.493
Iron (g) 14.8 12.29 (6.66) 12.43 (5.58) 0.950
Magnesium (mg) 270 214.10(43.89) 250.80 (37.15) 0.019*
Sodium (mg) 1600 2497.90 (619.13) 2347.10(596.37) 0.490
Potassium (mg) 3500 2368.17(542.62) 2808.40 (423.59) 0.021*
Zinc (mg) 7 6.32(1.24) 7.14(1.73) 0.092
Copper (mg) 1.2 0.87(0.19) 0.98 (0.12) 0.124
Selenium (ug) 60 53.20(18.01) 52.00(13.00) 0.845
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In women without NVP, intake of magnesium and potassium were significantly 
higher than were shown for women who did experience NVP. See Figures 6.5.a and b.
Figure 6.5.a Magnesium intake (mg/d) in women with and without NVP
NVP
Figure 6.5.b Potassium intake (mg/d) in women with and without NVP
NVP
A comparison between the macronutrient intake in the first and second trimester, in 
both women with and without NVP is shown in Table 6.5.b
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Table 6.5.b Macronutrient intake in the first and second trimesters in both 
women with and without NVP
Nutrient First trimester | Third trimester R and p  value
NVP yes
Energy (Kcal) (SD) 1690(400) 1650(370) R=.507,p-.003*
Fat (g) (SD) 65.94(21.65) 62.45(19.01) R=.371,p-.033*
Protein (g) (SD) 61.55(13.17) 63.69(12.15) R=.383,p-.028*
Carbohydrates (g) (SD) 224.53 (55.26) 220.32(49.42) R=.557,p-.001*
NVP no
Energy (kcal) (SD) 1890(350) 1840(230) R=.631 ,p=.051
Fat (g) (SD) 77.78(19.38) 70.92(16.25) R=.537,/7=.1 10
Protein (g) (SD) 68.03(11.32) 68.25(13.28) R=.522,p=.122
Carbohydrates (g) (SD) 241.44 (49.10) 243.56(35.95) R=.704,p=.023*
As can be seen, in women with NVP, energy, fat and carbohydrate intake in the first 
trimester was significantly higher than that in the last trimester. In women with NVP 
protein intake in the last trimester was significantly higher than the first trimester.
As for women without NVP, no significant differences were seen between the intakes 
of energy, fat and protein between the first and last trimester, however, in these 
women, carbohydrate intake was significantly higher in the last trimester.
6.5.2 Effect of nutritional intake In late pregnancy on pregnancy outcomes
The only significant relationships seen between intake in the last trimester and 
pregnancy outcomes were a negative correlation between energy intake and APGAR 
scores, a positive correlation between copper intake and gestational age and a positive 
correlation between sodium intake and pondéral index. See Table 6.5.C.
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Table 6.5 c The relationships between nutritional intake in the last trimester and
Nutricmt Bwt Pwt ■ 0 # Hc:I PI
Energy
(kcals)
R-.059
P=.681
R=.048
P=.808
R=.179
P=.244
R=-.122
P =A 39
R=.050
P=.860
R=.143
P=.326
R=-.340
P=.046*
R=.252
P-.107
R=.236
P-.123
Fat (g) R=.036
P=.804
R=.100
P=.613
R=.069
P^.658
R=-.133
P=.391
R=-.047
P -.868
R=.121
P=.409
R--.261
P=.130
R=.199
P=.206
R=.250
P-.102
Protein
(g).
R=.033
P=.818
R=-.135
P-.492
R=.253
P=.098
R=.048
P^.757
R=-.076
P=.788
R=.015
P=.921
R=-.276
P=.109
R=.021
P=.893
R=.004
P=.981
CHO R=.104
P=.469
R=.025
P-.901
R=.214
P=.163
R=-.096
P-.535
R=.204
P=.465
R=.159
P=.275
R=-.301
P=.078
R=.261
P=.095
R=.238
P=.119
Thiami
n(m g)
R=.239
f=.091
R=-.061
P=.756
R=.002
P=.992
R=.161
f= .296
R=.481
P=.069
R=-.100
f= .493
R=-.045
P=.799
R=.094
P=.554
R=.072
P=.644
Ribofla
vin
(mg)
R-.012
P=.933
R=-.134
P=.495
R=.190
P = .2 \7
R=-.052
P=.738
R=.273
P = 3 2 5
R=-.062
P=.674
R=-.026
P=.880
R=.247
P=.115
R=.006
P-.968
Niacin
(mg)
R=.033
f= .820
R=-.056
P -.778
R=.171
P=.267
R=.094
P=.546
R=-.060
P=.831
R=-.041
P^.782
R=-.187
P=.282
R=-.053
P-.741
R=-.030
P=.845
Vitamin
B6
(mg)
R -.129
P=.368
R=.091
P = M A
R=.179
P=.244
R -.072
P=.644
R=.259
P ^ .35\
R=-.060
P=.682
R=.115
P=.510
R-.144
f - .4 7 4
R=.047
P -.760
Vitamin
B12
(ug)
R=.077
P=.631
R=.121
P=.591
R=.191
f= .272
R=.055
P=.752
R=-.238
P^.570
R=.180
P=.279
R=.261
P-.197
R=.014
f= .938
R=-.072
P=.683
Folate
(ug)
R=-.006
P^.967
R=.093
P=.637
R --.040
P=.797
R=-.035
/"-.819
R=.269
P^.333
R=-.076
P=.602
R=.014
f= .938
R=.188
P=.232
R=.087
P = 5 7 6
Vitamin
C(m g)
R=-.194
P = .\73
R=-.087
P-.660
R=-.165
P=.283
R=-.084
P=.590
R=-.169
P=.547
R=.046
P^.753
R=.020
f=.911
R=.002
P=.988
R=-.103
f = J 0 4
Vitamin
A (ug)
R=.021
P = M 5
R=-.038
P=.847
R=-.011
P ^.944
R=-.078
P=.614
R=.163
P =.562
R=.032
P=.827
R=.082
P -.640
R=.217
P=.167
R=-161
P=.295
Calciu
m (g)
R=.025
P=.864
R=-.162
f*=.404
R=.229
P ^ .\3 5
R=-.069
P = 6 5 5
R=.160
P=.568
R=.055
P=.710
R=-.305
f= .075
R=.277
P^.076
R=.138
P=.372
Iron (g) R=.042
P =.77\
R=-.122
P=.537
R=.256
P=.094
R=.032
P=.835
R=.016
P = 9 5 6
R=-.077
P=.600
R=-.203
P-=.24\
R=.066
P=.677
R =.0\ 1 
P=.945
Magnes
ium
(mg)
R=.008
P=.954
R=-.034
P = M 2
R=.103
P=.508
R=.057
P=.711
R=.141
P=.617
R-.163
P=.265
R=-.317
P^.064
R=.036
P=.818
R=-.038
P=.806
Sodium
(mg)
R=.099
P=.488
R=-.154
P =A 34
R=.058
P=.707
R=-.158
P=.305
R=.029
?=.919
R=-.105
P=.474
R=-.070
P=.691
R=.246
P=.117
R=.382
f=.011*
Potassiu 
m (mg)
R=-.055
f= .702
R=-.125
P=.525
R=.094
f= .545
R=-.115
P-=.458
R=.386
P=.155
R=.015
P=.920
R=-.183
P=.293
R=.218
P ^A 65
R=-.047
P-.763
Zinc
(mg)
R-.040
P=.779
R=.183
P=.350
R--.027
P=.861
R=.016
P=.916
R=.229
f= .412
R=-.135
P=.356
R=-.075
P = M 7
R=.050
P=.754
R=-.001
P=.997
Copper
(mg)
R=.088
P=.956
R=-.266
P^.246
R=.185
P = 2 2 9
R=.037
P=.813
R=.140
P=.618
R=.290
P=.043*
R=-.321
P=.060
R=.113
P =A 77
R=.096
P=.534
Seleniu
m (ug)
R=-.021
P=.885
R=.243
P=.213
R=-.071
P=.645
R-.265
f= .082
R=-.238
P=.393
R--.068
f= .644
R=-.287
P=.094
R=-.022
P-.891
R=-.147
P^.342
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( Abbreviations: PI is pondéral index, HC:L is head circumference to length ratio,
WT is birth weight, PWT is placental weight, HC is head circumference, LENG is 
length, APG is infant's APGAR scores, IGF-I is cord blood IGF-1 levels and GEST 
is gestational age) denotes statistical significance)
The relationships between intake and pregnancy outcome, were re-analyzed, taking 
NVP into consideration. In women with NVP, protein intake is negatively correlated 
with IGF-1 values. In addition, sodium was positively coiTelated with pondéral index. 
Copper intake was positively correlated with APGAR scores and selenium intake was 
negatively correlated with both IGF-1 and gestational age. See Table 6.5.d.
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Table 6.5.d Relationships between nutrient intake in the last trimester and
pregnancy outcome in women with NVP
Nutrient Bwt Pwt He Length IGF-1 APG Hc:I PI
Energy
(kcals)
R=.102
P-.533
R=.199
P=.252
R=.199
P=.252
R=-.041
P=.814
R=-.455
P=.219
R=.057
P =.72\
R=.194
P=.236
R=.219
P-.213
R=.165
P=.344
Fat (g) R=.134
P=.408
R=. 178 
P=.307
R=.178
P=.307
R=-.037
P=.831
R=-.469
P=.203
R=.086
P=.595
R=.277
P=.087
R=.192
P=.276
R=.188
P=.281
Protein
(g)
R=.807
P=.592
R=.273
P-.113
R=.273
P=.113
R=.189
P=.277
R=-.743
P=.022*
R=-.244
P=.124
R=-.007
P = 9 6 8
R=-.061
P=.731
R=-.120
P=.492
CHO R=.094
P=.564
R=.152
P=.385
R=.152
P=.385
R—-.062
P = J 2 5
R=-.257
P=.504
R-.096
P=.552
R=.153
P-.353
R=.230
P=.191
R=.195
P-.262
Thiami
n(m g)
R=.306
P=.055
R=-.052
P=.829
R— 106 
P=.545
R=.195
P = .26\
R-.155
P=.690
R=-.044
P=.784
R--.100
P=.543
R=.066
P=.709
R-.073
P=.677
Ribofla
vin
(mg)
R=-.047
P=.11A
R=-.133
P -.576
R=.032
P -.854
R=-.073
P=.678
R=-.029
P=.941
R=.070
P=.663
R=-.147
P=.372
R=.233
P=.184
R=-.012
P=.948
Niacin
(mg)
R=.085
P=.602
R=.043
P=.858
R=.140
P=.423
R=.175
P=.314
R=-.403
P=.282
R=-.190
P=.233
R=-.129
P=.433
R=-.122
P=.493
R=-.096
P=.584
Vitamin
B6
(mg)
R=.126
P=.439
R -.lO l
P=.671
R=.043
P=.808
R=.098
P=.574
R=.236
P-.540
R=-.090
P=.575
R=-.149
P=.365
R=.035
P=.844
R=-.025
P=.886
Vitamin
B12
(ug)
R=.066
P=.125
R=.235
P=.381
R=.145
P=.472
R=.077
P=.704
R=-.856
P=.144
R=-.110
P -.494
R=.148
P=.435
R=.023
P=.911
R=-.099
P=.623
Folate
(ug)
R=.013
P=.939
R=.076
P -.749
R=-.134
P=.443
R=-.052
P=.766
R=.314
P-.410
R=.026
P=.S72
R=-.157
P=.339
R=.155
P-.381
R=.024
P=.893
Vitamin 
C (mg)
R=-.083
P=.612
R=.018
P=.941
R=-.005
P=.979
R=-.005
P=.976
R=-.213
P=.582
R=.056
P=.728
R=.149
P = J64
R--.011
P=.950
R=-.162
P=.352
Vitamin
A (ug)
R=.096
P=.558
R-.047
P=.844
R=.086
P=.625
R=-.023
P=.895
R=.121
P=.7S6
R=.033
P -.840
R=.091
P=.583
R=.199
P=.258
R=.094
P=.591
Calciu
m (g)
R=.032
P=.846
R=-.168
P=.480
R=.261
P=.130
R --.017
P = .92\
R=-.284
P -.459
R=.084
P=.603
R=.098
P=.554
R=.252
P=.151
R=.083
P=.636
Iron (g) R=.027
P = M 9
R=.236
P=.316
R=-.058
P=.741
R=.049
P -.778
R=.127
P=.745
R=.107
P=.506
R=-.120
P=.468
R=.063
P=.724
R--.032
P=.853
Magnes
ium
(mg)
R=.136
P=.403
R=.123
P=.606
R=.162
P^.352
R=.186
P=.286
R—-.210 
P=.587
R=.061
P=.706
R=.290
P =.074
R--.055
P=.758
R=-.168
P=.335
Sodium
(mg)
R=.129
P=.428
R--.062
P -.794
R=.030
P=.866
R=-.080
P -.649
R=-.485
P-.186
R=.031
P=.846
R=-.116
P=.481
R=.216
P=.220
R=.356
P=.036*
Potassiu 
m (mg)
R=-.016
P=.924
R=-.001
P -.995
R=.123
P=.480
R=-.037
P-=.832
R=.110
P = J 7 7
R=-.041
P = 7 9 9
R=.103
P=.533
R=.205
P=.246
R=-.125
P=.474
Zinc
(mg)
R=.044
P=.788
R=-.082
P=.732
R=.170
P=.330
R=.099
P=.573
R=-.301
P=.431
R=-.198
P = .2 \6
R=-.172
P=.295
R=.020
P=.910
R=-.056
P=.751
Copper
(mg)
R=.156
P=.336
R=.283
P=.221
R=.138
P=.429
R=.054
P = J 6 0
R=-.384
P=.307
R=.001
P=.994
R=.344
P=.032*
R=.073
P=.683
R -.0 2 1 
P=.907
Seleniu 
m (ug)
R=.005
P=.915
R=-.016
P -.947
R=.297
P=.083
R=.165
P=.343
R=-.727
P=.026*
R=-.334
P=.033*
R=.000
P=.998
R=-.031 
P=.863
R=-.211
P=.223
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(  Abbreviations: PI is pondéral index, HC:L is head circumference to length ratio, 
WT is birth weight, PWT is placental weight, HC is head circumference, LENG is 
length, APG is APGAR, IGF-1 is cord blood IGF-1 levels and GEST is gestational 
age) denotes statistical significance)
In women without NVP, IGF-1 values were positively coiTelated with energy, 
carbohydrate, thiamin, calcium, iron, magnesium and potassimn intalces. Birthweight 
was negatively associated with vitamin C intakes. In addition, it was found that there 
was a negative correlation between fat and sodium intake and infant length at birth. 
See Table 6.5,e.
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Table 6.5.e Effect of dietary intake in the last trimester on pregnancy outcome in
women without NVP
Nutrient Bwt Pwt He Length - G e st APG Hc:l PI
Energy
(kcals)
R=-.017
P=.959
R=-.254
P=.543
R=.077
P=.843
R=-.590
P -.094
R=.815
P=.048*
R=.067
P=.853
R=.082
P=.846
R=.300
P=.471
R=.480
P=.192
Fat (g) R--.172
P=.612
R=-.362
P=.378
R=-.291
P-.448
R—-.678
P=.045*
R=.772
P=.072
R=-.399
P=.254
R=.247
P=.555
R-.053
P -.900
R=.462
P -.210
Protein
(g)
R=-.064
P=.851
R=-.354
P=.390
R - 195 
P -.615
R=-.534
P=.139
R=.610
P-.199
R=.074
P=.840
R=.247
P=.555
R=.448
P=.266
R=.358
P=.344
CHO R=.150
P=.660
R=-.057
P=.894
R=.375
P-.320
R=-.336
P=.376
R=.857
P=.029*
R=.067
P=.853
R=.247
P=.555
R=.331
P=.424
R=.397
P=.290
Thiami 
n (mg)
R=-.073
P=.832
R--.075
P=.860
R=.241
P=.532
R=-.250
P=.517
R=.919
P-.009*
R=-.080
P=.826
R=.083
P=.845
R=.017
P=.969
R=.101
P=.795
Ribofla
vin
(mg)
R=.195
P=.565
R=-.170
P=.688
R -.532
P=.141
R=-.032
P=.934
R=.759
P=.080
R=.018
P-.960
R=.247
P=.555
R=.152
P=.720
R=.062
P=.874
Niacin
(mg)
R=-.094
P-.783
R=-.158
P=.708
R=.265
P=.491
R=-.257
P -.504
R=.419
P=.409
R=.255
P=.476
R=-.082
P -.846
R=.348
P=.398
R-.187
P=.629
Vitamin
B6
(mg)
R=.143
P=.675
R=.087
P=.838
R=.415
P -.267
R=-.060
P=.879
R=.406
P=.424
R=.325
P=.359
R=.412
P=.310
R=.418
P=.303
R=.282
P=.463
Vitamin
B12
(ug)
R=.069
P=.860
R-.135
P=.799
R=.567
P=.143
R=.013
P-.977
R=.809
P-.191
R=.458
P=.254
R=-.008
P-.987
R=.078
P=.853
Folate
(ug)
R=-.052
P=.879
R=.109
P -.797
R=.148
P=.704
R=.042
P=.914
R=.267
P = M 9
R=.239
P=.506
R=.412
P=.310
R=.316
P=.446
R=.369
P=.328
Vitamin 
C (mg)
R=-.609
P=.047*
R=-.333
P=.420
R=-.603
P-.085
R=-.581
P=.101
R=-.055
P -.917
R—-.411
P=.238
R=-.577
P=.134
R=.249
P-.553
R=.228
P=.556
Vitamin 
A (ug)
R=-.187
P=.582
R=-.206
P=.625
R=-.259
P-.501
R=-.415
P^.267
R=.341
P=.508
R=-.l 17 
P=.748
R=-.412
P -.310
R=.278
P=.504
R=.417
P=.264
Calciu
m (g)
R=.022
P-.948
R=-.189
P=.653
R=.161
P=.679
R=-.441
P=.235
R=.870
P=.024*
R=-.025
P=.946
R=.082
P=.846
R=.361
P -.379
R=.393
P -.296
Iron (g) R=.095
P=.782
R -.297
P=.476
R=.266
P=.489
R=-.217
P = 5 7 5
R=.855
P=.030*
R=.157
P=.664
R=.167
P=.693
R=.341
P=.409
R=.465
P=.207
Magnes
ium
(mg)
R=-.264
P=.433
R=-.340
P=.411
R=-.162
P=.677
R=-.504
P=.166
R-.878
P=.021*
R=-.196
P=.587
R=-.412
P=.310
R=.294
P =A 79
R=.311
P=.415
Sodium
(mg)
R=.031 
P=.929
R=-.374
P =.36\
R=.118
P=.762
R=-.763
P -.017*
R—.606 
P=.202
R=.006
P=.987
R=.577
P=.134
R=.387
P=.343
R=.526
P=.146
Potassiu 
m (mg)
R~-. 171 
P=615
R=-.417
P=.304
R=-.137
P = 7 2 5
R=-.659
P-=.054
R-.903
P=.014*
R=-.282
P=.429
R=-.082
P -.846
R=.031
P-.943
R=.252
P=.513
Zinc
(mg)
R=-.040
P=.907
R=-.480
P=.229
R=.161
P=.679
R=-.229
P=.553
R=.546
P^.262
R=.133
P=.715
R=.249
P=.552
R=.014
P=.974
R=.143
P-.714Copper
(mg)
R=-.006
P=.987
R=-.082
P=.846
R=.188
P=.628
R--.315
P =A 09
R=.756
P=.082
R=.104
P = J 7 4
R=-.415
P=.307
R=.162
P-.701
R=.353
P=.351
Seleniu
m (ug)
R=-.377
P=.253
R--.136
P-.748
R=-.221
P = 5 6 9
R=-.109
P=.781
R=.459
P=.359
R=-.448
P=.194
R=.412
P=.310
R=.172
P=.683
R=.209
P=.589
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f  Abbreviations: P I is pondéral index, HC:L is head circumference to length ratio, 
WT is birth weight, PWT is placental weight, HC is head circumference, LENG is 
length, APG is APGAR, IGF-I is cord blood IGF-1 levels and GEST is gestational 
age) denotes statistical significance)
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7. DISCUSSION OF PROSPECTIVE STUDY
7.1 NVP
7.1.1 Symptoms of NVP
In this study, it was found that the prevalence of NVP was 79%, this compai*es well 
with other studies which found that NVP occurs in nearly 70% of the population 
(Broussard and Richter, 1998).
Within the sample of women with NVP, it was found that 23% had vomiting as well. 
In other studies on NVP, vomiting was reported in 38-62% of pregnant women 
(Vellacott et al, 1988, Kiebanoff et al, 1985, Tierson et al, 1986, Gadsby et al, 1993, 
Lacroix et al, 2000). This is slightly lower than that reported by other studies, this 
could be due to the fact that in most women, symptoms of NVP had started by the 
time of the first interview, and thus the actual number of episodes prior to the 
initiation of the symptom diary were not accurately remembered.
7.1.2 Onset and cessation of symptoms
In this study it was foimd that the mean week for NVP to start was 5.2 (median 6 
weeks) fi'om LMP. In all women with symptoms, symptoms had started by 9 weeks 
gestation. The mean week for cessation of symptoms was 14.3 (median 13), with 
87.2% of women ceasing to have symptoms by week 20.
In their prospective study, Gadsby et al (1993) found that the mean week for 
symptoms to start was 5.7 fiom the LMP. The mean week for cessation of symptoms
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in the study by Gadsby et al (1993) was week 12 from LMP, with 90.8% of women 
ceasing to have symptoms by week 16 from LMP.
In another prospective study carried out by Lacroix et al (2000) on 180 women using 
both symptom diaries and McGill Nausea Questionnaire, it was found that nausea was 
reported as early as 3 weeks gestation, although the mean gestational age at onset was 
5.7 weeks. Although 50% of individuals with nausea reported resolution of symptoms 
by 14 weeks, it was not until week 22 that symptoms had resolved in 90% of women.
Tierson et al (1986) in their prospective study foimd that the mean and median week 
of onset of nausea was week 6, with no difference in women who had nausea only 
compared to those with both. By the 4^ ’’ week, only 20% had symptoms, increasing to 
80% by week 8, and 98% of women by week 16. By week 15, 50% of women stopped 
having symptoms, and by week 20, 25% still had symptoms. Nausea persisted longer 
if accompanied by vomiting.
In a prospective study by Zhou et al (1999) on 103 women, the mean duration of 
symptoms was 15.2 weeks, with 73.2% reporting symptoms to have stopped by week 
24, 4% by 28-32 weeks and 22.8% persisting tlrroughout pregnancy.
Thus it can be seen that NVP seems to persist into the second trimester, and therefore 
it is important that caregivers are aware of this aspect of the natural history of NVP to 
avoid women becoming angry and disappointed when the symptoms persist (Lacroix 
et al, 2000).
205
7.1.3 Symptom severity
In oiu‘ study the median total number of hour s of symptoms was 80 hours, which 
lasted for a median of 8 weeks. Similarly, Gadsby et al (1993) also showed that the 
symptoms lasting for a median of 41 days (interquartile range 28-56 days), ie nearly 8 
weeks. However, the median total rumiber of hours of symptoms per pregnancy 
recorded by Gadsby et al (1993) was 56 hours (range 22-139), this was lower than 
that recorded in oin study, again this could probably be due to the inaccuracy of the 
information given by the women for the two weeks preceding the interview, since like 
us, Gadsby et al (1993) used recall for two weeks if the women could remember her 
symptom pattern.
7.1.4 Episodic nature of symptoms
The most common tlnee hour period for nausea to occur was between 06:00-09:00 
followed by 09:00-12:00 , 12:00-15:00, and 15:00 -18:00 . As for vomiting, the most 
common time was 06:00-09:00 and 18:00-21:00. 09:00-12:00 and 12:00-15:00 p.m 
also connnon times for vomiting to occui*.
This confmns the finding of the study by Gadsby et al (1993), who also found that the 
most common 3 hour period for symptoms to occur was between 09:00-12:00 in the 
morning, this was followed by 06:00-09:00, then 12:00-15:00, 15:00-18:00, 18:00- 
21:00. The most common six hour period being 06:00-12:00. Only 3.8% of women 
only experienced symptoms between 06:00-12:00 a.m. The majority of women 
experienced symptoms both before and after midday. For the women reporting 
vomiting, the most common time being 06:00-09:00, followed by 09:00-12:00.
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Lacroix et al (2000) also found that although 80.2% of women reported nausea in the 
morning, only 1.8% reported only morning sickness. NVP lasted until afternoon in 
3.7%, until after suppertime in 4.7% and all day long in 80%.
Similarly, Dilorio et al (1992) using 7 day diaries, also found that nauéea was equally 
likely to be distributed throughout the waking hour s. Another study car ried out by 
Vellacott et al (1988) fomid that only 19% of women had symptoms confined to the 
morning. These figures suggest that the term morning siclcness is misleading and 
should be avoided when one is referring to nausea and vomiting in pregnancy.
7.1,5 Number and length of episodes per day
In this study, 90.5% of women experienced days with only one episode of nausea, 
85.7% two episodes of nausea and 81% of women experienced three or more 
episodes. In 72% of episodes, the duration of each episode was half and horn to an 
hour, 17.9% lasted more than two hours and 3.8% more than 10 horns. Week 11.9 
was the week within which there were the longest episodes of NVP.
Similarly Gadsby et al (1993) found that 84.6% of women experienced days with two 
episodes of nausea and 55.8% experienced days with tlnee or more episodes at some 
time during their pregnancy. In 35.7% of episodes, the druation of each episode was 
between 1 and 2 hours, 35.3% lasted between 2 and 4 horns. Week 9 was the median 
week within which there were the longest episodes of NVP.
In this strrdy, it was foimd that women with more severe symptoms had more hours 
and longer duration of symptoms compared to those with less severe nausea. This
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finding confirmed the study by Gadsby et al (1993) who found that those women 
reporting more severe vomiting had longer hours of nausea..
7.1.6 Factors that alleviate and worsen symptoms
In this study it was shown that the most commonly used methods to alleviate 
symptoms were eating little and often, cai'bohydrate rich meals, consuming ginger 
containing foods and rest. These are the same measures reported by the women in the 
retrospective study mentioned in chapters 2-4. As for factors that made symptoms 
worse, this study found that both smells and tiredness were reported by most of the 
women witli NVP.
The effect of olfactory stimulation on exacerbating symptoms of NVP have been 
mentioned by O’Brien et al (1997), where olfactory stimulation such as smells, were 
reported by women as making symptoms worse. De la Ronde and Thirsk (1995) in 
their review stated that increased oestrogen levels may increase olfactory sensitivity. 
Odoui's such as perfume and smoke, in addition to aromas of cooking foods may also 
initiate nausea. Women could be advised to avoid cooking, and for the partner to cook 
instead. Alternatively, the women could prepare cold foods such as salads and 
sandwiches that do not produce aromas.
In devising the best advice for women it is important to note that rest helps alleviate 
symptoms and tiredness makes symptoms worse. As mentioned in section 4.1.6, rest 
is not mentioned in medical textbooks as a method to alleviate symptoms. As fatigue 
seems to exacerbate symptoms, women should be encoinaged to increase their rest 
while they are symptomatic and to seek assistance in such daily activities as child
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cai'e. It would therefore seem appropriate for health care providers to adopt a liberal 
attitude towards providing letters for leaves of absence from work. Such a policy will 
ultimately shorten the time lost from outside employment.
7.1.7 Factors related to NVP
The only factor found to be related to symptoms of NVP in this study was the 
women’s age. The finding that NVP was more common in yoimger women has been 
reported by Kiebanoff et al (1985), Kallen ( 1987), Depue et al (1987), Wiegel and 
Wiegel (1988) and Pettiti (1986). Some possible reasons for this include a greater 
cumulative experience in handling high oesti ogen levels during the course of normal 
menstrual cycles (Depue et al,1987), alterations in steroid synthesis (Wiegel and 
Wiegel, 1988), and poor placental frmction in the older women. Snell et al (1998) 
stated that the weight of evidence points to the trend of a reduced risk of NVP with 
increasing age. The authors speculated that because oestrogen levels decrease with 
age, if oestrogen level is an etiologic factor in the development of symptoms, tins 
could be the physiological basis for a decreased prevalence of NVP in older women.
On the other hand, Vellacott et al (1988), Jarnfelt-Samsioe et al (1983), Gadsby et al 
(1997) and Zhou et al (1999) did not find an association between maternal age and 
NVP. The variation in studies could be due to the different age categories used.
7,2 Cravings and aversions in pregnancy
7.2.1 Foods craved during pregnancy
In this study it was found that the foods most commonly craved dining pregnancy 
were fruit, grains and starches, sweets and dairy products. These cravings ai'e the
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same as those seen in the retrospective study mentioned in chapters 2-4. These 
findings reciprocate the findings of Dickens and Trethowan (1971), Finley et al 
(1985), Flaxman and Sherman (2000) and Bayley et al (2002).
7.2.2 Foods avoided during pregnancy
The most commonly avoided foods mentioned by the women in this study were 
stimulating drinks such as tea and coffee, meats, sweets, vegetables and ethnic and 
strong, spicy foods, these are similar to the aversions mentioned by the women in the 
retrospective study (chapter 2-4). Our results ai'e similar to those seen by Dickens and 
Trethowan (1971), Finley et al (1985), Flaxman and Sherman (2000),and Bayley et al 
(2002^
7.3 Pregnancy outcomes
7.3.1 Effect of maternal factors on pregnancy outcomes
7.3.1.1 Maternal birthweight
In this study, it was foimd that maternal birth weight was related to baby’s birth 
weight and placental weight. However the relationship between maternal birth weight 
and placental weight ceased to be significant when controlling for birth weight. This 
result is supported by the study canied out by Godfrey et al (1996) who also found a 
relationship between maternal birth weight and baby’s weight. In addition Godfrey et 
al (1996) reported that placental weight was also related to maternal birth weight. 
Godfrey et al (1996) reported that this stiong relationship supports the hypothesis that 
maternal constraint of fetal growth may operate largely through consti'aint of placental
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growth, perhaps as a consequence of impaired uterine or ovarian development during 
the mother’s own fetal life. Like Godfrey et al (1996), this study was based on 
recalled maternal birth weights. In the study by Godfrey et al (1996), it was found that 
there was a high degree of agreement between actual and recalled birth weights.
7.3.1.2 Maternal weight gain
In this study, it was found that maternal weight gain during pregnancy was positively 
related to gestational age. This is in contiast with Thame et al (1997), who reported 
that maternal weight gain was not related to any pregnancy outcome. Low gestational 
weight gain is laiown to be one of the greatest predictors of low birth weight for both 
preterm and small for gestational age births (Scholl et al, 1991). In a prospective study 
of 510 women by Aaionson and Macnee (1989) it was found that maternal weight 
gain was related to length of gestation. Abrams et al (2000) cited a review by 
Carmichael and Abrams (1997) which foimd that 11 out of 13 studies published 
between 1980 and 1996 found an association between a low rate of weight gain and 
an increased risk of preterm birth. Abrams et al (2000) reported that the pattern of 
weight gain as well as the total amoiuit gained should be considered as they might 
have an effect on preterm delivery.
7.3.1.3 Maternal pre-pregnancy weight
Maternal pre-pregnancy weight was related to the infants pondéral index (PI) in tliis 
study. Both Godfrey et al (1997) and Thame et al (1997) found no relationship 
between early pregnancy weight and PI. One possible reason for this difference is that 
in our study we used recalled pre-pregnancy weights, whereas Godfr ey et al (1997) 
and Thame et al (1997) used early pregnancy weights. Pondéral index is associated 
with increased risk of insulin resistance in later life (Godfrey and Baiker, 2001), tlius
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improving maternal nutritional status pre-pregnancy may protect her infant’s future 
health,
7,3.1.4 Smoking pre-pregnancy
Smoking pre-pregnancy was statistically significantly related to shorter babies with 
larger head circumference to length ratio. Godfrey et al (1997) also found that women 
who smoked during pregnancy had infants who were lighter and shorter than women 
who did not smoke. Williams and Poulton (1999) reported that smoking might have 
non-nutritional effects that exert a direct effect on the fetus and that may be mediated 
by an effect on the placental circulation. In addition, maternal smoking could exert its 
effects by affecting nutritional intake. In our study, it was found that women who 
smoked pre-pregnancy had lower intakes of potassium in eaiiy pregnancy and lower 
car otene in later pregnancy. We could not compar e the effect of smoking on 
nutritional intake during pregnancy with the nutritional intake of non-.smokers as there 
were only a small number of women who smoked dming pregnancy. Mathews et al 
(2000) in their prospective study using 7 day estimated food diaries on 774 pregnant 
women found that women who smoked had lower intakes of most nutrients compar ed 
to women who didn’t smoke. However, after adjusting for height, age and education, 
only levels of vitamin C and carotenoids were lower. In addition, it was found that 
yoimg women who smoked had the lowest intakes compared to the rest of the 
pregnant women
In a study by Vatten et al (2002) it was found that cord blood levels of IGF-1 were 
lower in women who reported smoking in early pregnancy compared to non-smokers. 
They reported a strong increase in cord IGF-1 levels with mcreasing birth weight and
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length. In this study, no association was found between smoking and IGF-1 levels 
probably due to the small sample size of our study compared to the sample of 585 
women used by Vatten at al (2002).
7.3.1,5 Maternal BMI
In this prospective study, it was found that maternal BMI was statistically 
significantly related to the infants pondéral index. In their retrospective study on 2394 
birth records, Thame et al (1997) reported that maternal BMI was not linearly related 
to pondéral index, although those women with the lowest BMI had infants with lowest 
PI.
7.3.2 Effect of NVP on pregnancy outcome
1. Effect on cord blood IGF-1 concentrations
This study found that cord blood IGF-1 values were affected by severity of NVP, 
where they were significantly higher in women with both nausea and vomiting 
compared to women without symptoms. It was also found that in women with NVP, 
IGF-1 was not related to energy intake, whereas in women without NVP, IGF-1 was 
directly related to energy intake.
The dominant influence on fetal IGF-1 levels at least in the second half of gestation 
seems to be nutrient status and in particular glucose availability to the fetus and 
subsequent changes in fetal insulin release. Little is known of the factors that might 
regulate nutrient transfer across the placenta (Gluckman, 1995). There is moimting 
evidence that the IGFs can determine this paititioning. Elevations in fetal IGF-1 seem 
to partition nutrients between the placenta and fetus in favoiu* of the fetus (Gluclanan,
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1995). Gluckman and Harding (1997) stated that fetal IGF-1 has an effect on placental 
metabolism by reducing placental lactate production and placental demands for amino 
acids, which allows an increased substrate supply to the fetus. However, how NVP is 
related to IGF-1 can be explained by one or all of the following thr ee ways.
Firstly, the hormones, which have been associated with NVP, might have a role to 
play in improved placental fonction, and thus improved substrate availability, leading 
to elevated fetal IGF-1 levels. Woilhington-Robeits and Williams (1993) stated that 
from the earliest days of pregnancy, the cells of the trophoblast and those 
differentiated fr om them in the placenta manufacture a variety of hormones; the first 
hormone to be synthesised is human chorionic gonadotrophin hormone (hCG). Early 
in the differentiation of the trophoblast, this hormone is found coating the 
trophoblast’s outer cell surface where it is thought to act as an inimunologically 
protective layer preventing the rejection of the blastocyst and thereby facilitating 
implantation. hCG has been implicated in the aetiology of NVP as its levels peak in 
the first trimester when the frequency of NVP peaks (Masson et al, 1985). hCG 
production plays an important part in rescuing the corpus luteum and in maintaining 
progesterone production of the corpus luteum. During the first six weeks of gestation, 
the corpus luteum is believed to be the prime source of progesterone production and 
thereafter the placenta becomes the main somce (Maruo et al, 1992). Progesterone 
production is important for placental and fetal growth. Kleeman et al (1994) found 
that administration of exogenous progesterone to pregnant rats increased fetal and 
placental growth. hCG has also been shown to activate the thyroid, stimulating the 
release of thyroxine, wliich is a potent stimulator of placental growth (Mori et al, 
1988) . Thyroid hormones can stimulate the production of a number of placental
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hormones, including placental lactogen, progesterone, and oestradiol-17p in placental 
tissue (Symonds, 1995). This in vitro placental response is confined to the early part 
of gestation and is not seen near to term (Symonds, 1995). Taken together, these 
findings indicate that thyroid hormones play a primary role in maintaining function of 
the differentiated trophoblast, over a period in which growth and metabolic 
requirements are maximal (Symonds, 1995). The ability to alter maternal thyroid 
hormone production during early pregnancy could serve a dual purpose in promoting 
placental growth, as well as supplying serum thyroxine (T4) to the fetus before 
development of fetal thyroid (Symonds, 1995).
Other hormones known to affect placental metabolism include maternal IGF-1, 
placental GH and placental lactogen. Elevation of maternal IGF-1 may enlrance 
nutrient transfer from mother to placenta and so alter placental metabolism. Maternal 
IGF-1 in the second half of pregnancy is associated with an increase in mRNA for the 
glucose transporters 1 and 3 (Bauer et al, 1998). Bauer et al (1998) reported that 
ontogenic studies in sheep have found that levels of mRNA for GLUT 1 increase with 
placental size in early gestation and GLUT 3 increases with placental function in late 
gestation. Bauer et al (1998) speculated that GLUT 1 might be responsible for transfer 
between the mother and placenta, and GLUT 3 between the placenta and the fetus.
Alsat et al (1998) reported that up to 15-20 weeks gestation, pituitary GH is the main 
form present in the maternal circulation after which placental GH is produced and 
suppresses pituitary GH. Placental GH is only secreted into the maternal circulation 
and its levels increase with increasing placental size (Alsat et al, 1998). Placental 
growth hormone may have a role in placental development and syncytiotrophoblast
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differentiation and function via an autocrine or paracrine mechanism as seen by 
specific receptors on this tissue (Alsat et al, 1998). Placental GH seems to regulate 
maternal IGF-1 production, and thus indirectly affects fetal growth (Alsat et al, 1998). 
Hull and Harvey (2001) suggested that placental growth hormone may enhance fetal 
growth by increasing placental size rather than by acting directly on the fetus, since 
placental growth hormone is not detected in the fetal circulation. Placental GH also 
stimulates placental IGF-1 production and enhances endometrial growth (Hull and 
Hai'vey, 2001). Placental GH may also alter endocrine activity of the placenta since it 
stimulates the production of placental lactogens, oestradiol and progesterone in vitro 
(Hull and Hai'vey, 2001). It also increases DNA synthesis and the growth of fetal 
tissues in rat and sheep fetuses dur ing the latter part of pregnancy (Hull and Harvey, 
2001).
The role of placental lactogen in maternal and fetal circulations remain unclear 
(Gluckman, 1995). There is some speculation that placental lactogen might be a 
regulator of maternal metabolism to partition nutrients in favoiu of the fetus 
(Gluckman, 1995) Thus placental lactogen could have a role in fetal growth and in the 
regulation of maternal and fetal IGF-1.
Jansson and Powell (2000) reported that the study of placental nutrient transport is 
still in its infancy and that much more research is needed in the area of fetal growth 
and placental function, using a wide variety of methods such as molecular biology to 
whole animal physiology. Also studies in pregnant women using newly developed 
stable isotope techniques will be valuable to obtain an understanding of the 
metabolism and transport of nutrients in vivo.
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Secondly, it could be the maternal environment prior to pregnancy, which induces 
better placental growth and fimction. Wlieeler et al (1999) reported that during the 
first trimester, the trophoblast environment is usually hypoxaemic, because perfusion 
of the trophoblastic villi by maternal blood is established only between 10 and 12 
weeks gestation. Wheeler et al (1999) found liigher levels of hCG and placental 
lactogen in women with low haemoglobin levels. They found that the expression of 
mRNA for one of the vascular endothelial growth factors was increased in hypoxia 
suggesting that an increase in placental angiogenesis may be one of the mechanisms 
through which this is achieved as VEGF plays a role in angiogenesis. Circulating 
VEGF can be detected m maternal plasma at 6 weeks gestation and rises to a peak at 
the end of the first trimester in par allel with hCG. Villous trophoblast VEGF 
expression appear s to decline as pregnancy advances (Kingdom et al, 2000). Wheeler 
et al (1999) found that VEGF concentrations were positively correlated with placental 
volume at mid pregnancy and with fetal and placental weight at delivery. Wheeler et 
al (1999) speculated that placental growth is in par t determined by maternal factors 
that prevail before conception, one possibility was that these factors modify 
angiogenesis within the trophoblastic cells. Wheeler et al (1999) reported that the 
production of VEGF by vascular smooth muscle cells is increased by oestrogen. Thus 
it could be that in women with elevated oestrogen levels such as in younger women, 
non-smokers who are more susceptible to NVP, there are higher VEGF levels, and 
thus better placental growth and function and therefore higher placental hormones 
such as hCG, which then trigger NVP.
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Thirdly, it has been proposed that NVP is a result of a genetic conflict between the 
mother and fetus (Flaxman and Sherman, 2000). The preimplantation embiyo bathes 
in a fluid that is rich in IGFs (van Kleffens et al, 1998). IGF-11 is produced in 
abundance by the trophoblast cells of the placenta (van Kleffens et al, 1998). 
Successful implantation, placental development and fetal growth depend on migration 
of the IGF-2 producing trophoblast into the maternal decidua (Minniti et al, 1992). 
IGF-11 knockout mice have significant growth retardation especially in the early 
stages of gestation and IGF-11 gene disruption is associated with severe placental 
growth retardation (DeChiaia et al, 1990). Gaidner et al (1999) reported that IGF-11 
appears to have an effect on body composition in the mouse. It controls fluid uptake 
by direct action on the maternal capillaries by increasing VEGF. This increases 
capillary permeability and promotes angiogenesis.
The effects of the IGFs are mediated via 2 specific receptors, type-1 and type-2, 
which are expressed in high density on most fetal and placental cells, th e  type-1 and 
type-2 receptors co-localise witli IGF-II, which suggests the receptors compete for 
IGF-II (Zhou and Bondy, 1992). IGF-II interacts with type-1 and type-2 IGF receptors 
(IGF2R); the type-2 receptor binds IGF-II with high affinity and IGF-I with an 
affinity about 100-fold lower (Han and Carter, 2000). Whereas the type-1 receptor 
promotes growth, tire competitive non-signalling type-2 receptor limits growth 
(Czech, 1989); it is also implicated in IGF-II degradation (O’Dell and Day, 1998). A 
soluble circulating form of the type-2 receptor (IGFR2) inhibits IGF-II mediated DNA 
synthesis and therefore probably constrains fetal growth (Ong et al, 2000). Size at 
birth correlates with the ratio of circulating IGF-II and soluble IGF2R levels (Ong et 
al, 2000).
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It has been suggested by Haig (Haig and Graham, 1991) that as the gene for the type- 
2 receptor is maternally imprinted and IGF-II is paternally imprinted (DeChiara et al, 
1991), this presents an example of genetic conflict. Paternal genome expression 
promotes growth via the expression of IGF-II but the maternally expressed type-2 
receptor can act to mop up IGF-II preventing it from binding to the growth promoting 
type-1 receptor. Thus an excess of type-2 receptor expression will limit growth of the 
placenta and, therefore, constrain fetal growth so limiting the metabolic demands 
placed on the mother.
Thus the size and function of the placenta could be determined by genetic conflict. 
IGF-11 then stimulates VEGF production, which leads to better placental function, 
elevated hCG levels and thus NVP. IGF-11, which causes placental growth and 
development, leads to an increase in placental hormones and thus nutrient 
paititioning, this leads to increased fetal IGF-1. A summary of these effects is shown 
in diagrammatic form in figure 7.3.a.
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Figure 7.3.a Diagrainatic presentation of possible hormonal pathways leading to 
elevated IGF-1 levels in infants born to women with more severe symptoms 
of NVP compared to those with less severe symptoms
IGF-11
VEGF
hCG
Increased placental fimction/size ►increased placental hormones
Placental GH 
Placental lactogeniThyi'oxine
Maternal IGF-
Increased nutritional partitioning 
in favour of fetus
i Î
Elevation of fetal IGF-1
Although no significant effect of NVP on placental size was observed in this study, 
Gadsby et al (1997) did find larger placentas in women with NVP. Fiudhermore 
placental size does not necessarily reflect function, thus the effect of NVP could be to 
improve placental fimction without necessarily increasing placental size.
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2.Effect on placental ratio
The duration of NVP had an effect on placental ratio, with women with longer 
duration of NVP having a lower placental ratio compar ed to women with short 
dur ation of symptoms. The effect of NVP on placental ratio may be beneficial in the 
long run as Barker and colleagues have reported that the risk of hypertension 
decreases with increasing birth weight, and increases with increased placental weight 
and placental ratio (Perry et al, 1995). Care should be taken when interpreting effects 
on placental ratio as it is not known whether the effect is on the birthweight or the 
placental weight.
No other effect of NVP on outcome was observed. This is supported by other studies, 
where no effect of NVP on outcome was observed, except on reducing risk of 
miscarriage (Flaxman and Sherman, 2000). However, due to the fact that the numbers 
required to achieve 80% power based on birth outcomes was not achieved, the 
relationship between NVP and pregnancy outcomes such as birth and placental weight 
cannot be considered.
7.4 Nutritional intake in early pregnancy
In general, the energy and nutritional intake of the women in this study compared well 
with the DRV for pregnant women. The energy intake was slightly lower than DRV, 
but this could be due to imderreporting by the women. Folate levels were slightly 
lower, but this does not take into consideration folate supplements, which most 
women were taking. Vitamin D levels were also lower than DRV values but dietary 
vitamin D is not a main soiuce of this nutrient. Iron levels were also lower, but none 
of the women reported that they were anaemic, or that they had been advised to take
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iron supplements. Finally selenium levels were lower than the DRV values. This is 
similar to the findings of Mathews and Neil (1998), who carried out a .study on 774 
pregnant women in the second trimester of pregnancy, using 7 day semi-quantitaive 
food diaries.
Mathews and Neil (1998) reported that vitamin D intakes in their cohort were far 
below the RNI of 1 Oug/day, and are unlikely to be achieved without supplementation. 
However the main evidence on which the RNI is set comes from a non randomised 
trial of Vitamin D supplementation in Scottish women, which made no assessment of 
intake from food, and suggested that supplementation reduced the incidence of infant 
hypocalcaemia and defects of dental enamel. Mathews and Neil (1998) suggested that 
vitamin D synthesis may be somewhat higher in women from the south of England, 
such as the cohort they describe in Portsmouth and oui' study in Guildford. The 
authors suggest that it may be appropriate to reassess the recommendation that all 
pregnant women should have vitamin D intakes of 1 Oug/day as further research 
becomes available.
Mathews and Neil (1998) also reported that mtalces of iron in their cohort were low in 
comparison with the DRVs. However given that women found to be anaemic by 
routine antenatal haematology are normally prescribed iron supplements, severe iron 
deficiency in pregnancy seems unlikely with cuirent practices of care.
The findings of low selenium intakes in this study as well as the study by Mathews 
and Neil (1998) is consistent with tlie report by Rayman et al (1996) which reported 
low serum concentrations of selenium in pregnant British women compared with
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studies world-wide. Mathews and Neil (1998) suggested that some care should be 
taken into consideration in interpreting these findings because the seleniiun content of 
individual foods is known to vary widely, and thus it is unclear" how adequately food 
diaries used in conjunction with the Nutrient Databank can assess intake of this 
nutrient. Moreover, many foods in the databank have missing values for this nutrient. 
True intakes of selenium may therefore be considerably higher than those calculated. 
Mathews and Neil (1998) stated that in addition to the difficulties of measur ement 
error, there is also uncertainty about the fimctional significance of low selenium 
intakes and circulating concentrations in pregnancy, compar ed to the well- 
docmnented adverse effects of high intakes. Mathews and Neil (1998) specified that 
more research is needed before advice about supplementation witli seleniiun can be 
given with confidence to pregnant British women.
7.4.1 Effect of NVP on nutritional intake in early pregnancy
Women with NVP consume less riboflavin, biotin, calcium, magnesium, potassium, 
phosphorus, zinc and copper compared to women without NVP (it is important to 
remember that this does not include nutritional supplements). This could be due to the 
reduced intakes in women with NVP compared to women without NVP.
Alternatively, the reduced intake resembled that of women witli aversions, these 
women had lower intakes of carbohydrate, iron and riboflavin, and a trend for lower 
intakes of calcium, zinc, copper and vitamin Bg. However due to the small sample 
size, we could not test whether women witli NVP were at greater risk of aversions, 
but it was found that the majority of women with aversions had NVP. On examination 
of the foods avoided by women in pregnancy, which were meat, vegetables and 
chocolates, it was observed that these are good sources of calcium, vitamin Bg,
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magnesium, potassiimi, copper and zinc. In oui" retrospective study (see chapters 2-4), 
it was also found that NVP was highly related to aversions in pregnancy.
There are only a few studies, which have looked at the effect on NVP on nutritional 
intake in pregnancy.
The earliest study was carried out by Beal et al (1971) and was a prospective study of 
95 pregnancies in 54 women in America. The study found no effect of NVP on energy 
intake; some women increased their intake and others decreased. They found that a 
greater percentage of women with nausea changed their caloric intake compared to 
women without nausea, but the magnitude of change was similar* in the two groups. 
Women with minimal or moderate nausea were equally likely to increase or to 
decrease intake in the first trimester, but women with severe nausea were more likely 
to decrease their intalce.
In another prospective study carried out by Teirson et al (1986) on 414 women in 
America, using both 24 hour recall and 7 day diet liistories, it was found that there 
was a significant positive association between the total days of nausea experienced 
and an increased intalce of sodium dming week 12. A significant negative association 
was fomid between the total days of nausea and the intake of niacin during week 12. 
Also the total number of days of vomiting was negatively associated with intakes of 
both potassium and vitamin A.
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In a more recent study in Southampton, Robinson et al (2001) using a food frequency 
questionnaire at 15 weeks gestation with the exception of women with severe NVP, 
energy intake was not reduced in early pregnancy as a result of NVP.
7.4.2 Effect of nutrition in early pregnancy on pregnancy outcome
In our study, there were positive associations found between vitamin Bg and iron and 
birth length. Vitamin B12 was negatively associated with APGAR scores. The thi*ee 
nutrients; thiamin, iron and folate were also positively associated with placental 
weight. Negative associations were found between potassium and vitamin C and PI, 
selenium and birth weight, and between selenium and gestational age.
These relationsliips seen in this study will be discussed below, however not all the 
relationships have been reported in the literatuie, thus only the associations found in 
the literatur e will be reported here.
• Selenium
The negative relationship seen between selenium intakes and birth weight and 
gestation age is similar* to findings of Langley-Evans and Langley-Evans (2002), who 
also found that selenium intakes were negatively related to birth weight. However, as 
mentioned in section 7.4, care should be taken in the interpretation of the findings of 
selenium due its variation in foods and missing data in the nutrient data banlcs.
• Iron
Iron deficiency can result not only in reduced oxygen carrying capacity due to lower 
haemoglobin levels but also can affect immunity and growth and development. A vast 
body of literature suggests that iron deficiency has adverse effects on birth outcomes,
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such as LEW, prematurity and perinatal mortality, but evidence that iron 
supplementation has an effect on improving fetal outcome is not conclusive 
(Ramala'ishnan et al, 1999). In this study, there was a positive relationship between 
iron intakes and infant length and placental weight. There is evidence that there is a U 
shape relationship between maternal haemoglobin status and birth outcomes. For 
example a study by Godfrey et al (1991) on 8684 women studied retrospectively, 
found that large placentas were associated with low maternal haemmoglobin levels 
and also a higher placental ratio in women with most severe anaemia and most fall in 
mean cell volume. This is probably due to placental hypertrophy that is 
disproportionate to fetal gi'owth. It is important to remember that only haemoglobin 
levels were examined and that other measures were not considered such as serum 
feiTitin, transferrin saturation, also anaemia may be due to other nutiitional factors 
such as folate and (Ramakrislman et al, 1999). However, in oui* study, the 
relationship observed between iron intakes and pregnancy outcomes was based on 
dietary methods rather than biochemical markers of iron status.
• Thiamin
The finding that thiamin was positively related to placental weight has been seen in 
animals. Ramalaislman et al (1999) reported that thiamine deficiency in rats has been 
shown to cause severe lUGR in the progeny as indicated by reduced body weight, 
placental weight and liver weight. As for humans, Ramaki*islman et al (1999) cited a 
study by Heinze and Weber (1990) which found that blood cell thiamin between the 
28^ to the 39^ '^  week was lower in women with lUGR compared to normal 
pregnancies. Doyle et al (1990) found that thiamin and niacin intakes were related to 
birth weight and head circumference. However the authors reported that these two
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nutrients camiot be separ ated from each other or from other B vitamins such as 
riboflavin and pyridoxine because they are clustered together in the same foods and 
the maternal intakes were highly correlated with one another,
• Vitamin Bg
The positive association between vitamin B6 and infant length has not been reported 
in other studies. Ramalaislman et al (1999) reported that in animal studies it has been 
shown that maternal B6 deficiency can have harmful effects on the fetus, however, 
this is not well studied in humans. Ramakrishnan et al (1999) cited a double blind 
randomly controlled trial by Schuster et al (1981) which found that infants of mothers 
taking 7.5rng or more of supplemental pyridoxine had a significantly higher one 
minute APGAR score compared to infants of mothers who received less than 5 mg. 
No difference was seen in 5 minute APGAR scores. No differences were seen in birth 
weight, length or placental weight, although the authors concluded that this could be 
due to the small sample size of 50 women.
• Folate
A positive association was seen between folate intakes and placental weight. 
Similarly, Mathews et al (1999) conducted a prospective study on 693 women in 
Portsmouth and found that placental weight was positively associated with intakes of 
vitamin C, vitamin E and total folate, the associations remained even after adjustment 
for maternal height. However, after adjustment for vitamin C intake, no other nutrient 
independently affected placental weight. Scholl and Jolmson (2000) in their literatirre 
review found that folate deficiency was associated with both birth weight and 
gestation age. The authors also reported that folate deficiency also interferes with
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growth of the conceptus, maternal eiytlii'opoeisis, growth of the uterus and mammaiy 
gland and growth of the placenta. Ramakrislman et al (1999) in their review reported 
that there is some evidence that folate deficiency may be related to LBW and 
prematurity, as in rapidly dividing cells, folate deficiency may lead to alterations in 
DNA syntliesis and cluomosomal aberrations. However, the data are still conflicting 
and there is an absence of good experimental studies to examine the benefits of folic 
acid in reducing the LBW, prematmity and other complications. However, there was 
no mention of any effect on placental weight.
The differences seen between the findings of oui* study and those reported in the 
literature could be due to different population sizes and different techniques used. In 
addition, in some studies, biochemical markers were used as opposed to nutritional 
intalce.
It is interesting to note that the effect of nutrients on outcome differ in women with 
NVP compared to those without NVP. In women with NVP positive relationships 
were seen between placental weight and iron intake and birthweight and iron intake. 
Negative relationships were seen between head circiunference to length ratio and 
vitamin Bn intalces and between potassium intakes and pondéral index.
In women without NVP, positive relationships were seen between IGF-1 and energy, 
carbohydrates, iron and sodium intakes. Negative relationships were seen between 
head circumference to length ratio and protein intakes.
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These valuations in relationships between nutrition and outcome in women with NVP 
and those without NVP could be tliat the factors that might be contributing factors of 
NVP, such as elevated hormonal levels, lead to this variation in effects of nutrients on 
outcome. Alternatively, owing to the small sample size and inaccuracies in food 
records and food tables, care must be taken in interpreting these findings. In addition 
there was a difference in the number of women in the no NVP group compared to the 
NVP group which could have affected tlie analysis.
It is interesting to see that although women with NVP were foimd to have 
significantly higher cord blood IGF-1 concentrations, there was no relationship 
between IGF-1 concentrations and energy intakes in women with NVP. Thus the 
effect of NVP on IGF-1 could be due to some factors such as honnones which ai*e 
causing the NVP. These hormones could lead to better nutritional partitioning in the 
women with NVP, thus a higher cord blood IGF-1. Thus NVP has an effect on intake, 
and intake has an effect on outcome, however, the effect of NVP on IGF-1 is probably 
not thi'ough the effect of diet, but other factors such as hormones.
7.5 Nutritional intake in late pregnancy
In this study, it was found that energy and nutrient intake in the third trimester was 
statistically significantly lower than that in the first trimester. This is supported by a 
number of studies. Beal et al (1971) also found a decrease in energy intalce in the third 
trimester mainly due to decreased fat and carbohydrate intake. Beal et al (1971) 
hypothesised that the decrease in intake could be due to efforts to control weight gain 
or a decreased appetite due to reduced physical activity. In addition the decreased 
intake could be due to the increase m fetal size leading to discomfort upon eating.
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Godfrey et al (1996) reported an intake in eaiiy pregnancy of 2329 kcal and later of 
2314 kcal, however tliey did not report whether these were significantly different. On 
the other hand, Mathews et al (1999) found an increase in intalce. This could be due to 
a variation in the methods used where Mathews et al (1999 ) used a 7 day diet diaiy 
followed by a food frequency questiomiaire. Food frequency questionnaires usually 
lead to higher level of nutrients (Robinson et al, 1996).
7.5.4 Effect of NVP on intake in late pregnancy
Magnesium and potassium intakes in the third trimester were found to be higher in 
women without NVP.
7.5.5 Effect of nutritional intake in late pregnancy on pregnancy outcomes
To summai'ise the findings of this study, positive relationships were seen between 
pondéral index and sodium intake and between gestational age and copper intake. 
Negative associations were found between APGAR scores and energy intalces.
Similar to nutritional intakes in early pregnancy, the effect of nutritional intake on 
pregnancy outcome differed in women with NVP compared to women without NVP. 
As in section 7.4.2, only relationships seen m the literature will be discussed below.
• Copper
The finding of a positive association between copper intake and gestational age is 
supported by the study by Doyle et al (1990) which found that length of gestation was 
correlated to the intake of copper, phosphorus, calcium, iron, chloride, sodiimi and 
magnesiimi in women who delivered pre-term infants.
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It is important to remember that many nuti’ients are interrelated and thus the effects on 
outcome may not be due to a specific nutrient, but rather due to a group of nutiients. 
This data is consistent with the findings of Mathews et al (1999) in that birth weight 
was not strongly related to maternal nuti'itional status either in eai’ly or late pregnancy, 
however like us, Langley-Evans and Langley-Evans (2002) reported relationships 
between nutrient intalces and infant body proportions. These observations that 
micronuti'ient intakes may be associated with body proportions at birth ar e consistent 
with the assertions of Barker and in general support the hypothesis that nutritional 
programming effects upon fetal development may manifest as readily measuiable 
markers at birth such as fetal size and thinness at birth, which may have implications 
for later life.
Thus a healthy well-balanced diet is important for pregnant women as well as all of 
women of child-bearing age. Maternal nutritional status at the time of conception is an 
important determinant of embryonic and fetal giowth (Doyle et al, 1990). The embryo 
is vulnerable to the effects of poor maternal diet dming the first few weeks of 
development, often before pregnancy had been confirmed. Cell differentiation is most 
rapid at this time and any abnormalities in cell division camiot be corrected at a later 
stage. Improving nutritional status in women prior to pregnancy has a beneficial effect 
on birth outcome. If all pregnant women were to eat a balanced varied and adequate 
diet, this would help to correct nutritional imbalances and would help to ensure that 
the fetus has the best nutritional enviromiient in which to develop.
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7.6 Study limitations
Apai't from the date nausea stalled, which was always retrospective, detailed 
prospective data were obtained. It has therefore been possible to describe in detail the 
condition and some featui'es of the natural history of NVP. Drawing women’s 
attention to nausea and vomiting by using a daily diary may result in greater accuracy 
of reported symptoms. Wliile vomiting is a clear* end point, the reporting of which is 
unlikely to be affected, nausea must be a personal judgement, but there is no reason 
why this should influence the overall episodic pattern of symptoms. Gadsby et al 
(1993) cited Morell and Wale (1976) who stated that they found that patients who 
keep health diaries give more accurate information than those recalling symptoms.
Seven day semi-quantitative food diar*ies are considered to give a good estimate of 
nutrient intake compared with other techniques (Bingham and Nelson, 1991), and are 
likely to achieve better* response rate than weighed methods. The usual concerns about 
the adequacy of nutritional databases, the validity and repeatability of dietary records, 
and the natm al var iability in the nutrient composition of food, should nevertheless be 
considered when interpreting the results of this study (Mathews and Neil, 1998). In 
addition, estimated food records do not give accm ate estimates of the intakes of most 
of the micronutrients, thus care should be taken in interpreting the relationships with 
micronutr ient intakes, especially as the sample size in this study was small.
Our fairly homogenous sample of highly educated, white women of high socio­
economic status limits the generalizability of the findings, hi addition, the small 
sample size of this study also limits the generalizability of our findings.
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This study had taken the cut off limit for statistical significance to be 5%. Cut off 
limits of 1% can be used in order to be more confident of the associations seen.
In this study we only measured cord blood IGF-1 levels. However, the effect of NVP 
on cord blood IGF-1 could be mediated by several factors which need to be measured 
before it can be understood how NVP affects fetal IGF-1.
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8. CONCLUSION
The incidence of NVP in the Guildford area was found to be aroiuid 70%, similar to 
the findings of otlier studies (Broussaid and Richter, 1998).
NVP was fomid to occur more often in non-smokers, women of higher education, 
higher parity in the retrospective study. In the prospective study NVP was found to 
occur more often in women of younger age.
Although NVP has been associated with increased birth weight and gestational age, 
no such association was seen in this study. However, the factors which may lead to a 
beneficial effect were investigated. Women with NVP were not found to consume 
either a smaller or larger intake, however, it was found that NVP had an effect on 
quality of the diet. This study found a very strong association between NVP and 
cravings and aversions in pregnancy, with the most commonly avoided foods being 
tea, coffee, vegetables, strong tasting and spicy foods. This data provides sound 
evidence to support the maternal fetal protection hypothesis, which states that NVP 
protects the mother fi om the ingestion of potentially harmful foods.
A new finding was the relationship between NVP and cord blood IGF-1 
concentrations, with IGF-1 concentiations increasing with increased severity of NVP. 
This effect seems to be regai'dless of nutritional intake, unlike in women without 
NVP. Some possible causes of this elevated lGF-1 concentrations could be due to the 
hormones which cause NVP, genetic conflict or maternal enviromnent pre-pregnancy.
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Another novel finding is the effect of duration of NVP on reducing placental ratio. 
This is important as Barker and his colleagues have shown relationships between 
increased placental ratio and hypertension in later life.
NVP does not guarantee a healthy pregnancy, nor does lack of it mean pregnancy 
failure, but it seems that that NVP has served an evolutionary protective fimction and 
should be considered as an adaptive rather than a pathological condition (Flaxman and 
Sherman, 2000; Forbes, 2002).
Flaxman and Sherman (2000) reported that there is no reason to believe that 
alleviating symptoms of NVP will improve the outcome of pregnancy. Indeed it could 
have an opposite effect if it does not prevent the expulsion of potentially hannful 
foods. Also discomaging women from avoiding foods to which they develop 
aversions could be detrimental if it means eating potentially harmful foods. However, 
more thorough testing of the maternal fetal protection hypothesis is needed before 
dietary practices based on this hypothesis ar e adopted.
8.1 Future Work
More thorough testing of the maternal and fetal protection hypothesis could be 
conducted first in animals such as rats to assess whether foods that cany teratogens 
are avoided dming pregnancy and whether such diet choice reduce the incidence of 
birth defects or spontaneous abortion (Forbes, 2002). As for humans, further 
observational work using larger sample sizes are needed.
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Further work is also needed to understand how nutrients influence normal fetal 
development and the extent to which deficits or excesses in select nutrients can trigger 
specific aberrant pathways. An understanding of how nutrients act to regulate 
embiyonic development requires an appreciation of a vai'iety of diverse processes 
including maternal nutiient metabolism, yolk and placental nutrient metabolism and 
transport, embiyonic and fetal nutrient metabolism and ontogenic changes in gene 
nutrient interactions. Models of whole annuals to cells culture need to be used to 
study the influence of essential nutrients on developmentally important processes at 
discrete stages of development (Hirshi and Keen, 2000).
The study of placental nutrient transport is still in its infancy (Jansson and Powell, 
2000) and much more reseai'ch is needed in the aiea of fetal growth and placental 
function, using a variety of methods such as molecular* biology to whole animal 
physiology. Also studies in pregnant women using doubly labelled stable isotope 
teclmiques will be valuable to obtain an understanding of the metabolism and 
transport of nutrients in vivo.
In conclusion, further studies, with lar'ger nmnbers using measurements of other 
hormones, biochemical mar'kers of nutritional statirs and on a wider population will be 
needed before any definite statements can be made about the effect of NVP on 
nutrition and outcome. In this study multiple testing was used to find relationships 
between factors related to NVP and factors related to outcome. Further studies could 
be conducted to look at specific nutrients or factors of interest. This would malce the 
statistical analysis stronger. Recently there has been much interest and research in the
236
ai*ea of NVP, which should offer further explanations on how this condition arises and 
how it has its effects.
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APPENDIX I
INSTRUCTIONS
• Please tick or fill in all the appropriate boxes.
• Some questions may have more than one answer, please tick all the boxes that 
apply to you.
• Some questions ask you to explain or describe your answer, please write it on the 
provided line.
• In section B, it is preferable if  the father completes his section. However, if this is 
not possible, please tick the box at the top of this section and try and answer as 
much of the section as you can.
• Not all the questions may apply to you.
Wlien you have finished, please post the questionnaire and one consent form to us 
in the pre-paid envelopes provided, even if you were not able to answer all of the 
questionnaire. We would be grateful if you could send the questionnaire back 
to us as soon as possible and preferably within 1 months tim e.
WE SHALL BE VERY GRATEFUL FOR YOUR HELP AND TIME.
SECTION A-INFORMATION ABOUT MOTHER
1. Date of birth□□ □□ □□
Day Month Year
2. Maiital status □ □
Single Living with husband/partner
3. Pre-pregnancy weight (in kilograms or stones and pounds)
4.What was your weight gain by the end of your pregnancy? (kilograms or 
stones and pounds)
5.Your birth weight (if known)
6. Your height (in meters or feet and inches)
7. a)Occupation.□ □
Paid employment Full time mother
Current or previous job title description
8. a) Did you smoke prior to your pregnancy?
□ □
Yes ' No
If yes, how many cigarettes per day did you smoke?□ □ □
1-9 10-20 >20
b) Did you smoke during your pregnancy?
□ □
Yes No
If yes, how many cigarettes per day did you smoke?□ □ □
1-9 10-20 >20
9. a)Did you drink alcohol prior to your pregnancy?□ □
Yes No
If yes, how many units per day did you drink? (1 unit = half a pint of beer, 1 
glass of wine, 1 measure of spirit such as gin or vodka)□ □ □
1-2 3-4 >4
b) Did you drink alcohol during your pregnancy?
□ □
Yes No
If yes, how many units per day did you drink? (1 unit = half a pint of beer, 1 
glass of wine, 1 measure of spirit such as gin or vodka)□ □ □
1-2 3-4 >4
10. Is this baby your first child?□ □
Yes No
If no, please write the number of children that you have, and their dates of 
birth (d.o.b) (excluding this baby)
11. a)Did you take any nutritional/dietary supplements pre-pregnancy?□ □
Yes No
If yes, please specify
b)Did you take any nutritional/dietary supplements throughout the pregnancy?□ □
Yes no
If yes, please explain eg Iron, Vitamin C, Multi Vitamins, and when did you 
start taking them.
12.Did you suffer firom nausea and/or vomiting during this pregnancy?
□ □
Yes no
IfnOi please go to question 20,
If yes, was it □ □ □
Mild moderate severe (hyperemesis gravidarum)
(nausea) (nausea
and vomiting)
13. At what time of day did the nausea and/or vomiting tend to occur?□ □ □ □
Only only a few the whole day (24hrs)
Mornings • nights hours/day
14.a) At what stage in your pregnancy did the nausea and vomiting start?
b) How long did the period of nausea and/or vomiting last ( days, weeks, 
months) ?
15.Were you hospitalised due to the nausea and/or vomiting?□ □
Yes no
16.Did the nausea and vomiting cause you to eat
□ □ □
more less the same
17. a)Did the nausea and/or vomiting cause you to avoid certain foods ?
□ □
Yes no
If yes, please explain which foods you avoided.
b) Where there any foods that you ate more of as they helped reduce the 
nausea and/or vomiting?
□ □
Yes no
If yes, please explain which food you at more of.
18.a)Did you seek help for the nausea and/or vomiting?□ □
Yes * no
b)Was this (please tick one or more)□ □ □
Anti sickness alternative other
Tablets therapy (please specify)
(please specify)
19.Did any foods, medication, alternative remedies, help to alleviate the 
symptoms? Please explain.
20.a)Did you suffer from dietaiy aversions during pregnancy?□ □
Yes no
Please explain (ie the foods you avoided and why)
b) Did you crave any foods during your pregnancy?□ □
Yes no
Please explain (ie the foods you craved and why)
21.Did you receive any dietary advice during pregnancy?□ □
Yes no
If yes, who was this from, (please tick one or more)
“ Doctor
- Midwife
- Dietitian
- Magazine
- Book
- Relative
- Friend
- Leaflets eg. From supermarkets
- Other (please specify)_______________________
22. Ethnic originn  White □
L-j Black Caribbean □
I—] Black African □
O  Black other
please specify
CD Chinese
Other
Indian
Pakistani
Bangladeshi
Please specify
23. Which of the following qualifications have you obtained? 
C g CSEs or equivalent 
C ]  A  levels or equivalent 
CU degree/ post A level education 
[ ]  other please specify
24. Approximate household income/year before tax is deducted is in the range
□ □ □ □ □
Upto £10,000- £20,000- £30,000- over
£9,999 £19,000 £29,000 £39,000 £40,000
SECTIONS  -  ABOUT FA TfTER
If the father is hot able to complete this section, please tick the box below and 
try and fill this section as much as possible.
It IS not possible for the father to complete the questionnaire
1. Father’s date of birth□□ □□ □□
Day Month Year
2. Father’s height (in meters or feet and inches)
3. Father’s own birth weight -  if  known (in kilograms or pounds)
4. Does the father smoke ?
□ □
Yes No
If yes, how many cigarettes per day does he smoke?□ □ □
1-9 10-20 >20
5. Occupation.□ □
Paid employment Unemployed
Current or previous job title description
6. Ethnic origin
CU White □
CU Black Caribbean □
L -j Black African □
CU Black other
please specify
CU Chinese
O  other
Indian
Pakistani
Bangladeshi
Please specify_
7. Which of the following qualifications has the father obtained?
C D g CSEs or equivalent
E U â  levels or equivalent
C U  degree/ post A level education
CH other please specify
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SECTION c -  INFORMATION ABOUT BABY
Some of the information may be obtained from your baby’s booklet
1. Baby’s date of birth
□□ □□ □□
Day Month Year
2. a)Baby’s birth weight (kilograms or pounds)
b) Baby’s length at birth (centimetres or inches) -  if known
c) Baby’s head circumference at birth (centimetres or inches)- if known
3. Baby’s gender
□ □
Male Female
4.Baby’s gestational age (weeks)
ie. At how many weeks of pregnancy did you give birth?
S.Number of babies delivered (ie. 1 for single, 2 for twins etc)
11
If you have any exti'a information that you may wish to add, please write it here.
12
THANK YOU FOR COMPLETING THIS 
QUESTIONNAIRE.
rr SHOULD PROVIDE us WITH VERY VALUABLE INFORMATION 
AS WELL AS BENEFITTING FUTURE MOTHERS AND THEIR
BABIES.
DR D.R. ELLIOTT ST LUKE'S SURGERY
DR J.G. WILLIAMS WARREN ROAD
DR A. P. CROSS GUILDFORD
DRJ.N.BARNARDO GU13JH
DR MARV MORRISON ^  Jow g 304379
INFORMATION
Dear
I am writing to ask for your help in a study into maternal nutrition and pregnancy outcome that is 
being carried out by the University of Surrey.
We are interested in the mother’s diet before and during her pregnancy, and how that affects the 
outcome of the pregnancy (such as birth weight and gestational age). In order to test this effect, we 
have to ask about other factors eg. mother’s background, father’s backgroimd and information about 
the pregnancy. This information, in addition to questions regarding maternal diet, will allow us to 
assess the relationship of maternal diet and the outcome of pregnancy.
We have chosen to look at all births from St.Luke’s Surgery in the past year, and I understand that 
you have given birth during that timerhence your name has been included in this selection.
All partners at St.Luke’s are in agreement to take part in this study.
I realize how busy you are with a new baby, but I would be very grateful if you could spare the time 
to fill in the enclosed questionnaire ,it should take about 15 minutes of your time._________ ______
The results of this study will help us in conducting ftirther studies. Moreover, we hope they will 
benefit future mothers and their babies.
Participation in this study is entirely voluntary. If you choose not to take part, this will in no way 
affect the care you receive in the future. If you do decide to take part in this study, please fill in and 
sign both consent forms provided, as well as answering the questionnaire. Please return the 
questionnaire in the pre-paid envelope marked questionnaire and one consent form in the pre-paid 
envelope marked consent form as soon as possible (preferably within one months time). The 
second consent form, as well as the information sheet is for you to keep.
The information you give to us is treated in strict confidence, and you will be identified by a code 
number only. No information about yom* name or address will be given to any members of the public 
or press. The results of this survey will be shown as statistics only.
This study has been approved by the South West Surrey Local Research Ethics Committee.
Thank you in advance for your help.
Yours faithfully,
Supported By 
Dr D R Elliott 
Dr 3 G Williams 
Dr A P Cross 
Dr 3 N Bernardo/^
Dr Mary Morrison
tvv
L \.
P.S If you have any queries regarding the questionnaire, please do not hesitate to contact
Buthaina Al-Rasasi
EMMS
Duke of Kent Building 
Levels
University of Surrey 
GU2 5TE
Telephone: 01483 300 800 
Ext 4580
( Calls preferably between 9:00 a.m and 5:00 p.m)
a ppe n d ix  III
REFERENCE NUMBER □  □  □  □
CONSENT FORM
MATERNAL NUTRITION AND PREGNANCY OUTCOME
1. I CONFIRM THAT I HAVE READ AND UNDERSTOOD □
THE INFORMATION SHEET DATED FOR
THE ABOVE STUDY.
2. I UNDERSTAND THAT MY PARTICIPATION IS VOLUNTARY □  
AND THAT WITHDRAWAL FROM THE STUDY AT ANY STAGE 
WILL NOT AFFECT MY CARE.
3 .1 AGREE TO TAKE PART IN THIS STUDY □
NAME OF PARTICIPANT, 
DATE
SIGNATURE
NAME OF RESEARCHER A&-
DATE  l l - Q - z  - 9 o Q O
SIGNATURE
a ppe n d ix  IV
REMINDER LETTER
/
Dear Madam,
I contacted you several months ago to ask for your help with a study on Nausea and Vomiting in 
Pregnancy, Maternal Nutrition and Pregnancy Outcome.
My records show that I have not yet received your questionnaire.
If you have already sent your questionnaire, please ignore this letter. -  .
However, if not, please fill in the consent form and questionnaire and post them in the pre paid 
envelopes provided, within two weeks if possible.
If you require a new questionnaire, please contact me at the address below.
I would really appreciate it if you could take part in this study. It should only take 15 minutes of your 
time.
The results of this study should help future mothers and then children.
Yours Faithfully,
"Huthaina Al-Rasasi 
EIHMS,
Duke of Kent Building, 
University of Surrey, 
GU2 5TE
Tel: 01483 300 800 
Ext. 4580
Or
Mobile:0403 312 834.
a ppe n d ix  V
1. Code 
Type 
Values 
Missing
2. dobm 
Variable name 
Type 
Values 
Missing
3. agem 
Variable name 
Type 
Values 
Missing
4. mar 
Variable name 
Type 
Values
Missing
5. pre-preg 
Variable name 
Type 
Values 
Missing
6. wtgain 
Variable name 
Type 
Values 
Missing
7. bwtm 
Variable name 
Type 
Values 
Missing
8. htm 
Variable name 
Type 
Values 
Missing
Numeric
None
999
mother’s date of birth
date
None
None
mother’s age 
numeric 
None 
999
marital status 
numeric 
1= single
2 -  living with husband/partner 
999
pre-pregnancy weight(kg)
numeric
None
999
weight gain during pregnancy (kg)
numeric
None
999
mother’s birth weight(kg)
numeric
None
999
mother’s height(m)
numeric
None
999
1. Code 
Type 
Values 
Missing
2. dobm 
Variable name 
Type 
Values 
Missing
3. agem 
Variable name 
Type 
Values 
Missing
4. mar 
Variable name 
Type 
Values
Missing
5. pre-preg 
Variable name 
Type 
Values 
Missing
6. wtgain 
Variable name 
Type 
Values 
Missing
7. bwtm 
Variable name 
Type 
Values 
Missing
8. htm 
Variable name 
Type 
Values 
Missing
Numeric
None
999
mother’s date of birth
date
None
None
mother’s age 
numeric 
None 
999
marital status 
numeric 
1= single
2= living with husband/paitner 
999
pre-pregnancy weight(kg)
numeric
None
999
weight gain during pregnancy (kg)
numeric
None
999
mother’s birth weight(kg)
numeric
None
999
mother’s height(m)
numeric
None
999
L _
15, unitspre 
Variable name 
Type 
Values
Missing
16. etohpreg 
Variable name 
Type 
Values
Missing
17. untpreg 
Variable name 
Type 
Values
Missing
units alcohol/day during pregnancy 
numeric 
,1= 1-2 
2=3-4 
3= >4
4= <l/week 
999
did mom consume alcohol during pregnancy
numeric
l=yes
2= no
999
units alcoho per week during pregnancy 
numeric 
1= 1-2 
2=3-4 
3= >4 
999
18. nochild 
Variable name 
Type 
Values 
Missing
19. supppre 
Variable name 
Type 
Values
Missing
20. suppreg 
Variable name 
Type 
Values
Missing
number of children excluding this child
numeric
none
999
did mom take any nutritional supplements pre-pregnancy
numeric
l=yes
2= no
999
mother’s occupation
numeric
1= full time
2= part-time
3= housewife
999
L..
21.nvp 
Variable name 
Type 
Values
Missing
22. type 
Variable name 
Type 
Values
Missing
23. time 
Variable name 
Type 
Values
Missing
24. stagenvp 
Variable name 
Type 
Values 
Missing
25. long 
Variable name 
Type 
Values 
Missing
26. hospital 
Variable name 
Type 
Values
Missing
did mom suffer from nvp 
numeric 
,l=yes 
2= no 
999
type of nvp 
numeric 
l=mild 
2= moderate 
3= severe 
999
time of day suffered 
numeric
1= only mornings 
2= only nights 
3= few hours 
4= all day 
999
when did nvp start (weeks)
numeric
none
999
how long did nvp last (weeks)
numeric
none
999
was mom hospitalized due to nvp
numeric
l=yes
2= no
999
27. eat 
Variable name 
Type 
Values
how did nvp affect mother’s eating
numeric
l=more
2= less
3= the same
Missing 999
28. avoid 
Variable name 
Type 
Values
Missing
29. more 
Variable name 
Type 
Values
Missing
30. helpnvp 
Variable name 
Type 
Values
Missing
31. aversions 
Variable name 
Type 
Values
Missing
32. cravings 
Variable name 
Type 
Values
Missing
did nvp cause mom to avoid any foods
numeric
l=yes
2= no
999
did nvp cause mom to eat more of some foods
numeric
l=yes
2= no
999
did mom seek help for the nvp
numeric
l=yes
2= no
999
did mom have any aversions
numeric
l=yes
2= no
999
did mom have any cravings
numeric
1= yes
2= no
999
33. advice 
Variable name 
Type 
Values
Missing
34. ethnicm 
Variable name 
Type 
Values
did mom receive any dietary advice
numeric
l=yes
2= no
999
mom’s ethnic origin 
numeric 
1- white
2= black Caribbean
Missing
35. income 
Variable name 
Type 
Values
Missing
36. dobd 
Variable name 
Type 
Values 
Missing
37, weightd 
Variable name 
Type 
Values 
Missing
3= black african 
4= black other 
5= Chinese 
6^= Indian 
7= Pakistani 
8= bangladeshi 
9= other 
999
household income 
numeric 
1= upto 9,999 
2= 10,000-19,000 
3= 20,000-29,000 
4= 30,000-39,000 
5= >40,000 
999
father’s date of birth
date
none
none
father’s weight (kg)
numeric
none
999
38. heightd 
Variable name 
Type 
Values 
Missing
39. bwtd 
Variable name 
Type 
Values 
Missing
40. smoked 
Variable name 
Type 
Values
Missing
father’s height (m)
numeric
none
999
father’s birth weight (kg)
date
none
999
does dad smoke
numeric
l=yes
2= no
999
41. nocigd 
Variable name 
Type 
Values
Missing
number of cigarettes smoked/day 
numeric 
1-9 
2=  10-20 
3= >20 
999
42. occd 
Variable name 
Type 
Values
Missing
43. ethnicd 
Variable name 
Type 
Values
Missing
44. quald 
Variable name 
Type 
Values
Missing
45. dobb 
Variable name 
Type 
Values 
Missing
father’s occupation 
numeric 
1= full time 
2= part-time 
3= unemployed 
999
father’s ethnic origin 
numeric 
1= white
2= black Caribbean 
3= black african 
4= black other 
5= Chinese 
6= indian 
1~  Pakistani 
8= bangladeshi 
9= other 
999
father’s qualifications 
numeric 
1= GCSE ■
2= A-Levei 
3= degree 
4= post degree 
5= none 
999
baby’s date of birth
none
none
none
46. bwtb 
Variable name 
Type 
Values 
Missing
baby’s birth weight (kg)
numeric
none
' 9 9 9
47. lengb 
Variable name 
Type 
Values 
Missing
48. hcb 
Variable name 
Type 
Values 
Missing
49. gender 
Variable name 
Type 
Values
Missing
50. gestatio 
Variable name 
Type 
Values 
Missing
51. number 
Variable name 
Type 
Values 
Missing
baby’s length (cm)
numeric
none
999
baby’s head circumference (cm)
numeric
none
999
baby’s gender 
numeric 
1= male 
2= female 
999
gestational age of baby (weeks)
numeric
none
999
number of babies delivered
numeric
none
999
52. bmi 
Variable name 
Type 
Values 
Missing
mother’ s bmi
numeric
none
999
53. aged 
Variable name 
Type 
Values 
Missing
54. socialm 
Variable name 
Type 
Values
Missing
55. sociald 
Vaiiable name 
Type 
Values
Missing
56, sec
Variable name
Type
Values
Missing
father’s age 
numeric 
none 
999
mother’s social class 
numeric 
1=1 
2=n
3=nin 
4=nim 
5= IV 
6=V
7= unemployed 
999
father’s social class 
numeric 
1=1 
2=11 
3=IIIn 
4= lUm 
5= IV 
6=V
7= unemployed 
999
joint social class 
numeric 
1=1 
2=11 
3=IIIn 
4= Him 
5= IV 
6=V
7= unemployed 
999
57. qual2 
Variable name 
Type 
Values
Missing
mother’s qualifications
numeric
l=post degree
2= degree
3= A-Level
4= GSCE
5= none
999
a pp e n d ix  VI
SOUTH WEST SURREY LOCAL RESEARCH ETHICS COMMITTEE
Postgraduate Medical Centre,
The Royal Surrey County Hospital, Egerton Road 
Guildford, Surrey GU2 5XX 
Tel: 01483 571122 ext 4382 Fax: 01483 303691
Chairman: Professor D L Russell-Jones MD FRCP Co-ordinator: Mr J Kerslake
Our Ref: ECl 18/99
9 February 2000
Miss B Al-Rasasi 
Mole 4 
Surrey Court 
University of Surrey 
GUILDFORD 
GU2 5XH
Dear Miss Al-Rasasi
Morning sickness, maternal nutrition and pregnancy outcome; A Questionnaire Survey
Further to my letter of 18 January I am pleased to inform you that at its meeting held on 25 
January 2000 the Ethics Committee ratified Chairman’s Action and approved the above study.
The Committee’s decision was based on its review of your Application Form dated 23 
November 1999 which enclosed a Protocol, Information letter, Consent Form, Questionnaire 
and GP agreement to the study. The Committee also took account of your response to the 
Committee’s concerns set out in your letter to me dated 15 December 1999 and the 
Information Letter, Consent Form and revised questionnaire which you enclosed with that ‘ 
letter.
The Committee’s approval is subject to the following conditions:
(i) No deviations from or changes of the protocol should be initiated without prior 
written agreement of the Committee.
(ii) The Committee should be provided with a copy of the report on the outcome of the 
study or a copy of any published document.
(iii) If the start of the project is- delayed by more than one year from the date of 
approval the protocol should be resubmitted to the Committee for further review.
Yours sincerely
JOHN KERSLAKE 
Co-ordinator
a ppe n d ix  VII
Unis
15 February 2000
Miss Buthaina Al-Rasasi
European Institute of Health & Medical Sciences
University of Surrey
University 
of Surrey
Guildford
Surrey GU2 5XH. UK 
Telephone
+44 (0)1483 3 0 0 8 0 0  
Facsimile
+44 (0)1483 873811
Registry
Dear Miss Al-Rasasi
Morning Sickness. Maternal Nutrition and pregnancy Outcome:
A Questionnaire Survey fACE/2000/n/EIHMS)
I am writing to inform you that the Advisory Committee on Ethics has considered the 
above protocol and the subsequent information supplied and has approved it on the 
understanding that the Ethics Guidelines are observed.
The letter of approval relates only to the study specified in your research protocol 
(ACE/2000/11/EEHMS). The Committee should be notified of any changes to the 
proposal, any adverse reactions and if the study is terminated earlier than expected 
(with reasons). I enclose a copy of the Ethics Guidelines for your information.
Date of approval by the Advisory Committee on Ethics: 15 February 2000
Date of expiry of Advisory Committee on Ethics approval: 14 February 2005
Please inform me when the research has been completed.
Yours sincerely
Helen Schuyleman (Mrs)
Secretary, University Advisory Committee on Ethics 
Registry
cc: Professor L J King, Chairman, ACE 
Dr Jane Coad, EIHMS 
Dr Jane Morgan, SBS
Morning S ickness in Pregnancy
Morning sickness is very common in pregnancy. It is very likely that you have suffered from it, or 
know someone who has. Momiiig sickness is also known as nausea and vomiting in pregnancy, as it 
can occur anytime during the day, not only in the morning.
Have you ever wondered why some women suffer from  nausea and vomiting in pregnancy and 
others do not? What causes these symptoms? What can be done to reduce it? What effect does it 
have on the outcome ofpregnancy? A study is being carried out by the University of Surrey and 
doctors from Fairlands, Dapdune and St.Luke’s Medical Centres, which is looking to answer these 
questions.
We are looking for women who are suffering from morning sickness, and those women who are not, 
so that we can compare the results. The results of the study should help other pregnant women.
What does this studv involve?
♦ A short interview with a dietitian about your social and dietary history. Your weight and body fat 
will be measured. This should not last more than 15 minutes.
♦ You will be asked to keep a record of your food intake for one week in your early pregnancy and 
for another week towards the end of your pregnancy.
♦ If you suffer from morning sickness, you will be asked to record your symptoms.
♦ On delivery, the weight of your baby, and the placenta will be recorded by the midwife.
All information collected in the study will be kept strictly confidential, and will not be disclosed in 
any way that would allow identification of you or your family. Participation in this study is entirely 
voluntary. If you chose not to take part, this will not affect the care you receive in the future.
Thank you for your co-operation.
For further information, please contact: 
Beth Al-Rasasi
Telephone: 01483 300 800 ext 4580
Address: EIHMS, Duke of Kent Building 
University of Surrey 
Guildford, GU2 7TE
e-mail: b.al-rasasi@surrev.ac.uk
APPENDIX IX
Reference Number
CONSENT FORM
Nausea and vomiting in pregnancy, maternal nutrition and 
Pregnancy outcome: A prospective study.
Researcher: Buthaina Al-Rasasi
EIHMS, Duke of Kent Building, University of Surrey, GU2 7TE 
01483 300 800 EXT 4580 ------
1. I confirm that I have read and understand the information sheet 
for the above study.□
2, I understand that my participation is voluntary and that I am free 
to withdraw at any time, without giving any reason, without my 
medical care or legal rights being affected.□
3. I understand that sections my medical notes may be looked at 
by the researcher only, where it is relevant to the research. I 
give permission for the researcher to have access to my records.□
4. I agree to take part in the study.
University of Surrey
European Institute of Health and Medical Sciences
□
Name of Volunteer 
Date
Signature
Name of Researcher 
Date
Signature
.«az, /b  / a.(Tgo
Please complete all three consent forms, keep one with you, and send the other two in the 
pre~paid envelope provided. One will be kept in your medical records, and the other is for 
the researcher.
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APPENDIX XI
Reference Number
0-
SYMPTOM DIARY
Name
Date Started symptom diary 
Date completed symptom diary
I ''^Researcher Buthaina Al-Rasasi
Instructions\  ---------------------------------------
Please fill this diary on a daily basis, until the nausea and vomiting resolves. 
For days that are symptom free, the diary does not need to be completed. 
Please make sure to date all entries.
Please write down the time you wake up and the time you go to bed.
Your symptoms should be recorded on a half hourly basis.
If you feel nauseous, write the letter ‘N’.
If you vomit, write the letter *V’.
If you suffer from retching, write the letter ‘R’.
Follow the example on the following page.
If you have no symptoms, then leave the box empty.
Some other names for nausea, vomiting and retching include 
Nausea Vomiting Retching
Feeling sick throwing up heaving
Queasy spewing gagging
Bilious chucking up dry boak
Off colour regurgitating diy heaves
Green at the gills puking
Under the weather barfing
Sick at the stomach chundering
Waterbash
• In the end of the diary, there is a section about any measures which you tried to help alleviate the 
nausea and vomiting, this could include foods, medication, alternative therapies. Please mention 
if any of them worked for you.
• Once your symptoms have resolved, and you have had two weeks symptom free weeks, please 
send the symptom diary in the pre-paid envelope provided.
Day |Mo Tue We Thu Sat SunfMo Tue We Thu Sat SunlMo Tue SunjWe SatThu
Time
12:30
01:00
01:30
02:00
02:30
03:00
03:30
04:00
04:30
05:00
05:30
06:00
06:30
07:00
07:30
08:00
08:30
09:00
09:30
10:00
10:30
11:00
11:30
12:00
12:30
01:00
01:30
02:00
02:30
03:00
03:30
04:00
04:30
05:00
05:30
06:00
06:30
07:00
07:30
08:00
08:30
09:00
09:30
10:00
10:30
11:00
11:30
12:00
Time woke up 
"me went to sleep
Measures used ttf help alleviate Nausea and Vomiting
Thank you for completing this diary, it should provide us with valuable 
information.
If you have any queries, please contact 
Buthaina Al-Rasasi 
Tel 01483 300 800 ext 4580 
EIHMS, Duke of Kent BuiIding,Üniversity of Surrey,Guildford,GU2 STB 
e-mail: b.al-rasasi@surrey.ac.rk
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SECTION A -INFORMATION ABOUT MOTHER
1. Date of birth□ □ ■ □□ □□
Day Month Year
2. Marital status □ □
Single Living with husband/partner
3. Pre-pregnancy weight (in kilograms or stones and pounds)
4. Your birth weight (if known)
5.Your height (in meters or feet and inches)
6. a)Occupation.□ □
Paid employment Full time mother
Current or previous job title description
7. a) Did you smoke prior to your pregnancy?
□ □
Yes No
If yes, how many cigarettes per day did you smoke? 
1-9 10-20 >20
b) Did you smoke during your pregnancy?
□ , □
Yes V No
If yes, how many cigarettes per day did you smoke?□ □ □
1-9 10-20 >20
8. a)Did you drink alcohol prior to your pregnancy?□ □
Yes No
If yes, how many units per day did you drink? (1 unit = half a pint of beer, 1 
glass of wine, 1 measure of spirit such as gin or vodka)□ □ □
1-2 3-4 >4
b) Did you drink alcohol during your pregnancy?
□ □
Yes No
If yes, how many units per day did you drink? (1 unit = half a pint of beer, 1 
glass of wine, 1 measure of spirit such as gin or vodka)□ □ □
1-2 3-4 >4
9. Is this baby your first child?□ □
Yes No
If no, please wnte the number of children that you have, and their dates of 
birth (d.o.b) (excluding this baby)
10. a)Did you take any nutritional/dietary supplements pre-pregnancy?□ □
Yes  ^ No?cIf yes, please specify
b)Did you take any nutritional/dietary supplements throughout the pregnancy?□ □
Yes no
If yes, please explain eg Iron, Vitamin C, Multi Vitamins, and when did you 
start taking them.
11.Did you suffer from nausea and/or vomiting during this pregnancy?
□ □
Yes no
I f  nOf please go to question 19,
If yes, was it □ □ □
Mild moderate severe (hyperemesis gravidarum)
(nausea) (nausea
and vomiting)
12. At what time of day did the nausea and/or vomiting tend to occur?□ □ □ □
Only only a few the whole day (24hrs)
Mornings nights hours/day
13.a) At what stage in your pregnancy did the nausea and vomiting start?
b) How long did the period of nausea and/or vomiting last ( days, weeks, 
months) ?
14. Were you hospitalised due to the nausea and/or vomiting?□ □
Yes no
15.Did the nausea and vomiting cause you to eat
□ □ □
more less the same
16. a)Did the nausea and/or vomiting cause you to avoid certain foods ?
□ □
Yes no
If yes, please explain which foods you avoided.
b) Where there any foods that you ate more of as they helped reduce the 
nausea and/or vomiting?
□ □
Yes no
If yes, please explain which food you at more of.
17.a)Did you seek help for the nausea and/or vomiting?□ □
Yes no
b)Was this (please tick one or more)□ □ □
Anti sickness alternative other
Tablets therapy (please specify)
(please specify)
IS.Did any foods, medication, alternative remedies, help to alleviate the 
symptoms? Please explain.
19.a)Did you suffer from dietary aversions during pregnancy?□ □
Yes no
Please explain (ie the foods you avoided and why)
b) Did you crave any foods during your pregnancy?□ □
Yes no
Please explain (ie the foods you craved and why)
20.Did you receive any dietary advice during pregnancy?□ □
Yes no
If yes, who was this from, (please tick one or more)
- Doctor
- Midwife
- Dietitian
- Magazine
- Book
- Relative
- Friend
- Leaflets eg. From supermarkets
- Other (please specify)________________________
21. Ethnic originn  White □
EZ] Black Caribbean □
EZ] Black African □
ED Black other
please specify
O  Chinese
ED Other
Indian
Pakistani
Bangladeshi
Please specify_
22. Which of the following qualifications have you obtained?
CZIg CSEs or equivalent
[Z I a  levels or equivalent
C n  degree/ post A  level education
E D  other please specify
23 .Approximate household income/year before tax is deducted is in the range
□ □ □ □ □
Upto £10,000- £20,000- £30,000- over
£9,999 £19,000 £29,000 £39,000 £40,000
SECTION B -  ABOUT FA THER
If the father is not able to complete this section, please tick the box below and 
try and fill this section as much as possible.
It IS not possible for the father to complete the questionnaire
1. Father’s date of birth□□ □□ □□
Day Month Year
2. Father’s height (in meters or feet and inches)
3. Father’s own birth weight -  if known (in kilograms or pounds)
4. Does the father smoke ?
□ □
Yes No
If yes, how many cigarettes per day does he smoke?□ □ □
1-9 10-20 >20
5. Occupation.□ □
Paid employment Unemployed
Current or previous job title description
6. Ethnie origin
n  White
L—j Black CaribbeanED Black AfricanEU Black other 
please specify___
ED Chinese ED other
Please specify_
ED Indian ED Pakistani ED Bangladeshi
7. Which of the following qualifications has the father obtained? 
^ D  GCSEs or equivalent ED A  levels or equivalent ED degree/ post A level education ED other please specify
APPENDIX Xni
SOUTH WEST SURREY LOCAL RESEARCH ETHICS COMMITTEE
Postgraduate Medical Centre,
The Royal Surrey County Hospital, Egcrton Road 
Guildford, Surrey GU2 5XX 
Tel: 01483 571122 ext 4382 Fax: 01483 303691
Chairman: Professor D L Russell-Jones MD FRCP Co-ordinator: Mr J Kersiake
Our Ref: EC51/00
17 May 2000
Miss B AI-Rasasi 
Mole 4 
Surrey Court 
University of Surrey 
GUILDFORD 
GU2 5XH
Dear Miss Al-Rasasi
Nausea and vomiting in pregnancy, maternal nutrition and pregnancy outcome: A 
prospective study
I am pleased to inform you that at its meeting held on 16 May 2000 the Ethics Committee 
approved the above study.
The Committee’s decision was based on its review of your Application Form dated 28 March 
2000 including appendixeil to 11 inclusive.
The Committee’s approval is subject to the following conditions:
(i) No deviations from or changes of the protocol should be initiated without prior 
written agreement of the Committee.
(ii) The Committee should be provided with a copy of the report on the outcome of the 
study or a copy of any published document.
(iii) If the start of the project is delayed by more that one year from the date of
approval the protocol should be resubmiit'^ ^d to the Committee for further review.
(iv) The Consent Form (appendix 8) and the Information Sheet (appendix 10) should 
both be produced on headed paper.
Yours sincerely
JOHN KERSLAKE 
Co-ordinator
/
APPENDIX XIV
SOUTH WEST SURREY LOCAL RESEARCH ETHICS COMMITTEE
Postgraduate Medical Centre,
The Royal Surrey County Hospital, Egerton Road 
Guildford, Surrey GÜ2 7XX 
Tel: 01483 571122 ext 4382 Fax: 01483 303691
Chairman: Professor D L Russell-Jones MD FRCP Co-ordinator: Mr J Kersiake
Our Ref: EC51/00
7 August 2000
Ms B Al-Rasasai 
EIHMS
Duke of Kent Building 
University of Surrey 
GUILDFORD 
GU2 7TE
Dear Ms Al-Rasasai
Nausea and Vomiting in Pregnancy, Maternal Nutrition and Pregnancy Outcome: A 
prospective study
Thank you for your letter of 4 July.
I am pleased to be able to inform you that the Vice-Chairman has approved the extension of 
recruitment for this study to include St Luke’s Surgery and Dapdune House Surgery.
The Vice-Chairman’s decision is subject to ratification by the Committee when it meets on 12 
September. I will be in touch with you again shortly after that date.
Yours sincerely
P JOfiNKERSLAICE
Co-ordinator
APPENDIX XV
Unis
05 July 2000
Miss Buthaina Al-Rasasi
European Institute of Health & Medical Sciences 
University of Surrey
University of Surrey
Guildford
Surrey GU2 7XH, UK 
Telephone
+ 4 4(0 )1483  3 0 0 8 0 0  
Facsimile
+ 44(0)1483  873811
Registry
Dear Miss Al-Rasasi
Nausea and vomiting in pregnancy, maternal nutrition and pregnancy outcome; 
A perspective study (ACE/2000/52/ErHMS)
I am writing to inform you that the Advisory Committee on Ethics has considered the 
above protocol and the subsequent information supplied and has approved it on the 
understanding that the Ethics Guidelines are observed.
The letter of approval relates only to the study specified in your research protocol 
(ACE/2000/52/EïHMS). The Committee should be notified of any changes to the 
proposal, any adverse reactions and if the study is terminated earlier than expected 
(with reasons). I enclose a copy of the Ethics Guidelines for your information.
Date of approval by the Advisory Committee on Ethics: 05 July 2000
Date of expiry of Advisory Committee on Ethics approval: 04 July 2005
Please inform me when the research has been completed.
Yours sincefëlv
\ p- Helen Schuyleman (Mrs) ^ /V
Secretary, University Advisory Corr^ittee on Ethics 
Registry
cc: Professor L J King, Chairman, ACE
Dr Jane Coad, Principal Investigator, EIHMS
Dr Jane Morgan, Principal Investigator, SBS
Dr J Nichols, Co-Investigator, Fairlands Practice, Guildford
